SY2811 personal page - To The Moon

SY2811

SY2811

No personal profile

21Follow

6Followers

0Topic

0Badge

2022-01-10

I hope the stock price will go up...

Sorry, the original content has been removed

2022-01-10

Thanks for the insight...

Consumer Price Index, Bank Earnings: What to Know This Week

2022-01-03

Good read...

Sorry, the original content has been removed

2022-01-03

Thank you for this review!

Sorry, the original content has been removed

2022-01-09

Wow!

3 COVID Stocks That Will Make Billions in 2022

2022-01-05

Interesting read

3 Top Value Stocks for 2022 and Beyond

2022-01-11

Mmmmm

Nasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022

2022-01-04

A bit too much...

22 Stocks That Could Double Your Money in 2022

2022-01-11

Good read

Toplines Before US Market Open on Monday

2022-01-11

Wow! Must think abt it!

Want $1 Million? 2 Monster Stocks to Buy and Hold for the Next Decade

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4100919763196210","uuid":"4100919763196210","gmtCreate":1640409663975,"gmtModify":1640482926338,"name":"SY2811","pinyin":"sy2811","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":21,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.02.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9006791460,"gmtCreate":1641832013278,"gmtModify":1676533652450,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Ty","listText":"Ty","text":"Ty","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791460","repostId":"1185484249","repostType":4,"repost":{"id":"1185484249","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641813442,"share":"https://ttm.financial/m/news/1185484249?lang=en_US&edition=fundamental","pubTime":"2022-01-10 19:17","market":"us","language":"en","title":"Apria shares surged more than 21% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1185484249","media":"Tiger Newspress","summary":"Apria shares surged more than 21% in premarket trading.Owens & Minor Inc(OMI.N)will acquire home hea","content":"<html><head></head><body><p>Apria shares surged more than 21% in premarket trading.<img src=\"https://static.tigerbbs.com/e592aef572f8e41c7e231247227475a0\" tg-width=\"716\" tg-height=\"598\" width=\"100%\" height=\"auto\"/>Owens &amp; Minor Inc(OMI.N)will acquire home healthcare services provider Apria Inc(APR.O)for about $1.45 billion in cash, the companies said on Monday.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apria shares surged more than 21% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApria shares surged more than 21% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 19:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Apria shares surged more than 21% in premarket trading.<img src=\"https://static.tigerbbs.com/e592aef572f8e41c7e231247227475a0\" tg-width=\"716\" tg-height=\"598\" width=\"100%\" height=\"auto\"/>Owens &amp; Minor Inc(OMI.N)will acquire home healthcare services provider Apria Inc(APR.O)for about $1.45 billion in cash, the companies said on Monday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185484249","content_text":"Apria shares surged more than 21% in premarket trading.Owens & Minor Inc(OMI.N)will acquire home healthcare services provider Apria Inc(APR.O)for about $1.45 billion in cash, the companies said on Monday.","news_type":1,"symbols_score_info":{"APR":0.9,"OMI":0.9}},"isVote":1,"tweetType":1,"viewCount":3414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006791518,"gmtCreate":1641831993359,"gmtModify":1676533652449,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791518","repostId":"1183350392","repostType":4,"repost":{"id":"1183350392","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641819664,"share":"https://ttm.financial/m/news/1183350392?lang=en_US&edition=fundamental","pubTime":"2022-01-10 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1183350392","media":"Tiger Newspress","summary":"U.S. stock index futures were subdued on Monday after posting losses for their first week of the new","content":"<html><head></head><body><p>U.S. stock index futures were subdued on Monday after posting losses for their first week of the new year, while big banks extended gains as U.S. Treasury yields climbed a new two-year high.</p><p>At 8:00 a.m. ET, Dow E-minis were down 63 points, or 0.17%, S&amp;P 500 E-minis were down 22 points, or 0.47% and Nasdaq 100 E-minis were down 151.25 points, or 0.97%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dd2a3781d52dbfcfb386f04e8d1b75eb\" tg-width=\"818\" tg-height=\"259\" referrerpolicy=\"no-referrer\"/><span>*Source From Tiger Trade, EST 08:00</span></p><p>The benchmark 10-year Treasury yield hit 1.80% in early trading - a level last seen in early 2020, having shot up 25 basis points last week in its biggest move since late 2019.read more</p><p>Big banks like JPMorgan Chase &amp; Co(JPM.N), Goldman Sachs(GS.N), Bank of America Corp(BAC.N), Morgan Stanley(MS.N)and Citigroup Inc(C.N)gained between 0.3% and 0.8% in premarket trading.</p><p>Megacap growth companies including Apple Inc(AAPL.O), Amazon.com Inc , Microsoft Corp(MSFT.O), Meta Platforms Inc(FB.O)and Tesla Inc(TSLA.O)fell between 0.2% and 1.1%.</p><p>Goldman Sachs expects the Fed to raise rates four times in 2022, compared to its previous forecast of three.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><a href=\"https://laohu8.com/S/ZNGA\">Zynga</a> (ZYNG) – The online game maker’s shares soared 48.2% in the premarket after it agreed to be acquired by video game makerTake-Two Interactive(TTWO)for $9.86 per share in cash and stock, implying a total deal value of $12.7 billion. Take-Two tumbled 8.9%.</p><p><a href=\"https://laohu8.com/S/LULU\">Lululemon Athletica</a> (LULU) – The athletic apparel maker said it now expects fourth-quarter earnings and revenue to come inat the low end of its projected ranges, saying it had experienced a number of negative consequences from the spread of the Covid-19 omicron variant. Lululemon slid 6.5% in premarket action.</p><p><a href=\"https://laohu8.com/S/APR\">Apria, Inc.</a> (APR) – The home health care services provider agreed to be acquired by health-care equipment and services companyOwens &amp; Minor(OMI) for about $1.45 billion in cash, or $37.50 per share. Apria had closed Friday at $29.72 per share, and its stock surged 24.5% in premarket trading. Owens &amp; Minor shares slumped 9.1%.</p><p><a href=\"https://laohu8.com/S/TLRY\">Tilray Inc.</a> (TLRY) – Tilray gained 3.6% in premarket trading after reporting an unexpected quarterly profit. Revenue increased by 20% from a year earlier on stronger demand for cannabis products, although its sales were below analysts’ forecasts.</p><p><a href=\"https://laohu8.com/S/BEAM\">Beam Therapeutics, Inc.</a> (BEAM) – Beam shares jumped 5.3% in the premarket following the announcement of a new partnership withPfizer(PFE). Pfizer will collaborate with Beam – which specializes in gene editing – to develop therapies for rare genetic diseases.</p><p><a href=\"https://laohu8.com/S/VIAC\">Viacom CBS</a> (VIAC) – ViacomCBS rallied 3.2% in the premarket after Deutsche Bank upgraded the media company’s stock to “buy” from “hold,” based on upbeat prospects for its streaming business and the likelihood of continuing industry consolidation.</p><p><a href=\"https://laohu8.com/S/SBGI\">Sinclair Broadcast</a> (SBGI) – Sinclair is close to finalizing a deal to carry NBA games on its planned new streaming app, according to a Bloomberg report quoting people familiar with the matter. The deal could be announced as soon as this week. Sinclair gained 1.4% in premarket action.</p><p><a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> (SEDG) – SolarEdge was added to the “Conviction Buy” list at Goldman Sachs, which raised the price target for the solar equipment company’s stock to $448 per share from $420 a share. Goldman cites improvements in battery storage capacity as well as the company’s prospects for increasing profit margins. SolarEdge rose 2.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/SWAV\">Shockwave Medical, Inc .</a> (SWAV) –Penumbra(PEN) is exploring a combination with its rival medical device maker, according to people with knowledge of the matter who spoke to Bloomberg. However, Penumbra told Bloomberg in an emailed statement that it is not in discussions with Shockwave to pursue a business combination or similar transaction. Shockwave jumped 6% in premarket trading.</p><p><a href=\"https://laohu8.com/S/DELL\">Dell Technologies Inc.</a> (DELL) – Bernstein upgraded Dell to “outperform” from “market perform,” noting Dell’s approximately six-week backlog in its PC business as well as a relatively high mix of commercial versus consumer business. Dell added 2.4% in the premarket.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stock index futures were subdued on Monday after posting losses for their first week of the new year, while big banks extended gains as U.S. Treasury yields climbed a new two-year high.</p><p>At 8:00 a.m. ET, Dow E-minis were down 63 points, or 0.17%, S&amp;P 500 E-minis were down 22 points, or 0.47% and Nasdaq 100 E-minis were down 151.25 points, or 0.97%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dd2a3781d52dbfcfb386f04e8d1b75eb\" tg-width=\"818\" tg-height=\"259\" referrerpolicy=\"no-referrer\"/><span>*Source From Tiger Trade, EST 08:00</span></p><p>The benchmark 10-year Treasury yield hit 1.80% in early trading - a level last seen in early 2020, having shot up 25 basis points last week in its biggest move since late 2019.read more</p><p>Big banks like JPMorgan Chase &amp; Co(JPM.N), Goldman Sachs(GS.N), Bank of America Corp(BAC.N), Morgan Stanley(MS.N)and Citigroup Inc(C.N)gained between 0.3% and 0.8% in premarket trading.</p><p>Megacap growth companies including Apple Inc(AAPL.O), Amazon.com Inc , Microsoft Corp(MSFT.O), Meta Platforms Inc(FB.O)and Tesla Inc(TSLA.O)fell between 0.2% and 1.1%.</p><p>Goldman Sachs expects the Fed to raise rates four times in 2022, compared to its previous forecast of three.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><a href=\"https://laohu8.com/S/ZNGA\">Zynga</a> (ZYNG) – The online game maker’s shares soared 48.2% in the premarket after it agreed to be acquired by video game makerTake-Two Interactive(TTWO)for $9.86 per share in cash and stock, implying a total deal value of $12.7 billion. Take-Two tumbled 8.9%.</p><p><a href=\"https://laohu8.com/S/LULU\">Lululemon Athletica</a> (LULU) – The athletic apparel maker said it now expects fourth-quarter earnings and revenue to come inat the low end of its projected ranges, saying it had experienced a number of negative consequences from the spread of the Covid-19 omicron variant. Lululemon slid 6.5% in premarket action.</p><p><a href=\"https://laohu8.com/S/APR\">Apria, Inc.</a> (APR) – The home health care services provider agreed to be acquired by health-care equipment and services companyOwens &amp; Minor(OMI) for about $1.45 billion in cash, or $37.50 per share. Apria had closed Friday at $29.72 per share, and its stock surged 24.5% in premarket trading. Owens &amp; Minor shares slumped 9.1%.</p><p><a href=\"https://laohu8.com/S/TLRY\">Tilray Inc.</a> (TLRY) – Tilray gained 3.6% in premarket trading after reporting an unexpected quarterly profit. Revenue increased by 20% from a year earlier on stronger demand for cannabis products, although its sales were below analysts’ forecasts.</p><p><a href=\"https://laohu8.com/S/BEAM\">Beam Therapeutics, Inc.</a> (BEAM) – Beam shares jumped 5.3% in the premarket following the announcement of a new partnership withPfizer(PFE). Pfizer will collaborate with Beam – which specializes in gene editing – to develop therapies for rare genetic diseases.</p><p><a href=\"https://laohu8.com/S/VIAC\">Viacom CBS</a> (VIAC) – ViacomCBS rallied 3.2% in the premarket after Deutsche Bank upgraded the media company’s stock to “buy” from “hold,” based on upbeat prospects for its streaming business and the likelihood of continuing industry consolidation.</p><p><a href=\"https://laohu8.com/S/SBGI\">Sinclair Broadcast</a> (SBGI) – Sinclair is close to finalizing a deal to carry NBA games on its planned new streaming app, according to a Bloomberg report quoting people familiar with the matter. The deal could be announced as soon as this week. Sinclair gained 1.4% in premarket action.</p><p><a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> (SEDG) – SolarEdge was added to the “Conviction Buy” list at Goldman Sachs, which raised the price target for the solar equipment company’s stock to $448 per share from $420 a share. Goldman cites improvements in battery storage capacity as well as the company’s prospects for increasing profit margins. SolarEdge rose 2.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/SWAV\">Shockwave Medical, Inc .</a> (SWAV) –Penumbra(PEN) is exploring a combination with its rival medical device maker, according to people with knowledge of the matter who spoke to Bloomberg. However, Penumbra told Bloomberg in an emailed statement that it is not in discussions with Shockwave to pursue a business combination or similar transaction. Shockwave jumped 6% in premarket trading.</p><p><a href=\"https://laohu8.com/S/DELL\">Dell Technologies Inc.</a> (DELL) – Bernstein upgraded Dell to “outperform” from “market perform,” noting Dell’s approximately six-week backlog in its PC business as well as a relatively high mix of commercial versus consumer business. Dell added 2.4% in the premarket.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183350392","content_text":"U.S. stock index futures were subdued on Monday after posting losses for their first week of the new year, while big banks extended gains as U.S. Treasury yields climbed a new two-year high.At 8:00 a.m. ET, Dow E-minis were down 63 points, or 0.17%, S&P 500 E-minis were down 22 points, or 0.47% and Nasdaq 100 E-minis were down 151.25 points, or 0.97%.*Source From Tiger Trade, EST 08:00The benchmark 10-year Treasury yield hit 1.80% in early trading - a level last seen in early 2020, having shot up 25 basis points last week in its biggest move since late 2019.read moreBig banks like JPMorgan Chase & Co(JPM.N), Goldman Sachs(GS.N), Bank of America Corp(BAC.N), Morgan Stanley(MS.N)and Citigroup Inc(C.N)gained between 0.3% and 0.8% in premarket trading.Megacap growth companies including Apple Inc(AAPL.O), Amazon.com Inc , Microsoft Corp(MSFT.O), Meta Platforms Inc(FB.O)and Tesla Inc(TSLA.O)fell between 0.2% and 1.1%.Goldman Sachs expects the Fed to raise rates four times in 2022, compared to its previous forecast of three.Stocks making the biggest moves in the premarket:Zynga (ZYNG) – The online game maker’s shares soared 48.2% in the premarket after it agreed to be acquired by video game makerTake-Two Interactive(TTWO)for $9.86 per share in cash and stock, implying a total deal value of $12.7 billion. Take-Two tumbled 8.9%.Lululemon Athletica (LULU) – The athletic apparel maker said it now expects fourth-quarter earnings and revenue to come inat the low end of its projected ranges, saying it had experienced a number of negative consequences from the spread of the Covid-19 omicron variant. Lululemon slid 6.5% in premarket action.Apria, Inc. (APR) – The home health care services provider agreed to be acquired by health-care equipment and services companyOwens & Minor(OMI) for about $1.45 billion in cash, or $37.50 per share. Apria had closed Friday at $29.72 per share, and its stock surged 24.5% in premarket trading. Owens & Minor shares slumped 9.1%.Tilray Inc. (TLRY) – Tilray gained 3.6% in premarket trading after reporting an unexpected quarterly profit. Revenue increased by 20% from a year earlier on stronger demand for cannabis products, although its sales were below analysts’ forecasts.Beam Therapeutics, Inc. (BEAM) – Beam shares jumped 5.3% in the premarket following the announcement of a new partnership withPfizer(PFE). Pfizer will collaborate with Beam – which specializes in gene editing – to develop therapies for rare genetic diseases.Viacom CBS (VIAC) – ViacomCBS rallied 3.2% in the premarket after Deutsche Bank upgraded the media company’s stock to “buy” from “hold,” based on upbeat prospects for its streaming business and the likelihood of continuing industry consolidation.Sinclair Broadcast (SBGI) – Sinclair is close to finalizing a deal to carry NBA games on its planned new streaming app, according to a Bloomberg report quoting people familiar with the matter. The deal could be announced as soon as this week. Sinclair gained 1.4% in premarket action.SolarEdge (SEDG) – SolarEdge was added to the “Conviction Buy” list at Goldman Sachs, which raised the price target for the solar equipment company’s stock to $448 per share from $420 a share. Goldman cites improvements in battery storage capacity as well as the company’s prospects for increasing profit margins. SolarEdge rose 2.4% in the premarket.Shockwave Medical, Inc . (SWAV) –Penumbra(PEN) is exploring a combination with its rival medical device maker, according to people with knowledge of the matter who spoke to Bloomberg. However, Penumbra told Bloomberg in an emailed statement that it is not in discussions with Shockwave to pursue a business combination or similar transaction. Shockwave jumped 6% in premarket trading.Dell Technologies Inc. (DELL) – Bernstein upgraded Dell to “outperform” from “market perform,” noting Dell’s approximately six-week backlog in its PC business as well as a relatively high mix of commercial versus consumer business. Dell added 2.4% in the premarket.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":2451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006791280,"gmtCreate":1641831967968,"gmtModify":1676533652449,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Tyvm for sharing&nbsp;","listText":"Tyvm for sharing&nbsp;","text":"Tyvm for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791280","repostId":"1117665745","repostType":4,"repost":{"id":"1117665745","kind":"news","pubTimestamp":1641822153,"share":"https://ttm.financial/m/news/1117665745?lang=en_US&edition=fundamental","pubTime":"2022-01-10 21:42","market":"us","language":"en","title":"How to Beat the S&P 500 in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1117665745","media":"Motley Fool","summary":"Famous investor Warren Buffett is famous for (among other things)winning a bet that money parked in ","content":"<html><head></head><body><p>Famous investor Warren Buffett is famous for (among other things)winning a bet that money parked in an <b>S&amp;P 500</b> index fund would outperform professional money managers over 10 years. It&#39;s not easy to consistently beat a collection of the world&#39;s largest and most influential companies.</p><p>But can it be done over one year? I think it can, and I&#39;m going to show you the crazy blueprint to do just that in 2022. Here is why and how you could beat the S&amp;P 500 this year.</p><p><b>The anatomy of the S&amp;P 500</b></p><p>The S&amp;P 500is an index constructed by a committee and owned by S&amp;P Dow Jones Indices, a joint venture majority-owned by<b>S&amp;P Global</b>, which specializes in analytics and information for the financial markets. The index includes 500 companies generally considered the most prominent in the United States and traditionally viewed as the best overall benchmark for the U.S. stock market.</p><p>But these 500 companies aren&#39;t represented equally. The top 10 highest-weighted members make up roughly 30% of the entire index. These companies include:</p><ol><li><b>Apple</b></li><li><b>Microsoft</b></li><li><b>Amazon</b></li><li><b>Alphabet</b>(Class A shares)</li><li><b>Tesla</b></li><li>Alphabet (Class C shares)</li><li><b>MetaPlatforms</b></li><li><b>Nvidia</b></li><li><b>BerkshireHathaway</b>(Class B shares)</li><li><b>UnitedHealthGroup</b></li></ol><p>That leaves the other 70% for the other 490 stocks. A broad market movement such as a bull market can move the index, but these larger members can also influence the index if their price movement is dramatic enough.</p><p><b>Many top members have stretched valuations</b></p><p>A similar situation could be playing out in the index right now -- the S&amp;P 500 is only 3% away from its all-time high. But the broader stock market doesn&#39;t seem relatively healthy if you look closer.</p><p>For example, let&#39;s look at the 500 stocks in the index. Only 357 of them are above their 200-day moving average, which indicates a stock&#39;s price momentum by averaging its closing price over the past 200 market sessions. In other words, more than one in four S&amp;P 500 components are struggling right now.</p><p>If we look at the <b>Nasdaq</b>, a fellow index that concentrates on technology stocks, just over one in four stocks are <i>above</i> their 200-day moving average. Put another way, more than three-quarters of the Nasdaq&#39;s stocks have negative price momentum!</p><p>It seems that tech companies are broadly having a tough time right now, which could be explained by the ongoing high inflation threatening to cause increased interest rates. Higher interest rates cancause stock valuations to decrease.</p><p>Some mega-cap stocks that sit at the top of the S&amp;P 500 have remained popular, which has resulted in continued price appreciation and high valuations.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/84806d538b8283647e68cfce7862abcb\" tg-width=\"720\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>AAPL PE RATIODATA BYYCHARTS.PE = PRICE-TO-EARNINGS.</span></p><p>Now, the S&amp;P 500 is at a price-to-earnings (PE) ratio of 24.5, roughly 50% higher than its historical average of 16. Nobody knows what will happen in the future, but it seems that the weakness of lower-weighted stocks in the major indexes could indicate the actual condition of the markets. If the mega-caps finally begin to correct, it could accelerate the decline of the S&amp;P 500.</p><p><b>Going against the grain for gains</b></p><p>This scenario is an opportunity to outperform the market. Human nature makes it feel &#34;safe&#34; to go buy the stocks that have already been going higher, but the real opportunity might be in the beaten-down stocks, those that have lost 50% to 80% over the past year.</p><p>It doesn&#39;t mean chasing low-quality stocks that are overly speculative or businesses losing tons of money. But the overall sentiment in the growth universe has brought most stocks down; quality names trading at expensive valuations have become reasonable or even cheap in some instances.</p><p>If growth stocks begin recovering this year, we could see the opposite of 2021 occur, when the S&amp;P marched higher while many growth stocks floundered.</p><p><b>Understand the risks</b></p><p>There&#39;s a large gap between the largest stocks in the indexes and the smaller ones underneath. I think there is a good chance that this gap will close, but nobody knows for sure when that will happen.</p><p>The price movement that happened throughout most of 2021 may continue through 2022. Perhaps a significant economic event will occur that is unforeseen and changes everything.</p><p>The point is that you can&#39;t know for sure; you can only look at facts to get a sense of what&#39;s happening around you. The best way to position your investments for success is to identify high-quality stocks whether small-, mid-, or large-cap, take a long-term approach with your holdings, and manage your risk appetite. If you do that, you&#39;re bound to have success in 2022 and beyond.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How to Beat the S&P 500 in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow to Beat the S&P 500 in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 21:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/10/how-to-beat-the-sp-500-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Famous investor Warren Buffett is famous for (among other things)winning a bet that money parked in an S&P 500 index fund would outperform professional money managers over 10 years. It's not easy to ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/10/how-to-beat-the-sp-500-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://www.fool.com/investing/2022/01/10/how-to-beat-the-sp-500-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117665745","content_text":"Famous investor Warren Buffett is famous for (among other things)winning a bet that money parked in an S&P 500 index fund would outperform professional money managers over 10 years. It's not easy to consistently beat a collection of the world's largest and most influential companies.But can it be done over one year? I think it can, and I'm going to show you the crazy blueprint to do just that in 2022. Here is why and how you could beat the S&P 500 this year.The anatomy of the S&P 500The S&P 500is an index constructed by a committee and owned by S&P Dow Jones Indices, a joint venture majority-owned byS&P Global, which specializes in analytics and information for the financial markets. The index includes 500 companies generally considered the most prominent in the United States and traditionally viewed as the best overall benchmark for the U.S. stock market.But these 500 companies aren't represented equally. The top 10 highest-weighted members make up roughly 30% of the entire index. These companies include:AppleMicrosoftAmazonAlphabet(Class A shares)TeslaAlphabet (Class C shares)MetaPlatformsNvidiaBerkshireHathaway(Class B shares)UnitedHealthGroupThat leaves the other 70% for the other 490 stocks. A broad market movement such as a bull market can move the index, but these larger members can also influence the index if their price movement is dramatic enough.Many top members have stretched valuationsA similar situation could be playing out in the index right now -- the S&P 500 is only 3% away from its all-time high. But the broader stock market doesn't seem relatively healthy if you look closer.For example, let's look at the 500 stocks in the index. Only 357 of them are above their 200-day moving average, which indicates a stock's price momentum by averaging its closing price over the past 200 market sessions. In other words, more than one in four S&P 500 components are struggling right now.If we look at the Nasdaq, a fellow index that concentrates on technology stocks, just over one in four stocks are above their 200-day moving average. Put another way, more than three-quarters of the Nasdaq's stocks have negative price momentum!It seems that tech companies are broadly having a tough time right now, which could be explained by the ongoing high inflation threatening to cause increased interest rates. Higher interest rates cancause stock valuations to decrease.Some mega-cap stocks that sit at the top of the S&P 500 have remained popular, which has resulted in continued price appreciation and high valuations.AAPL PE RATIODATA BYYCHARTS.PE = PRICE-TO-EARNINGS.Now, the S&P 500 is at a price-to-earnings (PE) ratio of 24.5, roughly 50% higher than its historical average of 16. Nobody knows what will happen in the future, but it seems that the weakness of lower-weighted stocks in the major indexes could indicate the actual condition of the markets. If the mega-caps finally begin to correct, it could accelerate the decline of the S&P 500.Going against the grain for gainsThis scenario is an opportunity to outperform the market. Human nature makes it feel \"safe\" to go buy the stocks that have already been going higher, but the real opportunity might be in the beaten-down stocks, those that have lost 50% to 80% over the past year.It doesn't mean chasing low-quality stocks that are overly speculative or businesses losing tons of money. But the overall sentiment in the growth universe has brought most stocks down; quality names trading at expensive valuations have become reasonable or even cheap in some instances.If growth stocks begin recovering this year, we could see the opposite of 2021 occur, when the S&P marched higher while many growth stocks floundered.Understand the risksThere's a large gap between the largest stocks in the indexes and the smaller ones underneath. I think there is a good chance that this gap will close, but nobody knows for sure when that will happen.The price movement that happened throughout most of 2021 may continue through 2022. Perhaps a significant economic event will occur that is unforeseen and changes everything.The point is that you can't know for sure; you can only look at facts to get a sense of what's happening around you. The best way to position your investments for success is to identify high-quality stocks whether small-, mid-, or large-cap, take a long-term approach with your holdings, and manage your risk appetite. If you do that, you're bound to have success in 2022 and beyond.","news_type":1,"symbols_score_info":{".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006791617,"gmtCreate":1641831864078,"gmtModify":1676533652465,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Wow! Must think abt it!","listText":"Wow! Must think abt it!","text":"Wow! Must think abt it!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791617","repostId":"1127747237","repostType":4,"repost":{"id":"1127747237","kind":"news","pubTimestamp":1641822666,"share":"https://ttm.financial/m/news/1127747237?lang=en_US&edition=fundamental","pubTime":"2022-01-10 21:51","market":"us","language":"en","title":"Want $1 Million? 2 Monster Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1127747237","media":"Motley Fool","summary":"In Warren Buffett's 1993 shareholder letter, the legendary value investor cited this quote: \"In the ","content":"<html><head></head><body><p>In Warren Buffett&#39;s 1993 shareholder letter, the legendary value investor cited this quote: &#34;In the short run, the market is a voting machine [...] but in the long run, the market is a weighing machine.&#34; In other words, volatility is unavoidable. At times, great companies may lose a significant portion of their value, and not-so-great companies may achieve absurd valuations, but time is the great equalizer. As years pass, the great companies will outperform their peers.</p><p>Given the recent market volatility, I think that quote is particularly timely. It serves as a reminder to look beyond the here and now, and invest your money in high-quality stocks that you plan to hold for years or even decades. Doing so helps eliminate the impact of short-term volatility, and it gives your investment thesis plenty of time to play out.</p><p>Building on that idea, I think <b>DigitalOcean</b>(NYSE:DOCN)and <b>MongoDB</b>(NASDAQ:MDB)could grow fourfold in the next decade, a pace that would turn$250,000 into $1 million. Here&#39;s what you should know.</p><p><b>1. DigitalOcean</b></p><p>DigitalOcean specializes in cloud computing. Whereas tech titans like <b>Microsoft</b> and <b>Amazon</b> tailor their products to the needs of large enterprises, DigitalOcean focuses on small- and medium-sized businesses (SMBs) and individual developers. More specifically, the company focuses on simplicity. Its click-and-go interface makes it possible to provision cloud services within minutes, without any specialized training.</p><p>The company also provides 24/7 technical support, an extensive library of tutorials, and performance monitoring tools free of charge. Collectively, its cloud platform helps clients build and scale applications quickly, while eliminating the need to invest in costly on-site hardware. And that value proposition has translated into strong demand.</p><p>In the third quarter, DigitalOcean grew its customer base 7% to 598,000, and the average customer spent 16% more with the company. That compounding dynamic helped DigitalOcean report revenue of $111.4 million in the quarter, up 37% year over year. And cash from operations surged 73% to $40.3 million, meaning DigitalOcean is making enough money to pay the bills.</p><p>Currently, there are 100 million SMBs in the world, and 14 million new businesses are started each year. To that end, management estimates its addressable market will reach $116 billion by 2024. More importantly, DigitalOcean&#39;s developer-first business model is a big selling point, and it should bring more clients to the platform in the years ahead.</p><p>For that reason, I think this $7.5 billion company can grow fourfold (or more) in the next decade.</p><p><b>2. MongoDB</b></p><p>A database is at the heart of every application. This is where data is stored, organized, and accessed when it&#39;s needed. Legacy platforms relied on a relational model, requiring developers to format data into structured rows and columns. But 80% to 90% of data generated by modern applications is unstructured, such as videos posted to YouTube, photos shared on social media, and comments left on websites.</p><p>This type of data doesn&#39;t fit neatly into rows and columns, meaning it would be tedious for developers to maintain such a system. That&#39;s why MongoDB built a modern, general purpose database. Its platform uses a document model, allowing developers to store huge amounts of unstructured data. That flexibility drives productivity and efficiency, meaning clients can build and scale products more quickly. Compared to legacy solutions, MongoDB believes its software makes development three to five times faster and 70% less expensive.</p><p>Not surprisingly, the company has garnered a following in the developer community. In fact, it&#39;s the most popular non-relational database and the fifth most popular database of any kind, according to DB-Engines. Not surprisingly, that edge has translated into rapid growth.</p><p>In its fiscal third quarter, MongoDB&#39;s customer count grew 37% to over 31,000, and 1,201 of those customers now spend over $100,000 on an annualized basis. Additionally, the company&#39;s revenue expansion rate came in above 120%, meaning the average customer spent at least 20% more over the past year. In turn, revenue rose 50% to $226.9 million. And while MongoDB posted negative cash from operations of $5.8 million during the period, that figure marks an improvement over the prior year. More importantly, with $1.8 billion in cash and short-term investments on its balance sheet and just $1.1 billion in long-term debt, MongoDB can afford to continue investing in its growth.</p><p>Looking ahead, the company has plenty of room to grow. According to the International Data Corp., the data management software market will reach $121 billion by 2025. And given MongoDB&#39;s strong competitive position, I wouldn&#39;t be surprised to see its market cap grow at least fourfold over the next decade as well.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million? 2 Monster Stocks to Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million? 2 Monster Stocks to Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 21:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/10/want-1-million-2-monster-stocks-to-buy-and-hold/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In Warren Buffett's 1993 shareholder letter, the legendary value investor cited this quote: \"In the short run, the market is a voting machine [...] but in the long run, the market is a weighing ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/10/want-1-million-2-monster-stocks-to-buy-and-hold/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MDB":"MongoDB Inc.","DOCN":"DigitalOcean Holdings, Inc."},"source_url":"https://www.fool.com/investing/2022/01/10/want-1-million-2-monster-stocks-to-buy-and-hold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127747237","content_text":"In Warren Buffett's 1993 shareholder letter, the legendary value investor cited this quote: \"In the short run, the market is a voting machine [...] but in the long run, the market is a weighing machine.\" In other words, volatility is unavoidable. At times, great companies may lose a significant portion of their value, and not-so-great companies may achieve absurd valuations, but time is the great equalizer. As years pass, the great companies will outperform their peers.Given the recent market volatility, I think that quote is particularly timely. It serves as a reminder to look beyond the here and now, and invest your money in high-quality stocks that you plan to hold for years or even decades. Doing so helps eliminate the impact of short-term volatility, and it gives your investment thesis plenty of time to play out.Building on that idea, I think DigitalOcean(NYSE:DOCN)and MongoDB(NASDAQ:MDB)could grow fourfold in the next decade, a pace that would turn$250,000 into $1 million. Here's what you should know.1. DigitalOceanDigitalOcean specializes in cloud computing. Whereas tech titans like Microsoft and Amazon tailor their products to the needs of large enterprises, DigitalOcean focuses on small- and medium-sized businesses (SMBs) and individual developers. More specifically, the company focuses on simplicity. Its click-and-go interface makes it possible to provision cloud services within minutes, without any specialized training.The company also provides 24/7 technical support, an extensive library of tutorials, and performance monitoring tools free of charge. Collectively, its cloud platform helps clients build and scale applications quickly, while eliminating the need to invest in costly on-site hardware. And that value proposition has translated into strong demand.In the third quarter, DigitalOcean grew its customer base 7% to 598,000, and the average customer spent 16% more with the company. That compounding dynamic helped DigitalOcean report revenue of $111.4 million in the quarter, up 37% year over year. And cash from operations surged 73% to $40.3 million, meaning DigitalOcean is making enough money to pay the bills.Currently, there are 100 million SMBs in the world, and 14 million new businesses are started each year. To that end, management estimates its addressable market will reach $116 billion by 2024. More importantly, DigitalOcean's developer-first business model is a big selling point, and it should bring more clients to the platform in the years ahead.For that reason, I think this $7.5 billion company can grow fourfold (or more) in the next decade.2. MongoDBA database is at the heart of every application. This is where data is stored, organized, and accessed when it's needed. Legacy platforms relied on a relational model, requiring developers to format data into structured rows and columns. But 80% to 90% of data generated by modern applications is unstructured, such as videos posted to YouTube, photos shared on social media, and comments left on websites.This type of data doesn't fit neatly into rows and columns, meaning it would be tedious for developers to maintain such a system. That's why MongoDB built a modern, general purpose database. Its platform uses a document model, allowing developers to store huge amounts of unstructured data. That flexibility drives productivity and efficiency, meaning clients can build and scale products more quickly. Compared to legacy solutions, MongoDB believes its software makes development three to five times faster and 70% less expensive.Not surprisingly, the company has garnered a following in the developer community. In fact, it's the most popular non-relational database and the fifth most popular database of any kind, according to DB-Engines. Not surprisingly, that edge has translated into rapid growth.In its fiscal third quarter, MongoDB's customer count grew 37% to over 31,000, and 1,201 of those customers now spend over $100,000 on an annualized basis. Additionally, the company's revenue expansion rate came in above 120%, meaning the average customer spent at least 20% more over the past year. In turn, revenue rose 50% to $226.9 million. And while MongoDB posted negative cash from operations of $5.8 million during the period, that figure marks an improvement over the prior year. More importantly, with $1.8 billion in cash and short-term investments on its balance sheet and just $1.1 billion in long-term debt, MongoDB can afford to continue investing in its growth.Looking ahead, the company has plenty of room to grow. According to the International Data Corp., the data management software market will reach $121 billion by 2025. And given MongoDB's strong competitive position, I wouldn't be surprised to see its market cap grow at least fourfold over the next decade as well.","news_type":1,"symbols_score_info":{"MDB":0.9,"DOCN":0.9}},"isVote":1,"tweetType":1,"viewCount":2346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006791104,"gmtCreate":1641831816225,"gmtModify":1676533652441,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Mmmmm","listText":"Mmmmm","text":"Mmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791104","repostId":"1173383930","repostType":4,"repost":{"id":"1173383930","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641828185,"share":"https://ttm.financial/m/news/1173383930?lang=en_US&edition=fundamental","pubTime":"2022-01-10 23:23","market":"us","language":"en","title":"Nasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1173383930","media":"Tiger Newspress","summary":"U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rate","content":"<html><head></head><body><p>U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.</p><p>TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&amp;P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.</p><p><img src=\"https://static.tigerbbs.com/3271886bd069566f888a2ed6fdbf7524\" tg-width=\"955\" tg-height=\"233\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 23:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.</p><p>TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&amp;P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.</p><p><img src=\"https://static.tigerbbs.com/3271886bd069566f888a2ed6fdbf7524\" tg-width=\"955\" tg-height=\"233\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173383930","content_text":"U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":3339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006521474,"gmtCreate":1641788816098,"gmtModify":1676533648413,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Good!","listText":"Good!","text":"Good!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006521474","repostId":"1198290127","repostType":4,"repost":{"id":"1198290127","kind":"news","pubTimestamp":1641702682,"share":"https://ttm.financial/m/news/1198290127?lang=en_US&edition=fundamental","pubTime":"2022-01-09 12:31","market":"us","language":"en","title":"Can Apple Stock Reclaim $3 Trillion And Thrive In 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=1198290127","media":"TheStreet","summary":"A market cap of $3 trillion has, so far, proven to be a ceiling that Apple stock does not seem ready","content":"<html><head></head><body><p>A market cap of $3 trillion has, so far, proven to be a ceiling that Apple stock does not seem ready to break through yet. Can shares reclaim the milestone soon and head higher in 2022?</p><p>Recently, Apple stock flirted with $3 trillion in market cap, but quickly dipped below $2.9 trillion — as the broad market reacted to monetary tightening that should now happen more rapidly than previously expected.</p><p>Can shares of the Cupertino company finally find its way north in 2022 and meet the expectations of so many bulls on Wall Street? Or will bearishness take over during a year of rising interest rates and lingering inflation?</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1f77cd919bf55f9c7b79f631b0255910\" tg-width=\"1240\" tg-height=\"697\" referrerpolicy=\"no-referrer\"/><span>Figure 1: Apple Park in Cupertino, CA.</span></p><p><b>AAPL: the bull case</b></p><p>As Apple stock climbed viciously between late November and early December, many Wall Street experts piled on in support of “AAPL $3T”. Wedbush’s Dan Ives, for example, has been talking about the market cap milestone since our conversation in Q3 of last year, at least.</p><p>But other analysts have also hopped on the bullish bandwagon recently. Morgan Stanley upped its price target to $200 per share in November, while the JPMorgan research team saw Apple stock heading to $3.5 trillion in market cap over the next 12 months.</p><p>One of the most vocal optimists came from the buy side. Loup’s Gene Munster thought that his previous price target had quickly become stale, and that $250 per share now seemed more reasonable. In his opinion, the multi-year opportunity in the metaverse will gain investor appreciation in the new year, which should reignite momentum that the stock had lost in the last few weeks of 2021.</p><p><b>AAPL: the bear case</b></p><p>Despite the upbeat expectations described above, mostly supported by company-specific factors, the market rolled into 2022 with its guard up. The boogieman of the moment seems to be the Federal Reserve’s anticipated reaction to near-full employment and sticky inflation, which should lead to higher interest rates in the next several months.</p><p>I have recently explained how tighter money supply can spell trouble for stocks that trade for relatively high multiples. While AAPL is no Tesla or Rivian, the stock’s forward P/E of nearly 30 times and only modest earnings growth expectations could be a drag for share price in 2022, as investors look for better deals in value and cyclical stocks.</p><p><b>The Apple Maven’s take</b></p><p>I continue to think that Apple is a great stock to buy and hold for the long term. Under the leadership of a CEO (and former COO) that is driven by operational excellence, the company seems to be in very good hands. Better yet, demand for Apple’s products and services, as well as consumer appreciation for the brand, seem to be at or near an all-time high.</p><p>That said, the setup for the first few weeks or months of 2022 looks challenging to me. Apple stock climbed relentlessly in 2020, and then again last year. Aided by a spike in pandemic-driven demand for tech devices and lavish liquidity in the system, AAPL recorded one of its best three years of returns ever between 2019 and 2021.</p><p>As much as the metaverse and autonomous vehicles can and likely will support the company’s financial results over the next many years, I think that AAPL stock is overdue for a breather. While shares will likely climb back above $3 trillion and head much higher from there eventually, I am not so confident that this rally will happen in the immediate future.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Stock Reclaim $3 Trillion And Thrive In 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Stock Reclaim $3 Trillion And Thrive In 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-09 12:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/can-apple-stock-reclaim-3-trillion-and-thrive-in-2022><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A market cap of $3 trillion has, so far, proven to be a ceiling that Apple stock does not seem ready to break through yet. Can shares reclaim the milestone soon and head higher in 2022?Recently, Apple...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/can-apple-stock-reclaim-3-trillion-and-thrive-in-2022\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/can-apple-stock-reclaim-3-trillion-and-thrive-in-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198290127","content_text":"A market cap of $3 trillion has, so far, proven to be a ceiling that Apple stock does not seem ready to break through yet. Can shares reclaim the milestone soon and head higher in 2022?Recently, Apple stock flirted with $3 trillion in market cap, but quickly dipped below $2.9 trillion — as the broad market reacted to monetary tightening that should now happen more rapidly than previously expected.Can shares of the Cupertino company finally find its way north in 2022 and meet the expectations of so many bulls on Wall Street? Or will bearishness take over during a year of rising interest rates and lingering inflation?Figure 1: Apple Park in Cupertino, CA.AAPL: the bull caseAs Apple stock climbed viciously between late November and early December, many Wall Street experts piled on in support of “AAPL $3T”. Wedbush’s Dan Ives, for example, has been talking about the market cap milestone since our conversation in Q3 of last year, at least.But other analysts have also hopped on the bullish bandwagon recently. Morgan Stanley upped its price target to $200 per share in November, while the JPMorgan research team saw Apple stock heading to $3.5 trillion in market cap over the next 12 months.One of the most vocal optimists came from the buy side. Loup’s Gene Munster thought that his previous price target had quickly become stale, and that $250 per share now seemed more reasonable. In his opinion, the multi-year opportunity in the metaverse will gain investor appreciation in the new year, which should reignite momentum that the stock had lost in the last few weeks of 2021.AAPL: the bear caseDespite the upbeat expectations described above, mostly supported by company-specific factors, the market rolled into 2022 with its guard up. The boogieman of the moment seems to be the Federal Reserve’s anticipated reaction to near-full employment and sticky inflation, which should lead to higher interest rates in the next several months.I have recently explained how tighter money supply can spell trouble for stocks that trade for relatively high multiples. While AAPL is no Tesla or Rivian, the stock’s forward P/E of nearly 30 times and only modest earnings growth expectations could be a drag for share price in 2022, as investors look for better deals in value and cyclical stocks.The Apple Maven’s takeI continue to think that Apple is a great stock to buy and hold for the long term. Under the leadership of a CEO (and former COO) that is driven by operational excellence, the company seems to be in very good hands. Better yet, demand for Apple’s products and services, as well as consumer appreciation for the brand, seem to be at or near an all-time high.That said, the setup for the first few weeks or months of 2022 looks challenging to me. Apple stock climbed relentlessly in 2020, and then again last year. Aided by a spike in pandemic-driven demand for tech devices and lavish liquidity in the system, AAPL recorded one of its best three years of returns ever between 2019 and 2021.As much as the metaverse and autonomous vehicles can and likely will support the company’s financial results over the next many years, I think that AAPL stock is overdue for a breather. While shares will likely climb back above $3 trillion and head much higher from there eventually, I am not so confident that this rally will happen in the immediate future.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006521589,"gmtCreate":1641788772507,"gmtModify":1676533648405,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Thanks for the insight...","listText":"Thanks for the insight...","text":"Thanks for the insight...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006521589","repostId":"1108030484","repostType":4,"repost":{"id":"1108030484","kind":"news","pubTimestamp":1641769386,"share":"https://ttm.financial/m/news/1108030484?lang=en_US&edition=fundamental","pubTime":"2022-01-10 07:03","market":"us","language":"en","title":"Consumer Price Index, Bank Earnings: What to Know This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1108030484","media":"Yahoo Finance","summary":"Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statist","content":"<html><head></head><body><p>Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statistics&#39; (BLS) latest Consumer Price Index (CPI) as the Federal Reserve&#39;s next monetary policy moves remain in focus. Quarterly earnings season also ramps up as some of the big banks report results.</p><p>Market participants are bracing for another historically hot reading on inflation in the latest CPI data, due out on Wednesday. On a year-over-year basis, consumer prices likely surged by 7.1% in December, based on Bloomberg consensus data, accelerating even further from November&#39;s 6.8% year-over-year clip.This would mark the fastest rate since 1982, when CPI rose as much as 8.4% on a year-over-year basis.</p><p>And on a month-over-month basis, consumer prices likely rose by 0.4% in December, slowing from November&#39;s 0.8% rise but still marking an eighteenth consecutive month of increases.</p><p>&#34;Recent months have seen consistent upside surprises as inflation has increasingly broadened out, and it&#39;s now the case that seven of the last nine CPI releases have seen the monthly headline increase come in above the consensus among economists on Bloomberg, which just demonstrates how this has taken a lot of people by surprise,&#34; Deutsche Bank economists Henry Allen and Jim Reid said in a note.</p><p>&#34;Our U.S. economists are projecting that year-on-year inflation will move higher once again, with an increase to +7.0%,&#34; they added. &#34;Interestingly though, they think we could be at a turning point with December marking the peak in the year-on-year readings, which they then project will fall back over 2022 and be at +3.0% by this December ahead.&#34;</p><p>Excluding more volatile food and energy prices, consumer prices likely rose at a 5.4% year-over-year rate in December, also speeding from November&#39;s 4.9% pace and coming in at the fastest since 1991.</p><p>While price increases have been broad-based in the recovering economy, some economists said rising vehicle prices will likely be one of the main drivers of inflation at year-end.</p><p>&#34;The main story will be the increase in autos inflation, with used cars the primary driver,&#34; Bank of America economists led by Ethan Harris wrote in a note Friday. &#34;Manheim data showed wholesale used car prices spiking 9.2% [month-over-month] in October, following a 5.3% increase in September. Given a roughly 2-month lag, this sends a signal of incredible strength for CPI used cars this month.&#34;</p><p>Used car and truck prices had risen 2.5% month-on-month in November, matching the prior month&#39;s rise, based on BLS data.</p><p>&#34;Outside of autos, we expect further gains in household furnishings and supplies and apparel, reflecting tight supply chains and fewer discounts as the holiday shopping season draws to a close,&#34; Harris added.</p><p>The December CPI will also be carefully parsed by investors as they gauge the next moves by the Federal Reserve, as some officials eye a quicker shift away from accommodative policies to rein in inflation.</p><p>Last week, the Fed&#39;s December meeting minutes suggested some officials favored speeding the central bank&#39;s asset-purchase tapering and hastening the timing of an initial interest rate hike from current near-zero levels. And against a backdrop of a &#34;stronger economic outlook [and] higher inflation,&#34; some officials also suggested they were contemplating the start of reducing the nearly $9 trillion in assets on the central bank&#39;s balance sheet. Hints that the Fed was considering tightening policy in the near-term sent equity markets into a tailspin last week.</p><p>&#34;The market does have to adjust to what is a surprise in terms of how aggressive the Federal Reserve may be in managing the economy around inflation,&#34; Rob Haworth, U.S. Bank Wealth Management senior investment strategist,told Yahoo Finance Livelast week.</p><p>Investors may also receive more commentary about how key members of the Federal Reserve expect to approach inflation with their monetary policy toolkit in two confirmation hearings before Congress this week. Federal Reserve Chair Jerome Powell&#39;s nomination hearing for a second term is set to take place before the Senate Banking Committee on Tuesday — or a day before the December CPI is released. However, Fed Governor Lael Brainard&#39;s nomination hearing to become vice chair of the Fed will take place on Thursday before the Senate Banking Committee, after the release of the latest inflation data.</p><p>Bank earnings</p><p>This week, investors will also see a pick-up in earnings reports, as some of the largest U.S. banks deliver their quarterly results at the end of the week. JPMorgan Chase (JPM), Citigroup (C) and Wells Fargo (WFC) are each slated to report Friday morning before the opening bell.</p><p>The results come following a strong run for bank stocks, with financials currently the second-best performing sector in the S&amp;P 500 in 2022, after energy. TheXLF, or exchange-traded fund tracking the financials sector, hit a record high on Friday and logged its best week since February 2021.</p><p>Expectations for higher interest rates this year have been one major factor lifting these shares, given that banks&#39; core lending businesses benefit from rising rates. On Friday, the benchmark 10-year Treasury yield rose to approximately 1.8%, or its highest level since January 2020. And robust market activity over the past year likely also helped further lift banks&#39; trading operations.</p><p>&#34;As far as the financials go, we think they&#39;re going to be pretty good. This last year has seen a lot of trading activity,&#34; Scott Ladner, Horizon Investments chief investment officer,told Yahoo Finance Live on Friday.&#34;And as we&#39;ve seen, what&#39;s going on right now with respect to yield curve, the yield curve steepened this week.&#34;</p><p>As fourth-quarter earnings begin to ramp up, many analysts are expecting to see another solid reporting season. However, the estimates are also taking into account slowing momentum after soaring earnings growth rates from earlier last year, helped in large part by easy comparisons to 2020&#39;s pandemic-depressed levels.</p><p>S&amp;P 500 earnings in aggregate are expected to grow 21.7% for the fourth-quarter of 2021, according to data from FactSet&#39;s John Butters as of Friday. If earnings come in as expected, this would mark a fourth consecutive quarter that earnings growth tops 20%.</p><p>Economic calendar</p><ul><li><p><b>Monday:</b>Wholesale inventories, month-over-month, November final (1.2% expected, 1.2% in previous print)</p></li><li><p><b>Tuesday:</b>NFIB Small Business Optimism, December (98.5 expected, 98.4 in November)</p></li><li><p><b>Wednesday:</b>MBA Mortgage Applications, week ended January 7 (-5.6% during prior week); Consumer Price Index (CPI), month-over-month, December (0.4% expected, 0.8% in November); CPI excluding food and energy, month-over-month, December (0.5% expected, 0.5% in November); CPI year-over-year, December (7.1% expected, 6.8% in November); CPI excluding food and energy, year-over-year, December (5.4% expected, 4.9% in November); Monthly budget statement, December (-$191.3 billion expected); U.S. Federal Reserve Releases Beige Book</p></li><li><p><b>Thursday:</b>Producer Price Index (PPI), month-over-month, December (0.4% expected, 0.8% in November); PPI excluding food and energy, month-over-month, December (0.4% expected, 0.7% in November); PPI year-over-year, December (9.8% expected, 9.6% in November); PPI excluding food and energy, year-over-year, December (8.0% expected, 7.7% in November); Initial jobless claims, week ended January 8 (210,000 expected, 207,000 during prior week); Continuing claims, week ended January 1 (1.754 million during prior week)</p></li><li><p><b>Friday:</b>Retail sales advance, month-over-month, December (0.0% expected, 0.3% in November); Retail sales excluding autos and gas, month-over-month, December (-0.1% expected, 0.2% in November); Import price index, month-over-month, December (0.2%. expected, 0.7% in November); Capacity utilization, December (77.0% expected); Industrial production, month-over-month, December (0.3% expected, 0.5% in November); University of Michigan sentiment, January preliminary (70.0 expected, 70.6 in December)</p></li></ul><p>Earnings calendar</p><ul><li><p><b>Monday:</b><i>No notable reports scheduled for release</i></p></li><li><p><b>Tuesday:</b><i>No notable reports scheduled for release</i></p></li><li><p><b>Wednesday:</b>Jefferies Financial Corp. (JEF) before market open</p></li><li><p><b>Thursday:</b>Delta Air Lines (DAL) before market open</p></li><li><p><b>Friday:</b>BlackRock (BLK), Citigroup (C), JPMorgan Chase (JPM), Wells Fargo (WFC) before market open</p></li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consumer Price Index, Bank Earnings: What to Know This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsumer Price Index, Bank Earnings: What to Know This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 07:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/consumer-price-index-bank-earnings-what-to-know-this-week-164559716.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statistics' (BLS) latest Consumer Price Index (CPI) as the Federal Reserve's next monetary policy moves ...</p>\n\n<a href=\"https://finance.yahoo.com/news/consumer-price-index-bank-earnings-what-to-know-this-week-164559716.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/consumer-price-index-bank-earnings-what-to-know-this-week-164559716.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108030484","content_text":"Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statistics' (BLS) latest Consumer Price Index (CPI) as the Federal Reserve's next monetary policy moves remain in focus. Quarterly earnings season also ramps up as some of the big banks report results.Market participants are bracing for another historically hot reading on inflation in the latest CPI data, due out on Wednesday. On a year-over-year basis, consumer prices likely surged by 7.1% in December, based on Bloomberg consensus data, accelerating even further from November's 6.8% year-over-year clip.This would mark the fastest rate since 1982, when CPI rose as much as 8.4% on a year-over-year basis.And on a month-over-month basis, consumer prices likely rose by 0.4% in December, slowing from November's 0.8% rise but still marking an eighteenth consecutive month of increases.\"Recent months have seen consistent upside surprises as inflation has increasingly broadened out, and it's now the case that seven of the last nine CPI releases have seen the monthly headline increase come in above the consensus among economists on Bloomberg, which just demonstrates how this has taken a lot of people by surprise,\" Deutsche Bank economists Henry Allen and Jim Reid said in a note.\"Our U.S. economists are projecting that year-on-year inflation will move higher once again, with an increase to +7.0%,\" they added. \"Interestingly though, they think we could be at a turning point with December marking the peak in the year-on-year readings, which they then project will fall back over 2022 and be at +3.0% by this December ahead.\"Excluding more volatile food and energy prices, consumer prices likely rose at a 5.4% year-over-year rate in December, also speeding from November's 4.9% pace and coming in at the fastest since 1991.While price increases have been broad-based in the recovering economy, some economists said rising vehicle prices will likely be one of the main drivers of inflation at year-end.\"The main story will be the increase in autos inflation, with used cars the primary driver,\" Bank of America economists led by Ethan Harris wrote in a note Friday. \"Manheim data showed wholesale used car prices spiking 9.2% [month-over-month] in October, following a 5.3% increase in September. Given a roughly 2-month lag, this sends a signal of incredible strength for CPI used cars this month.\"Used car and truck prices had risen 2.5% month-on-month in November, matching the prior month's rise, based on BLS data.\"Outside of autos, we expect further gains in household furnishings and supplies and apparel, reflecting tight supply chains and fewer discounts as the holiday shopping season draws to a close,\" Harris added.The December CPI will also be carefully parsed by investors as they gauge the next moves by the Federal Reserve, as some officials eye a quicker shift away from accommodative policies to rein in inflation.Last week, the Fed's December meeting minutes suggested some officials favored speeding the central bank's asset-purchase tapering and hastening the timing of an initial interest rate hike from current near-zero levels. And against a backdrop of a \"stronger economic outlook [and] higher inflation,\" some officials also suggested they were contemplating the start of reducing the nearly $9 trillion in assets on the central bank's balance sheet. Hints that the Fed was considering tightening policy in the near-term sent equity markets into a tailspin last week.\"The market does have to adjust to what is a surprise in terms of how aggressive the Federal Reserve may be in managing the economy around inflation,\" Rob Haworth, U.S. Bank Wealth Management senior investment strategist,told Yahoo Finance Livelast week.Investors may also receive more commentary about how key members of the Federal Reserve expect to approach inflation with their monetary policy toolkit in two confirmation hearings before Congress this week. Federal Reserve Chair Jerome Powell's nomination hearing for a second term is set to take place before the Senate Banking Committee on Tuesday — or a day before the December CPI is released. However, Fed Governor Lael Brainard's nomination hearing to become vice chair of the Fed will take place on Thursday before the Senate Banking Committee, after the release of the latest inflation data.Bank earningsThis week, investors will also see a pick-up in earnings reports, as some of the largest U.S. banks deliver their quarterly results at the end of the week. JPMorgan Chase (JPM), Citigroup (C) and Wells Fargo (WFC) are each slated to report Friday morning before the opening bell.The results come following a strong run for bank stocks, with financials currently the second-best performing sector in the S&P 500 in 2022, after energy. TheXLF, or exchange-traded fund tracking the financials sector, hit a record high on Friday and logged its best week since February 2021.Expectations for higher interest rates this year have been one major factor lifting these shares, given that banks' core lending businesses benefit from rising rates. On Friday, the benchmark 10-year Treasury yield rose to approximately 1.8%, or its highest level since January 2020. And robust market activity over the past year likely also helped further lift banks' trading operations.\"As far as the financials go, we think they're going to be pretty good. This last year has seen a lot of trading activity,\" Scott Ladner, Horizon Investments chief investment officer,told Yahoo Finance Live on Friday.\"And as we've seen, what's going on right now with respect to yield curve, the yield curve steepened this week.\"As fourth-quarter earnings begin to ramp up, many analysts are expecting to see another solid reporting season. However, the estimates are also taking into account slowing momentum after soaring earnings growth rates from earlier last year, helped in large part by easy comparisons to 2020's pandemic-depressed levels.S&P 500 earnings in aggregate are expected to grow 21.7% for the fourth-quarter of 2021, according to data from FactSet's John Butters as of Friday. If earnings come in as expected, this would mark a fourth consecutive quarter that earnings growth tops 20%.Economic calendarMonday:Wholesale inventories, month-over-month, November final (1.2% expected, 1.2% in previous print)Tuesday:NFIB Small Business Optimism, December (98.5 expected, 98.4 in November)Wednesday:MBA Mortgage Applications, week ended January 7 (-5.6% during prior week); Consumer Price Index (CPI), month-over-month, December (0.4% expected, 0.8% in November); CPI excluding food and energy, month-over-month, December (0.5% expected, 0.5% in November); CPI year-over-year, December (7.1% expected, 6.8% in November); CPI excluding food and energy, year-over-year, December (5.4% expected, 4.9% in November); Monthly budget statement, December (-$191.3 billion expected); U.S. Federal Reserve Releases Beige BookThursday:Producer Price Index (PPI), month-over-month, December (0.4% expected, 0.8% in November); PPI excluding food and energy, month-over-month, December (0.4% expected, 0.7% in November); PPI year-over-year, December (9.8% expected, 9.6% in November); PPI excluding food and energy, year-over-year, December (8.0% expected, 7.7% in November); Initial jobless claims, week ended January 8 (210,000 expected, 207,000 during prior week); Continuing claims, week ended January 1 (1.754 million during prior week)Friday:Retail sales advance, month-over-month, December (0.0% expected, 0.3% in November); Retail sales excluding autos and gas, month-over-month, December (-0.1% expected, 0.2% in November); Import price index, month-over-month, December (0.2%. expected, 0.7% in November); Capacity utilization, December (77.0% expected); Industrial production, month-over-month, December (0.3% expected, 0.5% in November); University of Michigan sentiment, January preliminary (70.0 expected, 70.6 in December)Earnings calendarMonday:No notable reports scheduled for releaseTuesday:No notable reports scheduled for releaseWednesday:Jefferies Financial Corp. (JEF) before market openThursday:Delta Air Lines (DAL) before market openFriday:BlackRock (BLK), Citigroup (C), JPMorgan Chase (JPM), Wells Fargo (WFC) before market open","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006521938,"gmtCreate":1641788667625,"gmtModify":1676533648390,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Oh dear","listText":"Oh dear","text":"Oh dear","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006521938","repostId":"1126310439","repostType":4,"isVote":1,"tweetType":1,"viewCount":3344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006523749,"gmtCreate":1641788623817,"gmtModify":1676533648382,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"I hope the stock price will go up...","listText":"I hope the stock price will go up...","text":"I hope the stock price will go up...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006523749","repostId":"1162597186","repostType":4,"isVote":1,"tweetType":1,"viewCount":3604,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3568898592347932","authorId":"3568898592347932","name":"YuTC968","avatar":"https://static.tigerbbs.com/2d421272489b6ef78e6ec097b142ae78","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3568898592347932","idStr":"3568898592347932"},"content":"give some time…it should up but bot sure how much ooo….","text":"give some time…it should up but bot sure how much ooo….","html":"give some time…it should up but bot sure how much ooo…."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006144241,"gmtCreate":1641664924043,"gmtModify":1676533637998,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Good!","listText":"Good!","text":"Good!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006144241","repostId":"2201260039","repostType":4,"repost":{"id":"2201260039","kind":"highlight","pubTimestamp":1641533791,"share":"https://ttm.financial/m/news/2201260039?lang=en_US&edition=fundamental","pubTime":"2022-01-07 13:36","market":"us","language":"en","title":"This 'cash cow' value-stock strategy can fatten your portfolio even if you fear the Fed","url":"https://stock-news.laohu8.com/highlight/detail?id=2201260039","media":"MarketWatch","summary":"A rising-rate environment spells risk for overvalued stocks. Companies with high cash flows can give","content":"<html><head></head><body><p>A rising-rate environment spells risk for overvalued stocks. Companies with high cash flows can give investors some protection.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fa675051bed7b1de03d0fe2990231ede\" tg-width=\"700\" tg-height=\"487\" width=\"100%\" height=\"auto\"/><span>Cash cows might be best for stock investors in a rising-interest-rate environment.</span></p><p>Value stocks have been outperforming growth stocks over the past six months, in part, because a change in Federal Reserve policy is signaling an extended period of rising interest rates. Within the value world, investors might be best-served by focusing on cash flow.</p><p>In the low-interest-rate environment through most of the coronavirus pandemic, growth strategies have worked best. But check out this six-month chart showing the total return of the $1.3 billion Pacer U.S. Cash Cows ETF compared with those of the Russell 1000 Growth and Value indexes and the benchmark S&amp;P 500 Index:</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/81a15f4cae6befe944066c2cb702c6b9\" tg-width=\"700\" tg-height=\"572\" width=\"100%\" height=\"auto\"/><span>FactSet</span></p><p>COWZ has beaten all three of the indexes over the past six months, and this action might continue, as stocks trading at high price-to-earnings valuations -- including the high-flying tech companies that have led the long bull market -- may continue to be more sensitive to rising interest rates than value stocks.</p><p>COWZ is rebalanced quarterly to hold the 100 stocks among the Russell 1000 that have the highest free cash flow yields for a rolling 12-month period. The stocks are equally weighted when the portfolio is rebalanced.</p><p>Pacer defines a company&#39;s free cash flow as its cash flow from operations after capital expenditures, which include expenses, interest, taxes and long-term investments. That figure for the past 12 months is divided by current market capitalizations each quarter when the exchange traded fund&#39;s portfolio is rebalanced. That means recent high-flyers are likely to be dropped from the portfolio.</p><p><b>Screening the cash cows</b></p><p>The COWZ strategy might appeal to investors who wish to diversify beyond the cap-weighted indexes that are most commonly tracked by index funds. For example, the top five companies held by the $456 billion SPDR S&amp;P 500 ETF Trust  -- Apple Inc., Microsoft Corp., Amazon.com Inc., Alphabet Inc. and Tesla Inc. -- make up 23% of the portfolio.</p><p>But some investors want to look at individual stocks. Here are three screens of the 100-stock COWZ portfolio. Each list includes market capitalization (in billions of dollars), dividend yields and a summary of opinions among analysts polled by FactSet:</p><p><b>Fattest cash cows</b></p><p>Here are the 10 largest stocks held in the COWZ portfolio, by market capitalization:</p><p><img src=\"https://static.tigerbbs.com/26707329f863a3a576d0cd1ccc613aa3\" tg-width=\"1023\" tg-height=\"613\" width=\"100%\" height=\"auto\"/></p><p>Then read Tomi Kilgore&#39;s detailed guide to the wealth of information available for free on the MarketWatch quote page.</p><p><b>Highest-yielding cash cows</b></p><p>Here are the 10 stocks in the COWZ portfolio with the highest dividend yields as of the close on Jan. 5:</p><p><img src=\"https://static.tigerbbs.com/2da99eb8c82f22edf4d8c2122e7a2e04\" tg-width=\"1027\" tg-height=\"674\" width=\"100%\" height=\"auto\"/></p><p><b>Wall Street&#39;s favorite cash cows</b></p><p>Finally, here are the 12 stocks in the COWZ portfolio with the highest percentage of &#34;buy&#34; or equivalent ratings among analysts polled by FactSet. This group includes a dozen stocks, not 10, because three were tied with 82% &#34;buy&#34; ratings:</p><p><img src=\"https://static.tigerbbs.com/ead369bb66cf15dd5f1f258d91ea3185\" tg-width=\"1020\" tg-height=\"751\" width=\"100%\" height=\"auto\"/></p></body></html>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This 'cash cow' value-stock strategy can fatten your portfolio even if you fear the Fed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis 'cash cow' value-stock strategy can fatten your portfolio even if you fear the Fed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-07 13:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/this-cash-cow-value-stock-strategy-can-fatten-your-portfolio-even-if-you-fear-the-fed-11641492520?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A rising-rate environment spells risk for overvalued stocks. Companies with high cash flows can give investors some protection.Cash cows might be best for stock investors in a rising-interest-rate ...</p>\n\n<a href=\"https://www.marketwatch.com/story/this-cash-cow-value-stock-strategy-can-fatten-your-portfolio-even-if-you-fear-the-fed-11641492520?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","TERN":"Terns Pharmaceuticals, Inc.","BK4527":"明星科技股","BK4077":"互动媒体与服务","MSFT":"微软",".DJI":"道琼斯","BK4553":"喜马拉雅资本持仓","INTC":"英特尔","BK4099":"汽车制造商","BK4534":"瑞士信贷持仓","CRCT":"Cricut, Inc.","SPY":"标普500ETF","BK4514":"搜索引擎","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","BK4122":"互联网与直销零售","AMZN":"亚马逊","HCTI":"Healthcare Triangle, Inc.","BK4535":"淡马锡持仓","BK4505":"高瓴资本持仓","BK4167":"医疗保健技术","BMY":"施贵宝","XOM":"埃克森美孚","BK4515":"5G概念","BK4538":"云计算","BK4559":"巴菲特持仓","COWZ":"Pacer US Cash Cows 100 ETF","BK4504":"桥水持仓","OLPX":"Olaplex Holdings, Inc.","BK4209":"餐馆","BK4191":"家用电器","BK4183":"个人用品","BK4550":"红杉资本持仓","BK4507":"流媒体概念","AAPL":"苹果","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边",".IXIC":"NASDAQ Composite","BK4524":"宅经济概念","BK4551":"寇图资本持仓","BK4525":"远程办公概念","BK4539":"次新股","BK4097":"系统软件",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/this-cash-cow-value-stock-strategy-can-fatten-your-portfolio-even-if-you-fear-the-fed-11641492520?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201260039","content_text":"A rising-rate environment spells risk for overvalued stocks. Companies with high cash flows can give investors some protection.Cash cows might be best for stock investors in a rising-interest-rate environment.Value stocks have been outperforming growth stocks over the past six months, in part, because a change in Federal Reserve policy is signaling an extended period of rising interest rates. Within the value world, investors might be best-served by focusing on cash flow.In the low-interest-rate environment through most of the coronavirus pandemic, growth strategies have worked best. But check out this six-month chart showing the total return of the $1.3 billion Pacer U.S. Cash Cows ETF compared with those of the Russell 1000 Growth and Value indexes and the benchmark S&P 500 Index:FactSetCOWZ has beaten all three of the indexes over the past six months, and this action might continue, as stocks trading at high price-to-earnings valuations -- including the high-flying tech companies that have led the long bull market -- may continue to be more sensitive to rising interest rates than value stocks.COWZ is rebalanced quarterly to hold the 100 stocks among the Russell 1000 that have the highest free cash flow yields for a rolling 12-month period. The stocks are equally weighted when the portfolio is rebalanced.Pacer defines a company's free cash flow as its cash flow from operations after capital expenditures, which include expenses, interest, taxes and long-term investments. That figure for the past 12 months is divided by current market capitalizations each quarter when the exchange traded fund's portfolio is rebalanced. That means recent high-flyers are likely to be dropped from the portfolio.Screening the cash cowsThe COWZ strategy might appeal to investors who wish to diversify beyond the cap-weighted indexes that are most commonly tracked by index funds. For example, the top five companies held by the $456 billion SPDR S&P 500 ETF Trust  -- Apple Inc., Microsoft Corp., Amazon.com Inc., Alphabet Inc. and Tesla Inc. -- make up 23% of the portfolio.But some investors want to look at individual stocks. Here are three screens of the 100-stock COWZ portfolio. Each list includes market capitalization (in billions of dollars), dividend yields and a summary of opinions among analysts polled by FactSet:Fattest cash cowsHere are the 10 largest stocks held in the COWZ portfolio, by market capitalization:Then read Tomi Kilgore's detailed guide to the wealth of information available for free on the MarketWatch quote page.Highest-yielding cash cowsHere are the 10 stocks in the COWZ portfolio with the highest dividend yields as of the close on Jan. 5:Wall Street's favorite cash cowsFinally, here are the 12 stocks in the COWZ portfolio with the highest percentage of \"buy\" or equivalent ratings among analysts polled by FactSet. This group includes a dozen stocks, not 10, because three were tied with 82% \"buy\" ratings:","news_type":1,"symbols_score_info":{"835174":1,"835184":1,"835185":1,"835305":1,"835368":1,"835508":1,"835640":1,"835670":1,"CRCT":0.63,"OLPX":0.63,".SPX":0.9,"MSFT":1,"COWZ":0.9,"AMZN":1,"HCTI":0.63,".DJI":0.9,"INTC":0.9,"AAPL":1,"BMY":0.9,"TERN":0.63,"SPY":0.9,"XOM":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006144647,"gmtCreate":1641664897066,"gmtModify":1676533638013,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"I hope so...hehe","listText":"I hope so...hehe","text":"I hope so...hehe","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006144647","repostId":"2201216295","repostType":4,"repost":{"id":"2201216295","kind":"highlight","pubTimestamp":1641569178,"share":"https://ttm.financial/m/news/2201216295?lang=en_US&edition=fundamental","pubTime":"2022-01-07 23:26","market":"us","language":"en","title":"3 Stocks that Can Turn $100,000 into $1 Million by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2201216295","media":"Motley Fool","summary":"There's a clear path for these stocks to deliver 10x gains by the end of the decade.","content":"<div>\n<p>There's something especially alluring about the potential to achieve a 10x return. Mutual-fund manager Peter Lynch called such investments 10-baggers. He found quite a few of them during his time ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-stocks-that-can-turn-100000-into-1-million-by-20/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks that Can Turn $100,000 into $1 Million by 2030</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks that Can Turn $100,000 into $1 Million by 2030\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-07 23:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-stocks-that-can-turn-100000-into-1-million-by-20/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There's something especially alluring about the potential to achieve a 10x return. Mutual-fund manager Peter Lynch called such investments 10-baggers. He found quite a few of them during his time ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-stocks-that-can-turn-100000-into-1-million-by-20/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NGS":"Natural Gas Services Group Inc","TWST":"Twist Bioscience Corp","BK4548":"巴美列捷福持仓","BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4139":"生物科技","MELI":"MercadoLibre","BK4122":"互联网与直销零售","U":"Unity Software Inc.","BK4566":"资本集团","BK4179":"石油天然气设备与服务"},"source_url":"https://www.fool.com/investing/2022/01/07/3-stocks-that-can-turn-100000-into-1-million-by-20/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201216295","content_text":"There's something especially alluring about the potential to achieve a 10x return. Mutual-fund manager Peter Lynch called such investments 10-baggers. He found quite a few of them during his time leading Fidelity Investments' Magellan Fund.But Lynch is one of the most successful investors ever. Can investors who aren't legends buy potential 10-baggers now?I think so. And it doesn't have to take decades to generate 10x returns. Here are three stocks that may be able to turn $100,000 into $1 million by 2030.1. MercadoLibreWhat do you get when you cross three huge opportunities with a fast-growing and underserved region? MercadoLibre (NASDAQ:MELI). The company stands as the leader in Latin American e-commerce, digital payments, and logistics with a market cap below $60 billion.I view MercadoLibre as one of the top growth stocks to buy for 2022. The stock is down more than 40% from its 52-week high, despite its business continuing to fire on all cylinders. My prediction is that it will rebound strongly this year.However, I'm even more excited about MercadoLibre's prospects throughout the rest of this decade. Investment-firm Morgan Stanley expects the e-commerce market-penetration rate in Latin America will double by 2025 and continue growing rapidly afterward. MercadoLibre will be the obvious winner if this projection is right -- both with its e-commerce and logistics services.There are also millions of people in Latin America who don't use banking services or have only limited banking services. MercadoLibre's MercadoPago payment platform provides a great solution for these individuals. I think that digital payments will become a much bigger business for the company and help it potentially deliver a 10x return by 2030.2. Unity SoftwareARK Invest founder Cathie Wood believes that the metaverse could be worth trillions of dollars. Matthew Ball, CEO of venture-capital firm Epyllion, projects that the metaverse opportunity could reach $30 trillion over the next 15 years. If they're anywhere close to being right, Unity Software (NYSE:U) could easily turn an initial investment of $100,000 into $1 million by the end of this decade.Unity isn't a company that's in the limelight all that much. However, its software was used to develop more than 700 of the top 1,000 mobile games. Unity's platform is No. 1, by far, in creating interactive, real-time 3D content.The rise of the metaverse should lead to a lot more of this content. That presents a massive opportunity for Unity -- one that the company fully intends to seize. CEO John Riccitiello said in Unity's third-quarter conference call that the company's goal is for between 60% and 80% of metaverse content to be built with its software.Riccitiello's range seems attainable based on Unity's past track record. If the metaverse delivers on its potential, it's not hard to envision Unity's market cap increasing from the current $37 billion to at least $370 billion by 2030.3. Twist BioscienceTwist Bioscience (NASDAQ:TWST) ranks as one of the most intriguing biotech stocks on the market. The company specializes in making synthetic DNA. This DNA is used in a variety of ways, including drug development and research.Twist estimates that the addressable market for its synthetic DNA is around $1.8 billion annually. It believes there's at least another $1 billion per-year opportunity in tools for next-generation sequencing (NGS) sample preparation.I don't think those markets are enough to make Twist a 10-bagger by 2030. However, the company is focusing on another area that could enable its stock to deliver a 10x or greater return over the next few years: DNA data storage, which presents a $35 billion opportunity. And DNA holds the potential to store data more cost-effectively for longer periods of time than other alternatives.Twist has a long way to go on this front. But the company is making progress, including confirming that it can synthesize DNA on a 1-micron chip.I think that Twist can get the costs of DNA data storage near $100 per terabyte. If it reaches this milestone, this stock should be a surefire 10-bagger.","news_type":1,"symbols_score_info":{"NGS":1,"U":1,"TWST":1,"MELI":0.6}},"isVote":1,"tweetType":1,"viewCount":1095,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006144925,"gmtCreate":1641664759637,"gmtModify":1676533637990,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Wow!","listText":"Wow!","text":"Wow!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006144925","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=en_US&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"VIR":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001737739,"gmtCreate":1641316563817,"gmtModify":1676533597162,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Interesting read","listText":"Interesting read","text":"Interesting read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001737739","repostId":"2200081405","repostType":4,"repost":{"id":"2200081405","kind":"highlight","pubTimestamp":1641298279,"share":"https://ttm.financial/m/news/2200081405?lang=en_US&edition=fundamental","pubTime":"2022-01-04 20:11","market":"us","language":"en","title":"3 Top Value Stocks for 2022 and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2200081405","media":"Motley Fool","summary":"The market is pessimistic on these beaten-down stocks, but they all have good growth stories to tell.","content":"<div>\n<p>Value investing is a lot more than simply buying stocks that look cheap. Shares of a business in permanent decline may look inexpensive, relative to earnings, sales, book value, or another metric, but...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Value Stocks for 2022 and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Value Stocks for 2022 and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 20:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Value investing is a lot more than simply buying stocks that look cheap. Shares of a business in permanent decline may look inexpensive, relative to earnings, sales, book value, or another metric, but...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4535":"淡马锡持仓","BK4554":"元宇宙及AR概念","BK4515":"5G概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4134":"信息科技咨询与其它服务","BK4529":"IDC概念","BK4512":"苹果概念","BK4538":"云计算","BK4527":"明星科技股","IBM":"IBM","T":"At&T","BK4550":"红杉资本持仓","BK4141":"半导体产品","BK4534":"瑞士信贷持仓","INTC":"英特尔","BK4507":"流媒体概念","BK4115":"综合电信业务"},"source_url":"https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200081405","content_text":"Value investing is a lot more than simply buying stocks that look cheap. Shares of a business in permanent decline may look inexpensive, relative to earnings, sales, book value, or another metric, but they're cheap for a reason.The best value stocks are cheap because the market is wrong about their potential. Sometimes, a solid company that has a good shot at turning itself around after facing some temporary setbacks can be priced like the world is ending. If the world doesn't end, that stock can produce stunning returns in the long run.As we enter 2022, AT&T (NYSE:T), International Business Machines (NYSE:IBM), and Intel (NASDAQ:INTC) all fit into this category. All three have a decent growth story to tell, and all three have a lot of pessimism priced in.AT&TShares of AT&T have been hammered over the past few years as the company's acquisitions of DirecTV and Time Warner failed to deliver. AT&T fancied itself a media conglomerate, and it spent heavily in a bungled attempt to fulfill that vision.DirecTV has been spun off, and Time Warner (now WarnerMedia) is set to be merged with Discovery to create a media and streaming giant. After the dust settles, AT&T will be a telecom company again, free from the distractions of the media business and better able to invest in its core business.AT&T expects to produce around $20 billion of free cash flow in the first full year after the WarnerMedia deal closes. With a current market capitalization of around $175 billion, the market is clearly pessimistic. AT&T shareholders will also own 71% of the media company created by the spin-off. That media company is expected to produce $52 billion of revenue in 2023.This all seems like a pretty good deal. Buy AT&T for less than 10 times expected post-spin-off free cash flow, and later this year you'll own a leading telecom company and a big chunk of a new media and streaming giant. AT&T will cut its dividend once the deal closes, which is probably weighing on the shares. And AT&T's post-spin-off estimates could very well be overly optimistic. But given the rock-bottom valuation and the stability of the core wireless business, it's hard to see an investment in AT&T going all that badly over the next five years.International Business MachinesIBM has dumped its slow-growing and labor-intensive managed infrastructure services business, spinning it off as a new company called Kyndryl. What's left of the century-old tech giant is now laser focused on hybrid cloud computing and artificial intelligence.While IBM's cloud business has grown substantially over the past decade, the company has been weighed down by legacy businesses. Revenues and profits have been trending lower for a long time. A sustainable return to growth has proved elusive.With around $19 billion of low-margin revenue now out of the picture, IBM's growth profile looks a lot better. The company expects sustainable mid-single-digit revenue growth to be the norm, along with high single-digit growth in free cash flow. Over the next three years, IBM expects to produce around $35 billion of free cash flow in total, or nearly $12 billion on average each year. The company is valued at just $120 billion.It's been a very long road for IBM shareholders betting on a turnaround, and the stock has a lot of pessimism priced in. If IBM can deliver on its targets, or even come close, the iconic tech company could be worth far more in five years than it's worth today.IntelChip giant Intel is working on its own turnaround. Under CEO Pat Gelsinger, an Intel veteran lured back to right the ship, the company is embarking on a costly plan to regain its manufacturing edge and build a world-class foundry business.Intel is still a highly profitable company, but years of delays bringing new process nodes to volume production have degraded its key competitive advantages. Third-party foundries like Taiwan Semiconductor have surpassed Intel on the manufacturing side, and rival AMD has taken advantage. AMD is now producing PC and server chips that are as good or better than what Intel is producing.Intel's plan is to pour cash into new manufacturing facilities. The company will spend as much as $28 billion on capital expenditures this year, and that number may increase in future years. For comparison, the company expected to spend around $19 billion in 2021.Intel's manufacturing push will take years to play out, and earnings will take a hit until the company's heavy investments pay off. But if Intel gets it right, it can maintain its dominant position in the PC and server chip markets while claiming a big chunk of the foundry market. Foundries soaked up around $100 billion of spending last year, and there's no reason Intel can't compete in that growing market.Even factoring in the expected earnings hit, Intel stock is priced at a pessimistic level. The stock trades for just 14 times the average analyst estimate for 2022 earnings. The market seems to be completely ignoring Intel's long-term potential.Intel has a proven leader at the helm and plenty of cash flow to fund much of its capital spending plans. Demand for semiconductors is high, supply is constrained, and it doesn't look like that situation will change anytime soon. Intel has a good story to tell. Add in a beaten-down valuation, and you've got yourself a stock that could soar.","news_type":1,"symbols_score_info":{"IBM":1,"INTC":1,"T":1}},"isVote":1,"tweetType":1,"viewCount":1493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001578627,"gmtCreate":1641289602460,"gmtModify":1676533593407,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Interesting...will keep watch","listText":"Interesting...will keep watch","text":"Interesting...will keep watch","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001578627","repostId":"2200657421","repostType":4,"isVote":1,"tweetType":1,"viewCount":1159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001571284,"gmtCreate":1641289447597,"gmtModify":1676533593390,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Looking forward to It's growth","listText":"Looking forward to It's growth","text":"Looking forward to It's growth","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001571284","repostId":"1159023933","repostType":4,"repost":{"id":"1159023933","kind":"news","pubTimestamp":1641260272,"share":"https://ttm.financial/m/news/1159023933?lang=en_US&edition=fundamental","pubTime":"2022-01-04 09:37","market":"us","language":"en","title":"3 Stocks That Can Double Again in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1159023933","media":"Motley Fool","summary":"Hundreds of stocks doubled in 2021. Let's look at some that can repeat the feat in the year ahead.","content":"<html><head></head><body><p><b>Key Points</b></p><ul><li>Crocs has exploded onto the footwear scene, and after four years of accelerating top-line growth, it&#39;s hard to dismiss it as a fad.</li><li>Ford bounced back in 2021 and even started paying dividends again. It could be just revving up with its push into electric vehicles.</li><li>Dick&#39;s Sporting Goods is posting strong growth, riding ascending trends, and trading at a low earnings multiple.</li></ul><p>A brutal lesson learned in 2021 is that what works one year may not hold up the following year. A lot of 2020&#39;s biggest stars fell apart last year. Winners don&#39;t typically repeat the feat. Looking over the list of roughly 160 stocks with market caps above $1 billion that more than doubled in 2021, it&#39;s hard to find names that will trounce the market again this year.</p><p>I believe that <b>Crocs</b>(NASDAQ:CROX),<b>Ford</b>(NYSE:F), and <b>Dick&#39;s Sporting Goods</b>(NYSE:DKS) are some of the 2021 champs that could stand tall again this year. They all doubled last year. Let&#39;s see why they could double again in 2022.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/363daf37d0a5f4ab87fcdb3f126ac122\" tg-width=\"2000\" tg-height=\"1305\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>Crocs</b></p><p>It&#39;s been 20 years since Crocs hit the market. Initially marketed as boating shoes for their ability to withstand slippery surfaces, the unique resin shoes eventually resonated with a much larger audience. Young consumers flocked to the shoes for their colorful styles and the ability to customize them with snap-on Jibbitz. Adults -- particularly nurses, teachers, and others who spend a lot of time on their feet -- turned to Crocs for their comfort.</p><p>The shoes have had their ups and downs over the years, and while that has resulted in some fair knocks on the brand as faddish, it&#39;s been doing a great job of sustaining and building on its growth since tapping a new CEO in 2017. Crocs has posted double-digit sales growth in each of the past three years, including a head-turning 77% increase through the first three quarters of last year.</p><p>The &#34;beat and raise&#34; quarters find Crocs raising the bar with every passing quarter, yet somehow Crocs is trading for just 14 times forward earnings. It was understandable that Crocs spiked in popularity during the early days of the pandemic when we spent so much time at home, but with celebrity endorsers piling up, Crocs has gone fashionably mainstream.</p><p>Growth will slow from here, but Crocs still sees revenue topping 20% this year with a long-term compounded annual growth rate of 17%. If that sounds conservative, keep in mind that the growing footwear maker has historically aimed lower than reality. It was originally forecasting 20% to 25% growth last year, and we saw how that played out.</p><p><b>Ford</b></p><p>If you were asked which automaker saw its stock double last year, you might be quick to think of Elon Musk, but it&#39;s another four-letter name. Shares of Ford soared 137% in 2021. The pioneering automaker can thank its push into electric vehicle versions of its favorite models for getting investors excited about its long-term growth prospects, but it&#39;s doing pretty well right now.</p><p>Revenue is growing again. Analysts see a return to double-digit top-line growth next year, something that investors haven&#39;t seen since 2013. Profitability is booming, and it has soundly beaten analyst expectations in each of the past four reports. If you think Crocs is cheap at 14 times earnings, Ford is fetching less than 11 times this New Year&#39;s projected bottom line. Ford also recently brought back its quarterly dividend after nixing it when the pandemic began, giving investors some income to go along with the monster capital appreciation.</p><p><b>Dick&#39;s Sporting Goods</b></p><p>Another big winner of 2021 trading at a cheap multiple despite more than doubling over the past year is Dick&#39;s Sporting Goods. The sporting goods chain is thriving with a refreshed retail vision that&#39;s making its superstores stand out against online specialists. We saw this happen in 2020, when it grew net sales by almost 10% in a climate where most brick-and-mortar retailers struggled. Business is picking up with a 38% top-line surge through the first three quarters of 2021.</p><p>The news is even better on the bottom line. Dick&#39;s Sporting Goods is achieving record profits, and it&#39;s been landing well ahead of Wall Street pros over the past year.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6ee66f062534ff908070aa8add04e00a\" tg-width=\"1149\" tg-height=\"338\" width=\"100%\" height=\"auto\"/><span>DATA SOURCE: YAHOO! FINANCE.</span></p><p>It&#39;s been a good time to play ball with sporting goods stocks. The pandemic has made us appreciate being outdoors, and sports is a big part of staying active outside. If you thought Crocs and Ford are cheap, Dick&#39;s Sporting Goods is trading for just eight times the midpoint of its adjusted profit per share guidance for the year that just ended.</p><p>All three stocks are more than reasonably priced. Growth should slow for Crocs and Dick&#39;s Sporting Goods next year, but there is still a lot to like with all three investments as we head into 2022.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Can Double Again in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Can Double Again in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 09:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/03/3-stocks-that-can-double-again-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key PointsCrocs has exploded onto the footwear scene, and after four years of accelerating top-line growth, it's hard to dismiss it as a fad.Ford bounced back in 2021 and even started paying dividends...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/3-stocks-that-can-double-again-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","CROX":"卡骆驰","DKS":"迪克体育用品"},"source_url":"https://www.fool.com/investing/2022/01/03/3-stocks-that-can-double-again-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159023933","content_text":"Key PointsCrocs has exploded onto the footwear scene, and after four years of accelerating top-line growth, it's hard to dismiss it as a fad.Ford bounced back in 2021 and even started paying dividends again. It could be just revving up with its push into electric vehicles.Dick's Sporting Goods is posting strong growth, riding ascending trends, and trading at a low earnings multiple.A brutal lesson learned in 2021 is that what works one year may not hold up the following year. A lot of 2020's biggest stars fell apart last year. Winners don't typically repeat the feat. Looking over the list of roughly 160 stocks with market caps above $1 billion that more than doubled in 2021, it's hard to find names that will trounce the market again this year.I believe that Crocs(NASDAQ:CROX),Ford(NYSE:F), and Dick's Sporting Goods(NYSE:DKS) are some of the 2021 champs that could stand tall again this year. They all doubled last year. Let's see why they could double again in 2022.IMAGE SOURCE: GETTY IMAGES.CrocsIt's been 20 years since Crocs hit the market. Initially marketed as boating shoes for their ability to withstand slippery surfaces, the unique resin shoes eventually resonated with a much larger audience. Young consumers flocked to the shoes for their colorful styles and the ability to customize them with snap-on Jibbitz. Adults -- particularly nurses, teachers, and others who spend a lot of time on their feet -- turned to Crocs for their comfort.The shoes have had their ups and downs over the years, and while that has resulted in some fair knocks on the brand as faddish, it's been doing a great job of sustaining and building on its growth since tapping a new CEO in 2017. Crocs has posted double-digit sales growth in each of the past three years, including a head-turning 77% increase through the first three quarters of last year.The \"beat and raise\" quarters find Crocs raising the bar with every passing quarter, yet somehow Crocs is trading for just 14 times forward earnings. It was understandable that Crocs spiked in popularity during the early days of the pandemic when we spent so much time at home, but with celebrity endorsers piling up, Crocs has gone fashionably mainstream.Growth will slow from here, but Crocs still sees revenue topping 20% this year with a long-term compounded annual growth rate of 17%. If that sounds conservative, keep in mind that the growing footwear maker has historically aimed lower than reality. It was originally forecasting 20% to 25% growth last year, and we saw how that played out.FordIf you were asked which automaker saw its stock double last year, you might be quick to think of Elon Musk, but it's another four-letter name. Shares of Ford soared 137% in 2021. The pioneering automaker can thank its push into electric vehicle versions of its favorite models for getting investors excited about its long-term growth prospects, but it's doing pretty well right now.Revenue is growing again. Analysts see a return to double-digit top-line growth next year, something that investors haven't seen since 2013. Profitability is booming, and it has soundly beaten analyst expectations in each of the past four reports. If you think Crocs is cheap at 14 times earnings, Ford is fetching less than 11 times this New Year's projected bottom line. Ford also recently brought back its quarterly dividend after nixing it when the pandemic began, giving investors some income to go along with the monster capital appreciation.Dick's Sporting GoodsAnother big winner of 2021 trading at a cheap multiple despite more than doubling over the past year is Dick's Sporting Goods. The sporting goods chain is thriving with a refreshed retail vision that's making its superstores stand out against online specialists. We saw this happen in 2020, when it grew net sales by almost 10% in a climate where most brick-and-mortar retailers struggled. Business is picking up with a 38% top-line surge through the first three quarters of 2021.The news is even better on the bottom line. Dick's Sporting Goods is achieving record profits, and it's been landing well ahead of Wall Street pros over the past year.DATA SOURCE: YAHOO! FINANCE.It's been a good time to play ball with sporting goods stocks. The pandemic has made us appreciate being outdoors, and sports is a big part of staying active outside. If you thought Crocs and Ford are cheap, Dick's Sporting Goods is trading for just eight times the midpoint of its adjusted profit per share guidance for the year that just ended.All three stocks are more than reasonably priced. Growth should slow for Crocs and Dick's Sporting Goods next year, but there is still a lot to like with all three investments as we head into 2022.","news_type":1,"symbols_score_info":{"CROX":0.9,"F":0.9,"DKS":0.9}},"isVote":1,"tweetType":1,"viewCount":1340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001571070,"gmtCreate":1641289320744,"gmtModify":1676533593377,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"[Like]&nbsp;","listText":"[Like]&nbsp;","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001571070","repostId":"1138187882","repostType":4,"repost":{"id":"1138187882","kind":"news","pubTimestamp":1641279427,"share":"https://ttm.financial/m/news/1138187882?lang=en_US&edition=fundamental","pubTime":"2022-01-04 14:57","market":"us","language":"en","title":"Tesla, Apple and This Chipmaker Are Seeing The Highest Interest On WallStreetBets Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1138187882","media":"Benzinga","summary":"Electric vehicle maker Tesla Inc. continues to be the most-discussed stock on Reddit’s r/WallStreetB","content":"<div>\n<p>Electric vehicle maker Tesla Inc. continues to be the most-discussed stock on Reddit’s r/WallStreetBets forum as of early Tuesday.What Happened: Tesla is seeing the highest interest on the forum with ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/24873642/tesla-apple-and-this-chipmaker-are-seeing-the-highest-interest-on-wallstreetbets-today\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, Apple and This Chipmaker Are Seeing The Highest Interest On WallStreetBets Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, Apple and This Chipmaker Are Seeing The Highest Interest On WallStreetBets Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/01/24873642/tesla-apple-and-this-chipmaker-are-seeing-the-highest-interest-on-wallstreetbets-today><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric vehicle maker Tesla Inc. continues to be the most-discussed stock on Reddit’s r/WallStreetBets forum as of early Tuesday.What Happened: Tesla is seeing the highest interest on the forum with ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/24873642/tesla-apple-and-this-chipmaker-are-seeing-the-highest-interest-on-wallstreetbets-today\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","TSLA":"特斯拉","AAPL":"苹果"},"source_url":"https://www.benzinga.com/news/22/01/24873642/tesla-apple-and-this-chipmaker-are-seeing-the-highest-interest-on-wallstreetbets-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138187882","content_text":"Electric vehicle maker Tesla Inc. continues to be the most-discussed stock on Reddit’s r/WallStreetBets forum as of early Tuesday.What Happened: Tesla is seeing the highest interest on the forum with 862 mentions as at press time, followed by exchange-traded fund SPDR S&P 500 ETF Trust with 341 mentions, data from Quiver Quantitative showed.Tech giant Apple Inc. and graphics chipmaker Nvidia Corp. are in the third and fourth positions, having attracted 145 and 122 mentions, respectively.Why It Matters: Tesla’s shares gained more than 13% in Monday’s regular trading session after the Elon Musk-led company reported record fourth-quarter deliveries despite global supply headwinds.Apple is seeing high interest on the forum after the iPhone maker on Monday became the first company to breach the$3 trillion market capitalization mark.Nvidia’s shares rose along with shares of other chipmakers on Monday after Citigroup analyst Christopher Danely cited a weekend report from the Semiconductor Industry Association and noted that November chip sales were “well above” seasonal trends, while lead times continued to get longer.Price Action: Tesla shares closed 13.5% higher in Monday’s regular trading session at $1,199.78 and further rose almost 0.9% in the after-hours session to $1,209.97.","news_type":1,"symbols_score_info":{"NVDA":0.9,"AAPL":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001695878,"gmtCreate":1641229544870,"gmtModify":1676533585718,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"A bit too much...","listText":"A bit too much...","text":"A bit too much...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001695878","repostId":"2200429489","repostType":4,"repost":{"id":"2200429489","kind":"highlight","pubTimestamp":1641208372,"share":"https://ttm.financial/m/news/2200429489?lang=en_US&edition=fundamental","pubTime":"2022-01-03 19:12","market":"us","language":"en","title":"22 Stocks That Could Double Your Money in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2200429489","media":"Motley Fool","summary":"Triple-digit returns could be just a click of the buy button away.","content":"<div>\n<p>New year, new you, new opportunities to get smarter, happier, and richer!Despite the tumult of the continuing pandemic, Wall Street had itself another fine year. The benchmark S&P 500 registered its ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>22 Stocks That Could Double Your Money in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n22 Stocks That Could Double Your Money in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 19:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New year, new you, new opportunities to get smarter, happier, and richer!Despite the tumult of the continuing pandemic, Wall Street had itself another fine year. The benchmark S&P 500 registered its ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4084":"特种房地产投资信托","BK4555":"新能源车","BK4122":"互联网与直销零售","AXON":"Axon Enterprise, Inc.","BK4562":"SPAC上市公司","BK4107":"财产与意外伤害保险","BK4566":"资本集团","BK4547":"WSB热门概念","BK4505":"高瓴资本持仓","BK4079":"房地产服务","BK4535":"淡马锡持仓","NVAX":"诺瓦瓦克斯医药","ARR":"ARMOUR住宅房地产公司","PRLB":"Proto Labs Inc","BK4546":"3D打印","PUBM":"PubMatic, Inc.","BK4504":"桥水持仓","BK4559":"巴菲特持仓","NIO":"蔚来","TEVA":"梯瓦制药","BK4110":"抵押房地产投资信托","BARK":"The Original Bark Corp.","PING":"Ping Identity Holding","BK4568":"美国抗疫概念","BK4147":"半导体设备","BK4548":"巴美列捷福持仓","KGC":"金罗斯黄金","BK4095":"家庭装饰品","BK4017":"黄金","BK4551":"寇图资本持仓","BK4526":"热门中概股","BK4509":"腾讯概念","PINS":"Pinterest, Inc.","BK4561":"索罗斯持仓","BK4009":"广告","BK4097":"系统软件","BK4508":"社交媒体","BK4532":"文艺复兴科技持仓","BK4187":"航天航空与国防","BK4161":"工业机械","ROOT":"Root, Inc.","BK4531":"中概回港概念","BK4077":"互动媒体与服务","BK4099":"汽车制造商","BK4534":"瑞士信贷持仓"},"source_url":"https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200429489","content_text":"New year, new you, new opportunities to get smarter, happier, and richer!Despite the tumult of the continuing pandemic, Wall Street had itself another fine year. The benchmark S&P 500 registered its second most all-time closing highs in a single year and ultimately more than doubled up its average annual total return of 11%, dating back to 1980.But no matter how high the broader market indexes climb, there will always be opportunities for investors to grow their wealth and possibly even double their money. As we steam forward into a new year, here are 22 stocks that could double your money in 2022.1. PinterestWhile you'll find plenty of small- and mid-cap stocks with 100%-plus upside potential on this list, don't overlook large-cap stocks like social media giant Pinterest (NYSE:PINS). After all, winners keep winning.In 2021, Wall Street struggled to digest modest sequential quarterly declines in Pinterest's monthly active users (MAUs). This decline was the expected reaction as coronavirus vaccination rates kept ticking higher and people returned to some activities outside their homes. But this laser-focus on Pinterest's MAUs misses two critical points that make it a screaming buy at its current share price.To begin with, there's been no slowdown in the monetization of Pinterest's MAUs, even if new user growth is returning to historic norms. The September quarter featured a global average revenue per user (ARPU) increase of 37%, with international ARPU rising 81%. In simple terms, advertisers have proved more than willing to pay up to get their message in front of Pinterest's 444 million monthly users.Second, Wall Street is apparently forgetting how perfect Pinterest's model is for attracting ad revenue. The entire premise is built on having its MAUs share the things, places, and services that interest them. With no guesswork involved, merchants can effectively target their ad dollars at users who'd be likely to make a purchase. This puts Pinterest on track to eventually become a force in e-commerce.2. PubMaticOne of the smartest ways to potentially double your money in 2022 is to consider putting it to work in cloud-based programmatic advertising technology company PubMatic (NASDAQ:PUBM).PubMatic is what's known as a sell-side platform. SSPs go to work for publishers by selling their display space to advertisers. Though its clients can provide input, such as setting the minimum price accepted to sell display space, PubMatic's cloud-based infrastructure handles everything with machine-learning algorithms. By optimizing what messages users see, PubMatic can keep advertisers happy while boosting the pricing power of its clients (i.e., publishers) over time.What really sets PubMatic up for success is its focus on digital advertising. According to the company, global digital ad spend should average a 10% annual increase between 2019 and 2024 as people shift their content consumption habits. However, PubMatic has consistently grown at two or more times this rate. That's because nearly two-thirds of its revenue comes from mobile and omnichannel formats, which includes connected TV.Furthermore, the company's clients really seem to love the service, as evidenced by four consecutive quarters of a net dollar-based retention rate of 150% (or more). In simple terms, that means existing clients have spent at least 50% more year-over-year for the past four quarters. With PubMatic consistently crushing Wall Street's expectations, this shift to digital ads could send its shares a lot higher this year.3. Planet 13 HoldingsCannabis may well be one of the most consistent double-digit growth opportunities of the decade. With the U.S. representing the epicenter of this growth, multistate operator (MSO) Planet 13 Holdings (OTC:PLNH.F) has a real shot to double your money.Most MSOs are all about establishing a presence in as many states as possible. That's not Planet 13's modus operandi. It's focused just as much on providing a unique experience for customers as it is on making sales.Planet 13 has only two operating dispensaries, but there's nothing else like them in the United States. The Las Vegas SuperStore spans 112,000 square feet (that's bigger than the average Walmart), and has a café, events center, and consumer-facing processing center. Meanwhile, the more recently opened Orange County SuperStore has 55,000 square feet of space, 16,500 square feet of which is devoted to selling.Planet 13's immersive and tech-integrated store designs do tend to work best in tourist-heavy locations. The next three stores to be opened will be in Chicago, Orlando, and Miami. However, the pandemic taught the company the value of appealing to local residents. With a steady stream of local customers mixed in with tourists, this company is ready to push to recurring profitability this year.4. Axon EnterpriseIt's not often you see a borderline large-cap company effectively double its total addressable market (TAM) overnight, but that's what Axon Enterprise (NASDAQ:AXON) dropped on investors with its third-quarter shareholder letter. Axon now believes its TAM is $52 billion, up from a prior forecast of $27 billion.Axon is the company behind the popular less-than-lethal Taser devices used by law enforcement. It's also responsible for many of the body cameras worn by peace officers, and it provides evidence-database software used in police departments. With many major cities focused on social reforms, Axon's products have become front-and-center solutions for greater law enforcement transparency.The secret sauce to Axon's TAM nearly doubling is its broadening focus to also include the consumer market. Management plans to roll out its less-than-lethal Taser products to consumers, as well as offer a consumer-focused smartphone app, which'll be unveiled in 2022. Based on management's estimates, the individual consumer market could offer a higher TAM than what law enforcement can bring in.Likewise, Axon has (pardon the pun) worlds of international potential. Even though domestic sales make up the lion's share of its existing revenue, international sales grew twice as fast as domestic revenue (70% vs. 34%) in the September-ended quarter. Representing close to $15 billion in TAM, overseas markets could be the icing on the cake that leads Axon to double in 2022.5. EverQuoteOne company I'm doubling down on is online insurance marketplace EverQuote (NASDAQ:EVER). I say \"double down\" because it was a stock I felt would outperform in 2021, but it fell flat in a big way. This year should hopefully flip the script for this fast-paced small-cap stock.Although the insurance industry is a moneymaker, it's generally slow-growing. EverQuote operates in arguably the fastest-growing subsection: digital advertising. The expectation is for insurance-related digital ad spend to increase by an annualized rate of 16% through 2024.EverQuote is already working with 19 of the top 20 auto insurers, which allows it to present thorough price comparisons to consumers. Meanwhile, its platform lures in motivated buyers, which essentially means insurers are able to more effectively utilize their marketing dollars. As consumer buying habits shift online, EverQuote's role as a leading insurance marketplace will only expand over time.Furthermore, EverQuote has moved into new verticals over the past couple of years, including home, rental, health, life, and commercial insurance. These verticals have grown at an even faster rate than its traditional auto insurance segment, and they provide a nice opportunity to book high-margin add-on revenue.6. NovavaxIt's no secret that coronavirus disease 2019 (COVID-19) stocks have been on fire since the pandemic began. But one COVID-19 stock still offers incredible upside and the real chance to double in 2022. Say hello to Novavax (NASDAQ:NVAX).Although the COVID-19 vaccine field continues to grow, Novavax stands out. The company's vaccine, NVX-CoV2373, was tested in two large-scale studies. It produced an 89.7% vaccine efficacy (VE) in the U.K. and a 90.4% VE in the U.S./Mexico trial. Including Novavax, only three COVID-19 vaccines have produced an efficacy of 90% or higher, which should allow the company to eventually slide in as the global No. 3 COVID-19 vaccine provider.The mutability of the SARS-CoV-2 virus that causes COVID-19 is also working in Novavax's favor. Instead of simply benefiting from an initial inoculation campaign, the introduction of new viral variants provides Novavax a way to generate recurring revenue. The company's drug-development platform is designed to with speed and efficacy in mind to develop booster shots and variant-specific vaccines.Best of all, you're getting Novavax at a discount. Short-term regulatory filings delays and production concerns held the company's share price down throughout 2021. Most of these worries are now in the rearview mirror. With the company likely to win numerous emergency-use authorizations this year, it's a good bet to become a key player in the ongoing fight against COVID-19.7. GrowGenerationFollowing a 21-month roller-coaster ride, retail hydroponic and organic gardening chain GrowGeneration (NASDAQ:GRWG) looks ripe for the picking and ready to double.Between March 2020 and February 2021, GrowGen was one of the hottest stocks on Wall Street, with shares skyrocketing more than twentyfold. But since hitting its 52-week high, shares are now down close to 80%. This huge reversion looks to be based on slowing organic growth, as well as higher inflation, which could weigh on the company's margins. Though its 80% reversion has been less than ideal for existing shareholders, it's the perfect entry point for new investors.The two-pronged strategy that'll allow GrowGeneration to be a portfolio superstar is its inorganic expansion, as well as its omnichannel presence. In terms of the former, GrowGen has regularly leaned on acquisitions to expand its reach into new and existing high-dollar markets. This is a company with lighting, nutrient, soil, and hydroponic solutions that appeal to both the consumer and enterprise markets, and it has been especially popular among cannabis growers. GrowGen currently has 62 stores in 13 states.Beyond leaning on buyouts, GrowGeneration is building up its e-commerce presence and focusing on private-label and proprietary brands to lift its long-term margins.Once valued at more than 10 times sales and over 200 times forecasted earnings, GrowGen now goes for well under 2 two times sales and closer to 40 times Wall Street's consensus earnings for 2022.8. BarkIn the U.S., 69 million households own a dog, according to the American Pet Products Association. Furthermore, pet owners haven't reduced year-over-year spending on their furry family members in over a quarter of a century. This makes dog-focused products and services company Bark (NYSE:BARK) the perfect candidate to fetch investors a double in 2022.What makes Bark so special is the company's subscription-based operating model. Even though its products can be found in more than 23,000 retail doors nationwide, 89% of the company's revenue derived from direct-to-consumer sales in the third quarter. The subscription model tends to lead to higher customer retention rates, predictable cash flow, and lower overhead expenses. As a result, Bark's gross margin has consistently hovered between a juicy 58% and 60%.The company's marketing campaigns are paying dividends, too. In less than two years, the number of subscribers has more than doubled from less than a million to approximately 2.1 million, as of September.And don't overlook Bark's innovation as a growth catalyst. The introduction of Bark Home, which provides basic necessities like collars and beds, and Bark Eats, a service that helps owners craft a customized dry-food diet for their pooch, are the perfect complements to drive add-on sales.9. Kinross GoldGold stocks didn't have a particularly good 2021. But the upcoming year could allow Kinross Gold (NYSE:KGC) to regain its luster in a big way.To state the obvious, gold-mining stocks benefit when the price of the metal they're digging out of the ground appreciates in value. The lustrous yellow metal should benefit from historically low bond yields (i.e., there aren't many ways to generate inflation-topping returns with bonds) and will probably receive a lift from inflation that's hit levels not seen since the Reagan administration. A bounce back year for gold seems likely.But Kinross isn't just sitting on its laurels and letting the physical price of gold do all the work. The most exciting advancement is the Tasiast 21k project. By the end of March, the company's throughput at the key Tasiast mine in Mauritania should reach 21,000 tonnes per day. By mid-2023, the Tasiast 24k project will be complete, and throughput will advance to 24,000 tonnes/day. These projects will nearly double the annual output of the mine and lower all-in sustaining costs to a mere $560 per gold ounce.Kinross Gold has a veritable mountain of long-term projects as well, including Fort Knox, La Coipa, and Chulbatkan. The company is regularly replenishing or growing its precious metal reserves.With Kinross expected to grow its output from 2.1 million gold equivalent ounces (GEO) in 2021 to 2.7 million GEO in 2022, a multiple of 3.6 times this year's estimated cash flow per share is too cheap to pass up.10. RootAll investments come with risk, but some are riskier than others. Innovative insurance company Root (NASDAQ:ROOT) falls into the high-risk/high-reward category. But if things go right in 2022, shares could very easily double.Root is attempting to disrupt a stodgy industry that's been pricing auto insurance policies using metrics that have absolutely nothing to do with the quality of someone's driving, such as credit score and marital status. It aims to do this by leaning on telematics. Using sensitive instrumentation found in smartphones, Root can measure G-forces based on braking, turning, and accelerating to determine how safe a driver really is behind the wheel. In short, the company believes it can offer drivers an accurately priced auto insurance policy on the spot.Initial operating results from Root have been mixed but encouraging. For the time being, the company is reporting sizable per-share losses as it focuses on signing up new customers and building up its brand. However, this hasn't stopped it from reporting gross accident period loss ratios below 100%. Any figure below 100% represents a profitably written policy. While loss ratios have been a bit erratic because of the pandemic, the initial takeaway is that a telematics-based approach can work.If Root's accident loss ratios stabilize or decline (a lower number means a more profitable policy) in 2022, it could be a big winner.11. NioA year ago, electric vehicle (EV) manufacturer Nio (NYSE:NIO) wasn't a company I'd touch with a 10-foot pole. But after watching management navigate the numerous challenges presented by the pandemic, I'm extremely impressed by the company's execution and have changed my tune -- so much so that I believe, under the right circumstances, Nio could double in 2022.Throughout the second and third quarters of 2021, the auto industry was constrained by semiconductor chip shortages and other supply chain snafus. This situation held back Nio's expansion efforts. But these issues are now abating, and the company's deliveries are soaring. In November, Nio delivered 10,878 vehicles, which equates to an annual run rate of more than 130,000 EVs. By the end of this year, management is targeting an annual run rate of 600,000 EVs. If this ramp-up continues, quadrupling sales by 2024 is easily doable.In addition to ramping production, Nio is being driven by innovation. It'll be introducing three new EVs this year, and it will continue to lean on the battery-as-a-service program (BaaS) that was introduced in August 2020. The BaaS program provides battery charging and swap-outs for Nio EV owners for a monthly fee. In exchange, buyers receive a discount off the initial purchase price of their vehicle. Nio is effectively trading some near-term revenue for improved customer loyalty and juicy fee-based margin over the long run.The topper is that the company is based in the largest auto market in the world, China. Everything appears set for Nio to floor it in 2022.12. Columbia CareAnother marijuana stock with the potential to double your money in the New Year is U.S. MSO Columbia Care (OTC:CCHWF).Like Planet 13, Columbia Care has a unique strategy that should pay long-term dividends. First, it tends to focus on a number of limited-license markets, such as Pennsylvania, Ohio, and Massachusetts. A limited-license market caps how many retail licenses are issued in total and/or to a single business. For some MSOs, this can inhibit their ability to dominate market share in a state. But for many MSOs, like Columbia Care, these limitations provide some degree of competitive protection that allows them to effectively build up their brands and garner a loyal following.The more important growth driver for Columbia Care is its love affair with acquisitions. Since June, the company has closed a $240 million deal to acquire Green Leaf Medical and a $42 million buyout of Medicine Man. The latter should increase Columbia Care's share in the United States' No. 2 weed market, Colorado, while the former gave it a sizable Mid-Atlantic presence.With sustainable double-digit organic sales growth and a steady diet of acquisitions, Columbia Care could easily top $1 billion in annual sales by 2023 after generating \"only\" $180 million in sales in 2020.13. Opendoor TechnologiesFor those of you with a higher tolerance for risk and reward, technology-driven residential real estate company Opendoor Technologies (NASDAQ:OPEN) could be the ticket to doubling your money in 2022.Opendoor is the leading company in what's known as iBuying. iBuying happens when a real estate company purchases a home for cash, thereby eliminating the real estate agents that would otherwise take a commission. The process tends to be relatively fast and can quickly put cash in the pockets of those who need it, or who don't want to deal with the hassles of showing a home for months on end. Opendoor keeps a 5% fee on the sales price of a home and deducts the cost of any repairs that need to be done.What's particularly interesting about Opendoor is that one of its top competitors, Zillow, recently announced it would shut down its iBuying program. Zillow announced in October that it would pause buying homes, and then in November it announced a total shutdown of the segment after miscalculating home values. This hasn't been an issue for Opendoor, which nearly quintupled its year-over-year home sales in the third quarter to 5,988. The company also more than doubled the number of markets it serves, from 21 to 44.The \"risk\" for Opendoor is that the Federal Reserve will almost certainly begin raising rates in 2022. In my opinion, this'll only create an incentive for fence-sitting sellers to make the leap. With plenty of liquidity and homes to back up the debt on its balance sheet, 2022 could be a booming year for Opendoor.14. Teva Pharmaceutical IndustriesEverQuote isn't the only company on the list that's making a repeat appearance. Brand-name and generic-drug stock Teva Pharmaceutical Industries (NYSE:TEVA) looks to have the puzzle pieces in place to double.In terms of valuation, pharmaceutical stocks don't come any cheaper. Shares can be scooped up for roughly 3 times Wall Street's forecasted earnings per share in 2022. This exceptionally low price-to-earnings ratio is a function of the opioid litigation Teva and its peers are facing, as well as other factors, such as generic-drug price weakness and a leveraged balance sheet.Teva's secret weapon continues to be its CEO, Kare Schultz, a turnaround specialist who, since taking over in late 2017, has slashed annual operating expenses by billions of dollars, jettisoned non-core assets, and reduced the company's net debt from north of $34 billion to about $22 billion. There's no question Teva has more financial flexibility now than it did four years ago.The key to Teva's doubling would be a resolution to the more than 40 state-level opioid lawsuits. The thing is, Teva and its peers recently won an opioid trial in California. With momentum now shifting, Schultz may be able to broker a nationwide deal that involves free or discounted generic medicines, as opposed to a cash settlement. If this litigation overhang disappears, Teva could soar.15. Alliance Resource PartnersWhat would you say if I told you that an ultra-high-yield dividend stock could double your money in 2022? Better yet, what if I noted that this company in question is primarily a coal producer? By now you probably think I'm nuts, but Alliance Resource Partners (NASDAQ:ARLP) could very well turn coal into diamonds for its shareholders this year.There's no sugarcoating that that Alliance Resource had a miserable 2020. Coal demand and per-ton pricing dropped considerably, as did the royalty revenue the company generates from its oil and natural gas assets. It was something of a perfect storm that caused this rock-solid dividend stock to halt its payout. But a turnaround is now well under way.According to CEO Joseph Craft, the conditions for coal, in terms of demand and pricing, remain favorable into 2023. A big increase in natural gas prices last year has lifted demand for coal production in the Eastern U.S., with capacity utilization of the company's domestic coal fleet hitting a three-year high.The company also has a track record of securing coal supply and price commitments domestically and abroad well in advance. Based on its expected output in 2021, perhaps 90% or more of 2022's output is already spoken for.A 7.6% yield with favorable industry trends and a forward price-to-earnings ratio of 4 gives this stock a real chance to shine.16. Ping Identity HoldingsOne of the smartest trends investors can put their money to work in this year is cybersecurity. Although most cybersecurity stocks trade at a premium, you can get double-digit growth and value -- along with the potential to double your money -- with Ping Identity (NYSE:PING).As its name implies, Ping's specialty is identity verification. The company's cloud-based platform relies on artificial intelligence to become smarter and more effective at recognizing and responding to potential threats over time. Ping is especially effective at working with on-premises security solution providers to create a unified platform. Ping is able to layer continuous verification, authentication, and authorization monitoring on users to improve overall data protection.Admittedly, Ping didn't perform all that well during the early stage of the pandemic. With some of its clients opting for shorter term-based licenses because of pandemic uncertainty, revenue growth stalled. However, annual recurring revenue (ARR) growth hasn't missed a beat. ARR is arguably a better measure of Ping's success, since virtually all of its revenue derives from subscriptions. The company's ARR has consistently grown by the mid- to high teens.Investors should also be excited about Ping's move to push software-as-a-service (SaaS) subscription solutions. SaaS cybersecurity solutions are high margin and should provide added incentive for clients to remain loyal to Ping. At roughly 6 times Wall Street's projected sales for 2022, this profitable cybersecurity stock is a steal.17. StoneCoFor investors who love risk and reward, fintech stock StoneCo (NASDAQ:STNE) is an excellent candidate to bounce back strongly in 2022, and potentially even double.Last year, the Brazilian-focused StoneCo struggled mightily. Its share price dropped in the neighborhood of 80%, with rapidly rising inflation and higher interest rates plaguing the Brazilian economy. Although inflation can be helpful if consumers keep buying goods and services, the costs to service StoneCo's loan segment, which is backed by its debt, becomes more expensive with rising rates.Though Brazil is entering 2022 in a less-than-ideal scenario, the thesis is that Wall Street has overreacted to StoneCo's recent struggles. As evidence, just take a closer look at micro- and small-business user and service utilization figures, which have all rocketed higher. The company's active paying client base more than doubled to 1.4 million, with its banking client base quadrupling to north of 422,000 in a year.At some point, StoneCo will have to raise its banking service prices to account for higher interest rates. But the user data clearly shows that Brazil is a largely untapped market for digital purchases and peer-to-peer loans, especially to small businesses and entrepreneurs.Furthermore, StoneCo has a history of generating adjusted profits, and its price-to-sales multiple has come down from north of 30 to approximately 3.5 times Wall Street's consensus revenue figure for 2022. That's a potential bargain.18. Jushi HoldingsThere's an insane amount of value among U.S. MSOs. But if my arm were twisted, small-cap stock Jushi Holdings (OTC:JUSHF) jumps to the top of the list.The company is a relative small fry compared with other MSOs. Last month, it opened just its 28th dispensary, with around 10 additional retail licenses waiting to be deployed. What really helps Jushi stand out is its three-state focus: Pennsylvania, Illinois, and Virginia. Last year, this trio is likely to have accounted for roughly 80% of total sales.Why Pennsylvania, Illinois, and Virginia? They're limited-license markets. If you recall from the discussion of Columbia Care, regulators in limited-license markets purposely encourage competition. While this can be a nuisance for larger MSOs, a smaller pot stock that's angling to build up its brand, like Jushi, can take advantage of these added protections. Both Pennsylvania, where Jushi has 18 of its 28 operating dispensaries, and Illinois limit how many retail licenses are issued in total and to a single business. Meanwhile, Virginia assigns licenses based on jurisdiction.Additional reasons to be excited about Jushi include management's willingness to deploy capital to make acquisitions in high-dollar markets, as well as having insiders with skin in the game. Approximately $45 million of the first $250 million the company raised came from insiders. Good things often happen when insiders and common-stock holders have the same monetary goal.19. Proto LabsA forgotten but undervalued name that could deliver sizable gains, and perhaps even a double in 2022, is digital manufacturing company Proto Labs (NYSE:PRLB).For anyone who's been investing in the stock market for the past decade, you're probably familiar with the hype and subsequent bubble-popping event that accompanied 3D printing. The application for 3D printers in healthcare and the industrial space remains insanely high. However, the uptake of individual printers sold commercially failed to come anywhere close to lofty expectations. After many years, Proto Labs is the company that looks to have emerged as the clear leader in digital manufacturing.Despite being plagued by supply chain issues and inflation in 2021, Proto Labs stands out for its operating approach. Rather than having to constantly spend to develop new 3D printing machines to sell to businesses, it acts as a one-stop shop for digital manufacturing services. If a business needs a quick turnaround for a prototype, Proto Labs can lean on injection molding, CNC machining, or 3D printing, to get the job done. Just as you'd go to FedEx for your shipping needs, Proto Labs is the higher-margin one-stop shop for enterprise prototyping needs.What's particularly encouraging is that all of its segments are growing, including year-over-year double-digit growth from 3D printing and CNC machining in the third quarter. With Proto Labs now valued at 3 times projected sales in 2022, down from more than 12 times sales a year ago, it looks like a value.20. LovesacWhen you think of innovation and growth, furniture stocks probably don't come to mind. That's because the furniture industry is typically reliant on foot traffic into brick-and-mortar stores, and everyone is buying similar wholesale products. But small-cap stock Lovesac (NASDAQ:LOVE) is completely shaking up the traditional furniture store operating model.The first way it's differentiating itself is with its furniture. Though it was originally known for its beanbag-styled chairs, called \"sacs,\" approximately 85% of its revenue these days derives from selling modular sectional couches known as \"sactionals.\"Sactionals can be rearranged in dozens of configurations, which allows them to fit any living space. There are also 200 cover choices for sactionals, meaning they'll match any color or theme of a home. Best of all, the yarn used in these covers is entirely made from recycled plastic water bottles. This combination of functionality, choice, and eco-friendliness is what's made Lovesac a favorite among millennial buyers.Lovesac's omnichannel presence is the other key component to its success. During the initial stages of the pandemic, when foot traffic to brick-and-mortar furniture stores dried up, the company was able to shift nearly half of its total sales online. Coupling direct-to-consumer sales with pop-up showrooms and a growing number of online and in-store partnerships has helped Lovesac dramatically lower its overhead costs and push to recurring profitability well ahead of schedule.21. Kulicke & SoffaEven though it outperformed in 2021, semiconductor equipment company Kulicke & Soffa (NASDAQ:KLIC) looks poised for an even better 2022.Although \"less is more\" is rarely a phrase that works on Wall Street, a shortage of semiconductor chips, largely caused by pandemic-related supply chain disruptions, has created a golden opportunity for Kulicke & Soffa to shine. Providing the equipment and machining solutions to help businesses meet their high-tech chip production needs is what generates most of its revenue. This is especially true for the rollout of 5G in connected devices, which represents one of the most sustainable growth opportunities in high-volume semiconductor output.But there's a lot more to this growth story than just traditional industries and sectors looking to beef up their production. Kulicke & Soffa is set to benefit from the need for more complex assembly equipment in relatively new but hypergrowth industries. Examples the company cited in its Investor Day presentation last September include automotive and industrial infrastructure for electric vehicles and their batteries.Likewise, my Foolish colleague Billy Duberstein has touched on Kulicke & Soffa's development of machines for micro- and mini-LED displays. Although these premium displays aren't raking in the cash yet, they could become a significant revenue driver within the next three years.Sporting nearly $700 million in net cash and a forward price-to-earnings ratio of around 10, Kulicke & Soffa appears cheap and fully capable of crushing Wall Street's expectations this year.22. LL FlooringThe 22nd and final stock that can double your money in 2022 is LL Flooring (NYSE:LL), the company that was previously known as Lumber Liquidators until a few days ago.LL Flooring has faced its fair share of challenges over the past year. There have been pandemic-related supply issues, higher material costs, and difficult year-over-year sales comparisons -- i.e., people were stuck in their homes during the initial waves of COVID-19 in 2020 and spent a lot of money on hard-surface flooring upgrades.In 2022, a lot of these hiccups will disappear. For example, the company will be up against more favorable year-over-year sales comps this year, and consumers will be looking for deals with lumber prices on the rise. In short, LL's reputation for providing high-quality hard surfaces at lower prices should make its stores a target destination for home remodels.The company is gaining traction with its Pro program, too. This is the segment that works hand in hand with hard surface installation professionals. By providing Pros with the products and software they need to grow their business, LL Flooring has worked out a mutually beneficial relationship for all parties.Look for LL to mop the floor with Wall Street's per-share profit projections in 2022.","news_type":1,"symbols_score_info":{"ROOT":1,"LL":1,"VE":1,"PINS":1,"BARK":1,"KGC":1,"NIO":1,"PING":1,"AXON":1,"PUBM":1,"NVAX":1,"TEVA":1,"MSO":1,"ARR":1,"PRLB":1}},"isVote":1,"tweetType":1,"viewCount":979,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001169968,"gmtCreate":1641192336559,"gmtModify":1676533581337,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Oh dear","listText":"Oh dear","text":"Oh dear","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001169968","repostId":"2195485524","repostType":4,"repost":{"id":"2195485524","kind":"highlight","pubTimestamp":1641007260,"share":"https://ttm.financial/m/news/2195485524?lang=en_US&edition=fundamental","pubTime":"2022-01-01 11:21","market":"us","language":"en","title":"Bargain Shopping? This Stock Is Down 77% in 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2195485524","media":"Motley Fool","summary":"This company thrived during the pandemic, but economic reopening has reversed the benefits.","content":"<div>\n<p>Investors looking for bargains can often find them in the stock market. Poor performance, negative perception, and the fear of losing money can all cause stocks to sell off and trade at lower-than-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/31/peloton-is-a-bargain-stock-price-crash-2022/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bargain Shopping? This Stock Is Down 77% in 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBargain Shopping? This Stock Is Down 77% in 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-01 11:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/31/peloton-is-a-bargain-stock-price-crash-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors looking for bargains can often find them in the stock market. Poor performance, negative perception, and the fear of losing money can all cause stocks to sell off and trade at lower-than-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/31/peloton-is-a-bargain-stock-price-crash-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","BK4566":"资本集团","PTON":"Peloton Interactive, Inc.","BK4190":"消闲用品","BK4548":"巴美列捷福持仓","BK4532":"文艺复兴科技持仓"},"source_url":"https://www.fool.com/investing/2021/12/31/peloton-is-a-bargain-stock-price-crash-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195485524","content_text":"Investors looking for bargains can often find them in the stock market. Poor performance, negative perception, and the fear of losing money can all cause stocks to sell off and trade at lower-than-usual prices.Peloton (NASDAQ:PTON) is one of those stocks that have sold off considerably in 2021. Indeed, the stock is down 77% this year. Let's look at what has caused it to fall so hard and whether it's a good value for bargain-shopping investors.Image source: Getty Images.Peloton management overcorrectedThe clearest reason Peloton's stock fell so much is the worldwide economic reopening. Peloton's products were in high demand when economies were in various phases of lockdowns and nonessential businesses, including gyms, were forced to close their doors to the public. That limited the ways folks could exercise, and they turned to Peloton in large numbers.The surge in demand was so pronounced that Peloton had difficulty fulfilling orders. At one point, customers had to wait more than ten weeks to receive their exercise equipment. In response, management made investments to increase manufacturing capacity and reduce delivery times.Unfortunately for Peloton, several effective vaccines against COVID-19 were developed, economies started reopening, and demand for in-home exercise equipment decreased. Meanwhile, Peloton is stuck with a higher expense base because of its investments to increase capacity. In its most recent quarter ended Sept. 30, Peloton reported a net loss of $367 million compared to a net profit of $69.3 million at the same time last year.To make matters worse, Peloton had decreased the price of its bike from $1,895 to $1,495. The move did create increased purchasing from price-sensitive consumers but not enough to offset the considerable price decrease. As a result, revenue in the connected-fitness-products segment (which includes bike sales) fell from $601 million in the third quarter of 2020 to $501 million in Q3 2021. Meanwhile, supply-chain disruptions are raising input and transportation costs; the cost to fulfill sales increased by 21.1% year over year in Q3.One potential, near-term bright spot for Peloton is the $1.27 billion of inventory it had on hand ahead of the lucrative holiday shopping season -- up from $937 million in the prior quarter. The quarter ending in December typically is the most lucrative for Peloton, coinciding with not only holiday gift-giving but also new year resolution-induced purchasing. So management is hopeful for strong sales this quarter.Peloton's stock is a relative bargainPeloton's stock has undoubtedly faced a steep price decline in 2021 -- and for clear reasons. Customer demand leveled off as economies reopened; meanwhile, management was making investments to increase capacity. All of this has shaken investor confidence. At one point in the last two years, Peloton's stock was selling at a price-to-sales ratio over 20. As of this writing, it's down to 2.7.Yet Peloton's stock price crash could now be a bargain for long-term investors who can tolerate any further volatility the company could go through in the short term as it adjusts to changing consumer behavior.","news_type":1,"symbols_score_info":{"PTON":1}},"isVote":1,"tweetType":1,"viewCount":1193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001169061,"gmtCreate":1641192293801,"gmtModify":1676533581336,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Thank you for sharing...","listText":"Thank you for sharing...","text":"Thank you for sharing...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001169061","repostId":"2200444738","repostType":4,"repost":{"id":"2200444738","kind":"highlight","pubTimestamp":1641099600,"share":"https://ttm.financial/m/news/2200444738?lang=en_US&edition=fundamental","pubTime":"2022-01-02 13:00","market":"us","language":"en","title":"If I Could Buy Only 1 Stock in 2022, This Would Be It","url":"https://stock-news.laohu8.com/highlight/detail?id=2200444738","media":"Motley Fool","summary":"Our favorite stock picks for the coming year.","content":"<div>\n<p>We're firm believers in the benefit of owning a diversified portfolio of stocks. However, we all have our favorite stocks.We asked some of our Fool.com contributors to whittle their favorites down to ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/01/if-i-could-buy-only-1-stock-in-2022-this-would-be/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If I Could Buy Only 1 Stock in 2022, This Would Be It</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf I Could Buy Only 1 Stock in 2022, This Would Be It\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-02 13:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/01/if-i-could-buy-only-1-stock-in-2022-this-would-be/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're firm believers in the benefit of owning a diversified portfolio of stocks. However, we all have our favorite stocks.We asked some of our Fool.com contributors to whittle their favorites down to ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/01/if-i-could-buy-only-1-stock-in-2022-this-would-be/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4135":"资产管理与托管银行","MMM":"3M","BEP":"Brookfield Renewable Partners LP","BK4133":"新能源发电业者","BEPC":"Brookfield Renewable Corp.","BK4206":"工业集团企业","BK4512":"苹果概念","BK4534":"瑞士信贷持仓","BAM":"布鲁克菲尔德资产管理","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.fool.com/investing/2022/01/01/if-i-could-buy-only-1-stock-in-2022-this-would-be/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200444738","content_text":"We're firm believers in the benefit of owning a diversified portfolio of stocks. However, we all have our favorite stocks.We asked some of our Fool.com contributors to whittle their favorites down to their top choice to buy in 2022 if they could only pick one. Here's why 3M (NYSE:MMM), Brookfield Asset Management (NYSE:BAM), and Brookfield Renewable (NYSE:BEP)(NYSE:BEPC) topped their lists as the one stock they'd buy this year. Image source: Getty Images.A diversified giant that's still on saleReuben Gregg Brewer (3M): Benjamin Graham, renowned value investor and mentor to Warren Buffet, explains that investors are partnered with \"Mr. Market,\" a mercurial fellow prone to fits of despair and jubilation. When he's overly excited, you should consider selling to him; when he's pessimistic, you should think about buying. Right now, Mr. Market is very downbeat on diversified international industrial giant 3M. One way to see this is that the company's dividend yield, at around 3.3%, is near the top end of its historical range.MMM Dividend Yield data by YChartsGraham had some other advice when it came to actually selecting stocks. Specifically, he argued that most investors would be wise sticking to large, financially strong companies, with strong dividend histories. 3M stacks up well on these measures. It has a market cap of $100 billion, which makes it a mega-cap stock. Its balance sheet is investment-grade rated by the major credit agencies, so it's financially strong. And it has increased its dividend annually for over 60 years, making it a very elite Dividend King.So why is Mr. Market pessimistic? The answer is a mixture of slowing growth and some product and environmental lawsuits. These are notable problems, but they're not insurmountable. On the business front, the industrial giant's operations wax and wane over time just like any other company. Given its history and focus on innovation, it should eventually get back on a better track. As for the lawsuits, they could be costly, but it's likely that 3M will be able to handle the hit. In the end, this is an attractively priced name with a great history that is dealing with issues that seem transitory.A proven value creatorMatt DiLallo (Brookfield Asset Management): I like to invest. Because of that, I routinely purchase a variety of stocks. However, if I could only buy one in the coming year, Brookfield Asset Management would be my top choice.For starters, I love the company's management. CEO Bruce Flatt is a personal favorite of mine. He's right up there with Warren Buffett in my book as one of the best value investors around. I enjoy reading his quarterly letter to shareholders, which Flatt fills with investing and economic insight. He's also a proven value creator. Since becoming CEO in 2002, he's helped Brookfield deliver a 15.7% total annualized return, pulverizing the S&P 500's 10.6% total return during that time frame. I also like the company's business model. Brookfield is a leading global alternative asset manager focused on real estate, infrastructure, and renewable energy -- three of my favorite investing themes. An investment in Brookfield provides broad exposure to those three asset classes and many more. Brookfield invests directly across those themes and manages private equity funds focused on those sectors.Finally, Brookfield has enormous upside potential. It expects to double its fee-bearing assets under management over the next five years. Combine that with performance-based earnings on its funds and the compounding value of its balance sheet investments, and it has the potential of generating up to 25% annualized total returns over the next five years. That upside, along with all the other positives, is why I'd buy Brookfield if it were the only stock I could purchase this year. Investors are overlooking the growth potential hereNeha Chamaria (Brookfield Renewable): 2021 is turning out to be a record-setting year for global renewable electricity addition, but this could just be the beginning. Yet shares of one of the largest pure-play renewables companies that's growing at a steady pace have languished this year, which is why Brookfield Renewable would be at the top of my shopping list of stocks to buy in 2022.Brookfield Renewable, in fact, generated record funds from operations (FFO) in its third quarter and believes it could grow FFO by nearly 20% per year through 2026 through a combination of organic and inorganic growth. 2021 was also a solid year in terms of growth initiatives, with Brookfield Renewable expanding its U.S. distributed-generation business by nearly five times, signing agreements to acquire multiple late-stage solar development projects in the U.S. and even making meaningful headway in the high-potential green hydrogen space.Brookfield Renewable's current development pipeline is larger than ever, and the company is committed to growing dividends annually by 5% to 9%. That shouldn't be tough given the solid pace of growth in its FFO. That dividend growth, its dividend yield of 3.4%, and the humongous growth potential in renewable energy are the biggest reasons why I consider Brookfield Renewable a top stock for 2022.","news_type":1,"symbols_score_info":{"BAM":1,"BEPC":1,"MMM":1,"BEP":1}},"isVote":1,"tweetType":1,"viewCount":1440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001160781,"gmtCreate":1641192246677,"gmtModify":1676533581359,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4100919763196210","idStr":"4100919763196210"},"themes":[],"htmlText":"Good read...","listText":"Good read...","text":"Good read...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001160781","repostId":"2200403714","repostType":4,"isVote":1,"tweetType":1,"viewCount":1207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9006523749,"gmtCreate":1641788623817,"gmtModify":1676533648382,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"I hope the stock price will go up...","listText":"I hope the stock price will go up...","text":"I hope the stock price will go up...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006523749","repostId":"1162597186","repostType":4,"isVote":1,"tweetType":1,"viewCount":3604,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3568898592347932","authorId":"3568898592347932","name":"YuTC968","avatar":"https://static.tigerbbs.com/2d421272489b6ef78e6ec097b142ae78","crmLevel":6,"crmLevelSwitch":1,"idStr":"3568898592347932","authorIdStr":"3568898592347932"},"content":"give some time…it should up but bot sure how much ooo….","text":"give some time…it should up but bot sure how much ooo….","html":"give some time…it should up but bot sure how much ooo…."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006521589,"gmtCreate":1641788772507,"gmtModify":1676533648405,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Thanks for the insight...","listText":"Thanks for the insight...","text":"Thanks for the insight...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006521589","repostId":"1108030484","repostType":4,"repost":{"id":"1108030484","kind":"news","pubTimestamp":1641769386,"share":"https://ttm.financial/m/news/1108030484?lang=en_US&edition=fundamental","pubTime":"2022-01-10 07:03","market":"us","language":"en","title":"Consumer Price Index, Bank Earnings: What to Know This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1108030484","media":"Yahoo Finance","summary":"Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statist","content":"<html><head></head><body><p>Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statistics&#39; (BLS) latest Consumer Price Index (CPI) as the Federal Reserve&#39;s next monetary policy moves remain in focus. Quarterly earnings season also ramps up as some of the big banks report results.</p><p>Market participants are bracing for another historically hot reading on inflation in the latest CPI data, due out on Wednesday. On a year-over-year basis, consumer prices likely surged by 7.1% in December, based on Bloomberg consensus data, accelerating even further from November&#39;s 6.8% year-over-year clip.This would mark the fastest rate since 1982, when CPI rose as much as 8.4% on a year-over-year basis.</p><p>And on a month-over-month basis, consumer prices likely rose by 0.4% in December, slowing from November&#39;s 0.8% rise but still marking an eighteenth consecutive month of increases.</p><p>&#34;Recent months have seen consistent upside surprises as inflation has increasingly broadened out, and it&#39;s now the case that seven of the last nine CPI releases have seen the monthly headline increase come in above the consensus among economists on Bloomberg, which just demonstrates how this has taken a lot of people by surprise,&#34; Deutsche Bank economists Henry Allen and Jim Reid said in a note.</p><p>&#34;Our U.S. economists are projecting that year-on-year inflation will move higher once again, with an increase to +7.0%,&#34; they added. &#34;Interestingly though, they think we could be at a turning point with December marking the peak in the year-on-year readings, which they then project will fall back over 2022 and be at +3.0% by this December ahead.&#34;</p><p>Excluding more volatile food and energy prices, consumer prices likely rose at a 5.4% year-over-year rate in December, also speeding from November&#39;s 4.9% pace and coming in at the fastest since 1991.</p><p>While price increases have been broad-based in the recovering economy, some economists said rising vehicle prices will likely be one of the main drivers of inflation at year-end.</p><p>&#34;The main story will be the increase in autos inflation, with used cars the primary driver,&#34; Bank of America economists led by Ethan Harris wrote in a note Friday. &#34;Manheim data showed wholesale used car prices spiking 9.2% [month-over-month] in October, following a 5.3% increase in September. Given a roughly 2-month lag, this sends a signal of incredible strength for CPI used cars this month.&#34;</p><p>Used car and truck prices had risen 2.5% month-on-month in November, matching the prior month&#39;s rise, based on BLS data.</p><p>&#34;Outside of autos, we expect further gains in household furnishings and supplies and apparel, reflecting tight supply chains and fewer discounts as the holiday shopping season draws to a close,&#34; Harris added.</p><p>The December CPI will also be carefully parsed by investors as they gauge the next moves by the Federal Reserve, as some officials eye a quicker shift away from accommodative policies to rein in inflation.</p><p>Last week, the Fed&#39;s December meeting minutes suggested some officials favored speeding the central bank&#39;s asset-purchase tapering and hastening the timing of an initial interest rate hike from current near-zero levels. And against a backdrop of a &#34;stronger economic outlook [and] higher inflation,&#34; some officials also suggested they were contemplating the start of reducing the nearly $9 trillion in assets on the central bank&#39;s balance sheet. Hints that the Fed was considering tightening policy in the near-term sent equity markets into a tailspin last week.</p><p>&#34;The market does have to adjust to what is a surprise in terms of how aggressive the Federal Reserve may be in managing the economy around inflation,&#34; Rob Haworth, U.S. Bank Wealth Management senior investment strategist,told Yahoo Finance Livelast week.</p><p>Investors may also receive more commentary about how key members of the Federal Reserve expect to approach inflation with their monetary policy toolkit in two confirmation hearings before Congress this week. Federal Reserve Chair Jerome Powell&#39;s nomination hearing for a second term is set to take place before the Senate Banking Committee on Tuesday — or a day before the December CPI is released. However, Fed Governor Lael Brainard&#39;s nomination hearing to become vice chair of the Fed will take place on Thursday before the Senate Banking Committee, after the release of the latest inflation data.</p><p>Bank earnings</p><p>This week, investors will also see a pick-up in earnings reports, as some of the largest U.S. banks deliver their quarterly results at the end of the week. JPMorgan Chase (JPM), Citigroup (C) and Wells Fargo (WFC) are each slated to report Friday morning before the opening bell.</p><p>The results come following a strong run for bank stocks, with financials currently the second-best performing sector in the S&amp;P 500 in 2022, after energy. TheXLF, or exchange-traded fund tracking the financials sector, hit a record high on Friday and logged its best week since February 2021.</p><p>Expectations for higher interest rates this year have been one major factor lifting these shares, given that banks&#39; core lending businesses benefit from rising rates. On Friday, the benchmark 10-year Treasury yield rose to approximately 1.8%, or its highest level since January 2020. And robust market activity over the past year likely also helped further lift banks&#39; trading operations.</p><p>&#34;As far as the financials go, we think they&#39;re going to be pretty good. This last year has seen a lot of trading activity,&#34; Scott Ladner, Horizon Investments chief investment officer,told Yahoo Finance Live on Friday.&#34;And as we&#39;ve seen, what&#39;s going on right now with respect to yield curve, the yield curve steepened this week.&#34;</p><p>As fourth-quarter earnings begin to ramp up, many analysts are expecting to see another solid reporting season. However, the estimates are also taking into account slowing momentum after soaring earnings growth rates from earlier last year, helped in large part by easy comparisons to 2020&#39;s pandemic-depressed levels.</p><p>S&amp;P 500 earnings in aggregate are expected to grow 21.7% for the fourth-quarter of 2021, according to data from FactSet&#39;s John Butters as of Friday. If earnings come in as expected, this would mark a fourth consecutive quarter that earnings growth tops 20%.</p><p>Economic calendar</p><ul><li><p><b>Monday:</b>Wholesale inventories, month-over-month, November final (1.2% expected, 1.2% in previous print)</p></li><li><p><b>Tuesday:</b>NFIB Small Business Optimism, December (98.5 expected, 98.4 in November)</p></li><li><p><b>Wednesday:</b>MBA Mortgage Applications, week ended January 7 (-5.6% during prior week); Consumer Price Index (CPI), month-over-month, December (0.4% expected, 0.8% in November); CPI excluding food and energy, month-over-month, December (0.5% expected, 0.5% in November); CPI year-over-year, December (7.1% expected, 6.8% in November); CPI excluding food and energy, year-over-year, December (5.4% expected, 4.9% in November); Monthly budget statement, December (-$191.3 billion expected); U.S. Federal Reserve Releases Beige Book</p></li><li><p><b>Thursday:</b>Producer Price Index (PPI), month-over-month, December (0.4% expected, 0.8% in November); PPI excluding food and energy, month-over-month, December (0.4% expected, 0.7% in November); PPI year-over-year, December (9.8% expected, 9.6% in November); PPI excluding food and energy, year-over-year, December (8.0% expected, 7.7% in November); Initial jobless claims, week ended January 8 (210,000 expected, 207,000 during prior week); Continuing claims, week ended January 1 (1.754 million during prior week)</p></li><li><p><b>Friday:</b>Retail sales advance, month-over-month, December (0.0% expected, 0.3% in November); Retail sales excluding autos and gas, month-over-month, December (-0.1% expected, 0.2% in November); Import price index, month-over-month, December (0.2%. expected, 0.7% in November); Capacity utilization, December (77.0% expected); Industrial production, month-over-month, December (0.3% expected, 0.5% in November); University of Michigan sentiment, January preliminary (70.0 expected, 70.6 in December)</p></li></ul><p>Earnings calendar</p><ul><li><p><b>Monday:</b><i>No notable reports scheduled for release</i></p></li><li><p><b>Tuesday:</b><i>No notable reports scheduled for release</i></p></li><li><p><b>Wednesday:</b>Jefferies Financial Corp. (JEF) before market open</p></li><li><p><b>Thursday:</b>Delta Air Lines (DAL) before market open</p></li><li><p><b>Friday:</b>BlackRock (BLK), Citigroup (C), JPMorgan Chase (JPM), Wells Fargo (WFC) before market open</p></li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consumer Price Index, Bank Earnings: What to Know This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsumer Price Index, Bank Earnings: What to Know This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 07:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/consumer-price-index-bank-earnings-what-to-know-this-week-164559716.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statistics' (BLS) latest Consumer Price Index (CPI) as the Federal Reserve's next monetary policy moves ...</p>\n\n<a href=\"https://finance.yahoo.com/news/consumer-price-index-bank-earnings-what-to-know-this-week-164559716.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/consumer-price-index-bank-earnings-what-to-know-this-week-164559716.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108030484","content_text":"Inflation data will be in focus this week, with investors set to receive the Bureau of Labor Statistics' (BLS) latest Consumer Price Index (CPI) as the Federal Reserve's next monetary policy moves remain in focus. Quarterly earnings season also ramps up as some of the big banks report results.Market participants are bracing for another historically hot reading on inflation in the latest CPI data, due out on Wednesday. On a year-over-year basis, consumer prices likely surged by 7.1% in December, based on Bloomberg consensus data, accelerating even further from November's 6.8% year-over-year clip.This would mark the fastest rate since 1982, when CPI rose as much as 8.4% on a year-over-year basis.And on a month-over-month basis, consumer prices likely rose by 0.4% in December, slowing from November's 0.8% rise but still marking an eighteenth consecutive month of increases.\"Recent months have seen consistent upside surprises as inflation has increasingly broadened out, and it's now the case that seven of the last nine CPI releases have seen the monthly headline increase come in above the consensus among economists on Bloomberg, which just demonstrates how this has taken a lot of people by surprise,\" Deutsche Bank economists Henry Allen and Jim Reid said in a note.\"Our U.S. economists are projecting that year-on-year inflation will move higher once again, with an increase to +7.0%,\" they added. \"Interestingly though, they think we could be at a turning point with December marking the peak in the year-on-year readings, which they then project will fall back over 2022 and be at +3.0% by this December ahead.\"Excluding more volatile food and energy prices, consumer prices likely rose at a 5.4% year-over-year rate in December, also speeding from November's 4.9% pace and coming in at the fastest since 1991.While price increases have been broad-based in the recovering economy, some economists said rising vehicle prices will likely be one of the main drivers of inflation at year-end.\"The main story will be the increase in autos inflation, with used cars the primary driver,\" Bank of America economists led by Ethan Harris wrote in a note Friday. \"Manheim data showed wholesale used car prices spiking 9.2% [month-over-month] in October, following a 5.3% increase in September. Given a roughly 2-month lag, this sends a signal of incredible strength for CPI used cars this month.\"Used car and truck prices had risen 2.5% month-on-month in November, matching the prior month's rise, based on BLS data.\"Outside of autos, we expect further gains in household furnishings and supplies and apparel, reflecting tight supply chains and fewer discounts as the holiday shopping season draws to a close,\" Harris added.The December CPI will also be carefully parsed by investors as they gauge the next moves by the Federal Reserve, as some officials eye a quicker shift away from accommodative policies to rein in inflation.Last week, the Fed's December meeting minutes suggested some officials favored speeding the central bank's asset-purchase tapering and hastening the timing of an initial interest rate hike from current near-zero levels. And against a backdrop of a \"stronger economic outlook [and] higher inflation,\" some officials also suggested they were contemplating the start of reducing the nearly $9 trillion in assets on the central bank's balance sheet. Hints that the Fed was considering tightening policy in the near-term sent equity markets into a tailspin last week.\"The market does have to adjust to what is a surprise in terms of how aggressive the Federal Reserve may be in managing the economy around inflation,\" Rob Haworth, U.S. Bank Wealth Management senior investment strategist,told Yahoo Finance Livelast week.Investors may also receive more commentary about how key members of the Federal Reserve expect to approach inflation with their monetary policy toolkit in two confirmation hearings before Congress this week. Federal Reserve Chair Jerome Powell's nomination hearing for a second term is set to take place before the Senate Banking Committee on Tuesday — or a day before the December CPI is released. However, Fed Governor Lael Brainard's nomination hearing to become vice chair of the Fed will take place on Thursday before the Senate Banking Committee, after the release of the latest inflation data.Bank earningsThis week, investors will also see a pick-up in earnings reports, as some of the largest U.S. banks deliver their quarterly results at the end of the week. JPMorgan Chase (JPM), Citigroup (C) and Wells Fargo (WFC) are each slated to report Friday morning before the opening bell.The results come following a strong run for bank stocks, with financials currently the second-best performing sector in the S&P 500 in 2022, after energy. TheXLF, or exchange-traded fund tracking the financials sector, hit a record high on Friday and logged its best week since February 2021.Expectations for higher interest rates this year have been one major factor lifting these shares, given that banks' core lending businesses benefit from rising rates. On Friday, the benchmark 10-year Treasury yield rose to approximately 1.8%, or its highest level since January 2020. And robust market activity over the past year likely also helped further lift banks' trading operations.\"As far as the financials go, we think they're going to be pretty good. This last year has seen a lot of trading activity,\" Scott Ladner, Horizon Investments chief investment officer,told Yahoo Finance Live on Friday.\"And as we've seen, what's going on right now with respect to yield curve, the yield curve steepened this week.\"As fourth-quarter earnings begin to ramp up, many analysts are expecting to see another solid reporting season. However, the estimates are also taking into account slowing momentum after soaring earnings growth rates from earlier last year, helped in large part by easy comparisons to 2020's pandemic-depressed levels.S&P 500 earnings in aggregate are expected to grow 21.7% for the fourth-quarter of 2021, according to data from FactSet's John Butters as of Friday. If earnings come in as expected, this would mark a fourth consecutive quarter that earnings growth tops 20%.Economic calendarMonday:Wholesale inventories, month-over-month, November final (1.2% expected, 1.2% in previous print)Tuesday:NFIB Small Business Optimism, December (98.5 expected, 98.4 in November)Wednesday:MBA Mortgage Applications, week ended January 7 (-5.6% during prior week); Consumer Price Index (CPI), month-over-month, December (0.4% expected, 0.8% in November); CPI excluding food and energy, month-over-month, December (0.5% expected, 0.5% in November); CPI year-over-year, December (7.1% expected, 6.8% in November); CPI excluding food and energy, year-over-year, December (5.4% expected, 4.9% in November); Monthly budget statement, December (-$191.3 billion expected); U.S. Federal Reserve Releases Beige BookThursday:Producer Price Index (PPI), month-over-month, December (0.4% expected, 0.8% in November); PPI excluding food and energy, month-over-month, December (0.4% expected, 0.7% in November); PPI year-over-year, December (9.8% expected, 9.6% in November); PPI excluding food and energy, year-over-year, December (8.0% expected, 7.7% in November); Initial jobless claims, week ended January 8 (210,000 expected, 207,000 during prior week); Continuing claims, week ended January 1 (1.754 million during prior week)Friday:Retail sales advance, month-over-month, December (0.0% expected, 0.3% in November); Retail sales excluding autos and gas, month-over-month, December (-0.1% expected, 0.2% in November); Import price index, month-over-month, December (0.2%. expected, 0.7% in November); Capacity utilization, December (77.0% expected); Industrial production, month-over-month, December (0.3% expected, 0.5% in November); University of Michigan sentiment, January preliminary (70.0 expected, 70.6 in December)Earnings calendarMonday:No notable reports scheduled for releaseTuesday:No notable reports scheduled for releaseWednesday:Jefferies Financial Corp. (JEF) before market openThursday:Delta Air Lines (DAL) before market openFriday:BlackRock (BLK), Citigroup (C), JPMorgan Chase (JPM), Wells Fargo (WFC) before market open","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001160781,"gmtCreate":1641192246677,"gmtModify":1676533581359,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Good read...","listText":"Good read...","text":"Good read...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001160781","repostId":"2200403714","repostType":4,"isVote":1,"tweetType":1,"viewCount":1207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001187724,"gmtCreate":1641191960328,"gmtModify":1676533581319,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Thank you for this review!","listText":"Thank you for this review!","text":"Thank you for this review!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001187724","repostId":"1106108901","repostType":4,"isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006144925,"gmtCreate":1641664759637,"gmtModify":1676533637990,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Wow!","listText":"Wow!","text":"Wow!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006144925","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=en_US&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"VIR":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001737739,"gmtCreate":1641316563817,"gmtModify":1676533597162,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Interesting read","listText":"Interesting read","text":"Interesting read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001737739","repostId":"2200081405","repostType":4,"repost":{"id":"2200081405","kind":"highlight","pubTimestamp":1641298279,"share":"https://ttm.financial/m/news/2200081405?lang=en_US&edition=fundamental","pubTime":"2022-01-04 20:11","market":"us","language":"en","title":"3 Top Value Stocks for 2022 and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2200081405","media":"Motley Fool","summary":"The market is pessimistic on these beaten-down stocks, but they all have good growth stories to tell.","content":"<div>\n<p>Value investing is a lot more than simply buying stocks that look cheap. Shares of a business in permanent decline may look inexpensive, relative to earnings, sales, book value, or another metric, but...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Value Stocks for 2022 and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Value Stocks for 2022 and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 20:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Value investing is a lot more than simply buying stocks that look cheap. Shares of a business in permanent decline may look inexpensive, relative to earnings, sales, book value, or another metric, but...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4535":"淡马锡持仓","BK4554":"元宇宙及AR概念","BK4515":"5G概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4134":"信息科技咨询与其它服务","BK4529":"IDC概念","BK4512":"苹果概念","BK4538":"云计算","BK4527":"明星科技股","IBM":"IBM","T":"At&T","BK4550":"红杉资本持仓","BK4141":"半导体产品","BK4534":"瑞士信贷持仓","INTC":"英特尔","BK4507":"流媒体概念","BK4115":"综合电信业务"},"source_url":"https://www.fool.com/investing/2022/01/04/3-top-value-stocks-for-2022-and-beyond/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200081405","content_text":"Value investing is a lot more than simply buying stocks that look cheap. Shares of a business in permanent decline may look inexpensive, relative to earnings, sales, book value, or another metric, but they're cheap for a reason.The best value stocks are cheap because the market is wrong about their potential. Sometimes, a solid company that has a good shot at turning itself around after facing some temporary setbacks can be priced like the world is ending. If the world doesn't end, that stock can produce stunning returns in the long run.As we enter 2022, AT&T (NYSE:T), International Business Machines (NYSE:IBM), and Intel (NASDAQ:INTC) all fit into this category. All three have a decent growth story to tell, and all three have a lot of pessimism priced in.AT&TShares of AT&T have been hammered over the past few years as the company's acquisitions of DirecTV and Time Warner failed to deliver. AT&T fancied itself a media conglomerate, and it spent heavily in a bungled attempt to fulfill that vision.DirecTV has been spun off, and Time Warner (now WarnerMedia) is set to be merged with Discovery to create a media and streaming giant. After the dust settles, AT&T will be a telecom company again, free from the distractions of the media business and better able to invest in its core business.AT&T expects to produce around $20 billion of free cash flow in the first full year after the WarnerMedia deal closes. With a current market capitalization of around $175 billion, the market is clearly pessimistic. AT&T shareholders will also own 71% of the media company created by the spin-off. That media company is expected to produce $52 billion of revenue in 2023.This all seems like a pretty good deal. Buy AT&T for less than 10 times expected post-spin-off free cash flow, and later this year you'll own a leading telecom company and a big chunk of a new media and streaming giant. AT&T will cut its dividend once the deal closes, which is probably weighing on the shares. And AT&T's post-spin-off estimates could very well be overly optimistic. But given the rock-bottom valuation and the stability of the core wireless business, it's hard to see an investment in AT&T going all that badly over the next five years.International Business MachinesIBM has dumped its slow-growing and labor-intensive managed infrastructure services business, spinning it off as a new company called Kyndryl. What's left of the century-old tech giant is now laser focused on hybrid cloud computing and artificial intelligence.While IBM's cloud business has grown substantially over the past decade, the company has been weighed down by legacy businesses. Revenues and profits have been trending lower for a long time. A sustainable return to growth has proved elusive.With around $19 billion of low-margin revenue now out of the picture, IBM's growth profile looks a lot better. The company expects sustainable mid-single-digit revenue growth to be the norm, along with high single-digit growth in free cash flow. Over the next three years, IBM expects to produce around $35 billion of free cash flow in total, or nearly $12 billion on average each year. The company is valued at just $120 billion.It's been a very long road for IBM shareholders betting on a turnaround, and the stock has a lot of pessimism priced in. If IBM can deliver on its targets, or even come close, the iconic tech company could be worth far more in five years than it's worth today.IntelChip giant Intel is working on its own turnaround. Under CEO Pat Gelsinger, an Intel veteran lured back to right the ship, the company is embarking on a costly plan to regain its manufacturing edge and build a world-class foundry business.Intel is still a highly profitable company, but years of delays bringing new process nodes to volume production have degraded its key competitive advantages. Third-party foundries like Taiwan Semiconductor have surpassed Intel on the manufacturing side, and rival AMD has taken advantage. AMD is now producing PC and server chips that are as good or better than what Intel is producing.Intel's plan is to pour cash into new manufacturing facilities. The company will spend as much as $28 billion on capital expenditures this year, and that number may increase in future years. For comparison, the company expected to spend around $19 billion in 2021.Intel's manufacturing push will take years to play out, and earnings will take a hit until the company's heavy investments pay off. But if Intel gets it right, it can maintain its dominant position in the PC and server chip markets while claiming a big chunk of the foundry market. Foundries soaked up around $100 billion of spending last year, and there's no reason Intel can't compete in that growing market.Even factoring in the expected earnings hit, Intel stock is priced at a pessimistic level. The stock trades for just 14 times the average analyst estimate for 2022 earnings. The market seems to be completely ignoring Intel's long-term potential.Intel has a proven leader at the helm and plenty of cash flow to fund much of its capital spending plans. Demand for semiconductors is high, supply is constrained, and it doesn't look like that situation will change anytime soon. Intel has a good story to tell. Add in a beaten-down valuation, and you've got yourself a stock that could soar.","news_type":1,"symbols_score_info":{"IBM":1,"INTC":1,"T":1}},"isVote":1,"tweetType":1,"viewCount":1493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006791104,"gmtCreate":1641831816225,"gmtModify":1676533652441,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Mmmmm","listText":"Mmmmm","text":"Mmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791104","repostId":"1173383930","repostType":4,"repost":{"id":"1173383930","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641828185,"share":"https://ttm.financial/m/news/1173383930?lang=en_US&edition=fundamental","pubTime":"2022-01-10 23:23","market":"us","language":"en","title":"Nasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1173383930","media":"Tiger Newspress","summary":"U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rate","content":"<html><head></head><body><p>U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.</p><p>TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&amp;P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.</p><p><img src=\"https://static.tigerbbs.com/3271886bd069566f888a2ed6fdbf7524\" tg-width=\"955\" tg-height=\"233\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 23:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.</p><p>TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&amp;P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.</p><p><img src=\"https://static.tigerbbs.com/3271886bd069566f888a2ed6fdbf7524\" tg-width=\"955\" tg-height=\"233\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173383930","content_text":"U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":3339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001695878,"gmtCreate":1641229544870,"gmtModify":1676533585718,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"A bit too much...","listText":"A bit too much...","text":"A bit too much...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001695878","repostId":"2200429489","repostType":4,"repost":{"id":"2200429489","kind":"highlight","pubTimestamp":1641208372,"share":"https://ttm.financial/m/news/2200429489?lang=en_US&edition=fundamental","pubTime":"2022-01-03 19:12","market":"us","language":"en","title":"22 Stocks That Could Double Your Money in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2200429489","media":"Motley Fool","summary":"Triple-digit returns could be just a click of the buy button away.","content":"<div>\n<p>New year, new you, new opportunities to get smarter, happier, and richer!Despite the tumult of the continuing pandemic, Wall Street had itself another fine year. The benchmark S&P 500 registered its ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>22 Stocks That Could Double Your Money in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n22 Stocks That Could Double Your Money in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 19:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New year, new you, new opportunities to get smarter, happier, and richer!Despite the tumult of the continuing pandemic, Wall Street had itself another fine year. The benchmark S&P 500 registered its ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4084":"特种房地产投资信托","BK4555":"新能源车","BK4122":"互联网与直销零售","AXON":"Axon Enterprise, Inc.","BK4562":"SPAC上市公司","BK4107":"财产与意外伤害保险","BK4566":"资本集团","BK4547":"WSB热门概念","BK4505":"高瓴资本持仓","BK4079":"房地产服务","BK4535":"淡马锡持仓","NVAX":"诺瓦瓦克斯医药","ARR":"ARMOUR住宅房地产公司","PRLB":"Proto Labs Inc","BK4546":"3D打印","PUBM":"PubMatic, Inc.","BK4504":"桥水持仓","BK4559":"巴菲特持仓","NIO":"蔚来","TEVA":"梯瓦制药","BK4110":"抵押房地产投资信托","BARK":"The Original Bark Corp.","PING":"Ping Identity Holding","BK4568":"美国抗疫概念","BK4147":"半导体设备","BK4548":"巴美列捷福持仓","KGC":"金罗斯黄金","BK4095":"家庭装饰品","BK4017":"黄金","BK4551":"寇图资本持仓","BK4526":"热门中概股","BK4509":"腾讯概念","PINS":"Pinterest, Inc.","BK4561":"索罗斯持仓","BK4009":"广告","BK4097":"系统软件","BK4508":"社交媒体","BK4532":"文艺复兴科技持仓","BK4187":"航天航空与国防","BK4161":"工业机械","ROOT":"Root, Inc.","BK4531":"中概回港概念","BK4077":"互动媒体与服务","BK4099":"汽车制造商","BK4534":"瑞士信贷持仓"},"source_url":"https://www.fool.com/investing/2022/01/03/22-stocks-that-could-double-your-money-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200429489","content_text":"New year, new you, new opportunities to get smarter, happier, and richer!Despite the tumult of the continuing pandemic, Wall Street had itself another fine year. The benchmark S&P 500 registered its second most all-time closing highs in a single year and ultimately more than doubled up its average annual total return of 11%, dating back to 1980.But no matter how high the broader market indexes climb, there will always be opportunities for investors to grow their wealth and possibly even double their money. As we steam forward into a new year, here are 22 stocks that could double your money in 2022.1. PinterestWhile you'll find plenty of small- and mid-cap stocks with 100%-plus upside potential on this list, don't overlook large-cap stocks like social media giant Pinterest (NYSE:PINS). After all, winners keep winning.In 2021, Wall Street struggled to digest modest sequential quarterly declines in Pinterest's monthly active users (MAUs). This decline was the expected reaction as coronavirus vaccination rates kept ticking higher and people returned to some activities outside their homes. But this laser-focus on Pinterest's MAUs misses two critical points that make it a screaming buy at its current share price.To begin with, there's been no slowdown in the monetization of Pinterest's MAUs, even if new user growth is returning to historic norms. The September quarter featured a global average revenue per user (ARPU) increase of 37%, with international ARPU rising 81%. In simple terms, advertisers have proved more than willing to pay up to get their message in front of Pinterest's 444 million monthly users.Second, Wall Street is apparently forgetting how perfect Pinterest's model is for attracting ad revenue. The entire premise is built on having its MAUs share the things, places, and services that interest them. With no guesswork involved, merchants can effectively target their ad dollars at users who'd be likely to make a purchase. This puts Pinterest on track to eventually become a force in e-commerce.2. PubMaticOne of the smartest ways to potentially double your money in 2022 is to consider putting it to work in cloud-based programmatic advertising technology company PubMatic (NASDAQ:PUBM).PubMatic is what's known as a sell-side platform. SSPs go to work for publishers by selling their display space to advertisers. Though its clients can provide input, such as setting the minimum price accepted to sell display space, PubMatic's cloud-based infrastructure handles everything with machine-learning algorithms. By optimizing what messages users see, PubMatic can keep advertisers happy while boosting the pricing power of its clients (i.e., publishers) over time.What really sets PubMatic up for success is its focus on digital advertising. According to the company, global digital ad spend should average a 10% annual increase between 2019 and 2024 as people shift their content consumption habits. However, PubMatic has consistently grown at two or more times this rate. That's because nearly two-thirds of its revenue comes from mobile and omnichannel formats, which includes connected TV.Furthermore, the company's clients really seem to love the service, as evidenced by four consecutive quarters of a net dollar-based retention rate of 150% (or more). In simple terms, that means existing clients have spent at least 50% more year-over-year for the past four quarters. With PubMatic consistently crushing Wall Street's expectations, this shift to digital ads could send its shares a lot higher this year.3. Planet 13 HoldingsCannabis may well be one of the most consistent double-digit growth opportunities of the decade. With the U.S. representing the epicenter of this growth, multistate operator (MSO) Planet 13 Holdings (OTC:PLNH.F) has a real shot to double your money.Most MSOs are all about establishing a presence in as many states as possible. That's not Planet 13's modus operandi. It's focused just as much on providing a unique experience for customers as it is on making sales.Planet 13 has only two operating dispensaries, but there's nothing else like them in the United States. The Las Vegas SuperStore spans 112,000 square feet (that's bigger than the average Walmart), and has a café, events center, and consumer-facing processing center. Meanwhile, the more recently opened Orange County SuperStore has 55,000 square feet of space, 16,500 square feet of which is devoted to selling.Planet 13's immersive and tech-integrated store designs do tend to work best in tourist-heavy locations. The next three stores to be opened will be in Chicago, Orlando, and Miami. However, the pandemic taught the company the value of appealing to local residents. With a steady stream of local customers mixed in with tourists, this company is ready to push to recurring profitability this year.4. Axon EnterpriseIt's not often you see a borderline large-cap company effectively double its total addressable market (TAM) overnight, but that's what Axon Enterprise (NASDAQ:AXON) dropped on investors with its third-quarter shareholder letter. Axon now believes its TAM is $52 billion, up from a prior forecast of $27 billion.Axon is the company behind the popular less-than-lethal Taser devices used by law enforcement. It's also responsible for many of the body cameras worn by peace officers, and it provides evidence-database software used in police departments. With many major cities focused on social reforms, Axon's products have become front-and-center solutions for greater law enforcement transparency.The secret sauce to Axon's TAM nearly doubling is its broadening focus to also include the consumer market. Management plans to roll out its less-than-lethal Taser products to consumers, as well as offer a consumer-focused smartphone app, which'll be unveiled in 2022. Based on management's estimates, the individual consumer market could offer a higher TAM than what law enforcement can bring in.Likewise, Axon has (pardon the pun) worlds of international potential. Even though domestic sales make up the lion's share of its existing revenue, international sales grew twice as fast as domestic revenue (70% vs. 34%) in the September-ended quarter. Representing close to $15 billion in TAM, overseas markets could be the icing on the cake that leads Axon to double in 2022.5. EverQuoteOne company I'm doubling down on is online insurance marketplace EverQuote (NASDAQ:EVER). I say \"double down\" because it was a stock I felt would outperform in 2021, but it fell flat in a big way. This year should hopefully flip the script for this fast-paced small-cap stock.Although the insurance industry is a moneymaker, it's generally slow-growing. EverQuote operates in arguably the fastest-growing subsection: digital advertising. The expectation is for insurance-related digital ad spend to increase by an annualized rate of 16% through 2024.EverQuote is already working with 19 of the top 20 auto insurers, which allows it to present thorough price comparisons to consumers. Meanwhile, its platform lures in motivated buyers, which essentially means insurers are able to more effectively utilize their marketing dollars. As consumer buying habits shift online, EverQuote's role as a leading insurance marketplace will only expand over time.Furthermore, EverQuote has moved into new verticals over the past couple of years, including home, rental, health, life, and commercial insurance. These verticals have grown at an even faster rate than its traditional auto insurance segment, and they provide a nice opportunity to book high-margin add-on revenue.6. NovavaxIt's no secret that coronavirus disease 2019 (COVID-19) stocks have been on fire since the pandemic began. But one COVID-19 stock still offers incredible upside and the real chance to double in 2022. Say hello to Novavax (NASDAQ:NVAX).Although the COVID-19 vaccine field continues to grow, Novavax stands out. The company's vaccine, NVX-CoV2373, was tested in two large-scale studies. It produced an 89.7% vaccine efficacy (VE) in the U.K. and a 90.4% VE in the U.S./Mexico trial. Including Novavax, only three COVID-19 vaccines have produced an efficacy of 90% or higher, which should allow the company to eventually slide in as the global No. 3 COVID-19 vaccine provider.The mutability of the SARS-CoV-2 virus that causes COVID-19 is also working in Novavax's favor. Instead of simply benefiting from an initial inoculation campaign, the introduction of new viral variants provides Novavax a way to generate recurring revenue. The company's drug-development platform is designed to with speed and efficacy in mind to develop booster shots and variant-specific vaccines.Best of all, you're getting Novavax at a discount. Short-term regulatory filings delays and production concerns held the company's share price down throughout 2021. Most of these worries are now in the rearview mirror. With the company likely to win numerous emergency-use authorizations this year, it's a good bet to become a key player in the ongoing fight against COVID-19.7. GrowGenerationFollowing a 21-month roller-coaster ride, retail hydroponic and organic gardening chain GrowGeneration (NASDAQ:GRWG) looks ripe for the picking and ready to double.Between March 2020 and February 2021, GrowGen was one of the hottest stocks on Wall Street, with shares skyrocketing more than twentyfold. But since hitting its 52-week high, shares are now down close to 80%. This huge reversion looks to be based on slowing organic growth, as well as higher inflation, which could weigh on the company's margins. Though its 80% reversion has been less than ideal for existing shareholders, it's the perfect entry point for new investors.The two-pronged strategy that'll allow GrowGeneration to be a portfolio superstar is its inorganic expansion, as well as its omnichannel presence. In terms of the former, GrowGen has regularly leaned on acquisitions to expand its reach into new and existing high-dollar markets. This is a company with lighting, nutrient, soil, and hydroponic solutions that appeal to both the consumer and enterprise markets, and it has been especially popular among cannabis growers. GrowGen currently has 62 stores in 13 states.Beyond leaning on buyouts, GrowGeneration is building up its e-commerce presence and focusing on private-label and proprietary brands to lift its long-term margins.Once valued at more than 10 times sales and over 200 times forecasted earnings, GrowGen now goes for well under 2 two times sales and closer to 40 times Wall Street's consensus earnings for 2022.8. BarkIn the U.S., 69 million households own a dog, according to the American Pet Products Association. Furthermore, pet owners haven't reduced year-over-year spending on their furry family members in over a quarter of a century. This makes dog-focused products and services company Bark (NYSE:BARK) the perfect candidate to fetch investors a double in 2022.What makes Bark so special is the company's subscription-based operating model. Even though its products can be found in more than 23,000 retail doors nationwide, 89% of the company's revenue derived from direct-to-consumer sales in the third quarter. The subscription model tends to lead to higher customer retention rates, predictable cash flow, and lower overhead expenses. As a result, Bark's gross margin has consistently hovered between a juicy 58% and 60%.The company's marketing campaigns are paying dividends, too. In less than two years, the number of subscribers has more than doubled from less than a million to approximately 2.1 million, as of September.And don't overlook Bark's innovation as a growth catalyst. The introduction of Bark Home, which provides basic necessities like collars and beds, and Bark Eats, a service that helps owners craft a customized dry-food diet for their pooch, are the perfect complements to drive add-on sales.9. Kinross GoldGold stocks didn't have a particularly good 2021. But the upcoming year could allow Kinross Gold (NYSE:KGC) to regain its luster in a big way.To state the obvious, gold-mining stocks benefit when the price of the metal they're digging out of the ground appreciates in value. The lustrous yellow metal should benefit from historically low bond yields (i.e., there aren't many ways to generate inflation-topping returns with bonds) and will probably receive a lift from inflation that's hit levels not seen since the Reagan administration. A bounce back year for gold seems likely.But Kinross isn't just sitting on its laurels and letting the physical price of gold do all the work. The most exciting advancement is the Tasiast 21k project. By the end of March, the company's throughput at the key Tasiast mine in Mauritania should reach 21,000 tonnes per day. By mid-2023, the Tasiast 24k project will be complete, and throughput will advance to 24,000 tonnes/day. These projects will nearly double the annual output of the mine and lower all-in sustaining costs to a mere $560 per gold ounce.Kinross Gold has a veritable mountain of long-term projects as well, including Fort Knox, La Coipa, and Chulbatkan. The company is regularly replenishing or growing its precious metal reserves.With Kinross expected to grow its output from 2.1 million gold equivalent ounces (GEO) in 2021 to 2.7 million GEO in 2022, a multiple of 3.6 times this year's estimated cash flow per share is too cheap to pass up.10. RootAll investments come with risk, but some are riskier than others. Innovative insurance company Root (NASDAQ:ROOT) falls into the high-risk/high-reward category. But if things go right in 2022, shares could very easily double.Root is attempting to disrupt a stodgy industry that's been pricing auto insurance policies using metrics that have absolutely nothing to do with the quality of someone's driving, such as credit score and marital status. It aims to do this by leaning on telematics. Using sensitive instrumentation found in smartphones, Root can measure G-forces based on braking, turning, and accelerating to determine how safe a driver really is behind the wheel. In short, the company believes it can offer drivers an accurately priced auto insurance policy on the spot.Initial operating results from Root have been mixed but encouraging. For the time being, the company is reporting sizable per-share losses as it focuses on signing up new customers and building up its brand. However, this hasn't stopped it from reporting gross accident period loss ratios below 100%. Any figure below 100% represents a profitably written policy. While loss ratios have been a bit erratic because of the pandemic, the initial takeaway is that a telematics-based approach can work.If Root's accident loss ratios stabilize or decline (a lower number means a more profitable policy) in 2022, it could be a big winner.11. NioA year ago, electric vehicle (EV) manufacturer Nio (NYSE:NIO) wasn't a company I'd touch with a 10-foot pole. But after watching management navigate the numerous challenges presented by the pandemic, I'm extremely impressed by the company's execution and have changed my tune -- so much so that I believe, under the right circumstances, Nio could double in 2022.Throughout the second and third quarters of 2021, the auto industry was constrained by semiconductor chip shortages and other supply chain snafus. This situation held back Nio's expansion efforts. But these issues are now abating, and the company's deliveries are soaring. In November, Nio delivered 10,878 vehicles, which equates to an annual run rate of more than 130,000 EVs. By the end of this year, management is targeting an annual run rate of 600,000 EVs. If this ramp-up continues, quadrupling sales by 2024 is easily doable.In addition to ramping production, Nio is being driven by innovation. It'll be introducing three new EVs this year, and it will continue to lean on the battery-as-a-service program (BaaS) that was introduced in August 2020. The BaaS program provides battery charging and swap-outs for Nio EV owners for a monthly fee. In exchange, buyers receive a discount off the initial purchase price of their vehicle. Nio is effectively trading some near-term revenue for improved customer loyalty and juicy fee-based margin over the long run.The topper is that the company is based in the largest auto market in the world, China. Everything appears set for Nio to floor it in 2022.12. Columbia CareAnother marijuana stock with the potential to double your money in the New Year is U.S. MSO Columbia Care (OTC:CCHWF).Like Planet 13, Columbia Care has a unique strategy that should pay long-term dividends. First, it tends to focus on a number of limited-license markets, such as Pennsylvania, Ohio, and Massachusetts. A limited-license market caps how many retail licenses are issued in total and/or to a single business. For some MSOs, this can inhibit their ability to dominate market share in a state. But for many MSOs, like Columbia Care, these limitations provide some degree of competitive protection that allows them to effectively build up their brands and garner a loyal following.The more important growth driver for Columbia Care is its love affair with acquisitions. Since June, the company has closed a $240 million deal to acquire Green Leaf Medical and a $42 million buyout of Medicine Man. The latter should increase Columbia Care's share in the United States' No. 2 weed market, Colorado, while the former gave it a sizable Mid-Atlantic presence.With sustainable double-digit organic sales growth and a steady diet of acquisitions, Columbia Care could easily top $1 billion in annual sales by 2023 after generating \"only\" $180 million in sales in 2020.13. Opendoor TechnologiesFor those of you with a higher tolerance for risk and reward, technology-driven residential real estate company Opendoor Technologies (NASDAQ:OPEN) could be the ticket to doubling your money in 2022.Opendoor is the leading company in what's known as iBuying. iBuying happens when a real estate company purchases a home for cash, thereby eliminating the real estate agents that would otherwise take a commission. The process tends to be relatively fast and can quickly put cash in the pockets of those who need it, or who don't want to deal with the hassles of showing a home for months on end. Opendoor keeps a 5% fee on the sales price of a home and deducts the cost of any repairs that need to be done.What's particularly interesting about Opendoor is that one of its top competitors, Zillow, recently announced it would shut down its iBuying program. Zillow announced in October that it would pause buying homes, and then in November it announced a total shutdown of the segment after miscalculating home values. This hasn't been an issue for Opendoor, which nearly quintupled its year-over-year home sales in the third quarter to 5,988. The company also more than doubled the number of markets it serves, from 21 to 44.The \"risk\" for Opendoor is that the Federal Reserve will almost certainly begin raising rates in 2022. In my opinion, this'll only create an incentive for fence-sitting sellers to make the leap. With plenty of liquidity and homes to back up the debt on its balance sheet, 2022 could be a booming year for Opendoor.14. Teva Pharmaceutical IndustriesEverQuote isn't the only company on the list that's making a repeat appearance. Brand-name and generic-drug stock Teva Pharmaceutical Industries (NYSE:TEVA) looks to have the puzzle pieces in place to double.In terms of valuation, pharmaceutical stocks don't come any cheaper. Shares can be scooped up for roughly 3 times Wall Street's forecasted earnings per share in 2022. This exceptionally low price-to-earnings ratio is a function of the opioid litigation Teva and its peers are facing, as well as other factors, such as generic-drug price weakness and a leveraged balance sheet.Teva's secret weapon continues to be its CEO, Kare Schultz, a turnaround specialist who, since taking over in late 2017, has slashed annual operating expenses by billions of dollars, jettisoned non-core assets, and reduced the company's net debt from north of $34 billion to about $22 billion. There's no question Teva has more financial flexibility now than it did four years ago.The key to Teva's doubling would be a resolution to the more than 40 state-level opioid lawsuits. The thing is, Teva and its peers recently won an opioid trial in California. With momentum now shifting, Schultz may be able to broker a nationwide deal that involves free or discounted generic medicines, as opposed to a cash settlement. If this litigation overhang disappears, Teva could soar.15. Alliance Resource PartnersWhat would you say if I told you that an ultra-high-yield dividend stock could double your money in 2022? Better yet, what if I noted that this company in question is primarily a coal producer? By now you probably think I'm nuts, but Alliance Resource Partners (NASDAQ:ARLP) could very well turn coal into diamonds for its shareholders this year.There's no sugarcoating that that Alliance Resource had a miserable 2020. Coal demand and per-ton pricing dropped considerably, as did the royalty revenue the company generates from its oil and natural gas assets. It was something of a perfect storm that caused this rock-solid dividend stock to halt its payout. But a turnaround is now well under way.According to CEO Joseph Craft, the conditions for coal, in terms of demand and pricing, remain favorable into 2023. A big increase in natural gas prices last year has lifted demand for coal production in the Eastern U.S., with capacity utilization of the company's domestic coal fleet hitting a three-year high.The company also has a track record of securing coal supply and price commitments domestically and abroad well in advance. Based on its expected output in 2021, perhaps 90% or more of 2022's output is already spoken for.A 7.6% yield with favorable industry trends and a forward price-to-earnings ratio of 4 gives this stock a real chance to shine.16. Ping Identity HoldingsOne of the smartest trends investors can put their money to work in this year is cybersecurity. Although most cybersecurity stocks trade at a premium, you can get double-digit growth and value -- along with the potential to double your money -- with Ping Identity (NYSE:PING).As its name implies, Ping's specialty is identity verification. The company's cloud-based platform relies on artificial intelligence to become smarter and more effective at recognizing and responding to potential threats over time. Ping is especially effective at working with on-premises security solution providers to create a unified platform. Ping is able to layer continuous verification, authentication, and authorization monitoring on users to improve overall data protection.Admittedly, Ping didn't perform all that well during the early stage of the pandemic. With some of its clients opting for shorter term-based licenses because of pandemic uncertainty, revenue growth stalled. However, annual recurring revenue (ARR) growth hasn't missed a beat. ARR is arguably a better measure of Ping's success, since virtually all of its revenue derives from subscriptions. The company's ARR has consistently grown by the mid- to high teens.Investors should also be excited about Ping's move to push software-as-a-service (SaaS) subscription solutions. SaaS cybersecurity solutions are high margin and should provide added incentive for clients to remain loyal to Ping. At roughly 6 times Wall Street's projected sales for 2022, this profitable cybersecurity stock is a steal.17. StoneCoFor investors who love risk and reward, fintech stock StoneCo (NASDAQ:STNE) is an excellent candidate to bounce back strongly in 2022, and potentially even double.Last year, the Brazilian-focused StoneCo struggled mightily. Its share price dropped in the neighborhood of 80%, with rapidly rising inflation and higher interest rates plaguing the Brazilian economy. Although inflation can be helpful if consumers keep buying goods and services, the costs to service StoneCo's loan segment, which is backed by its debt, becomes more expensive with rising rates.Though Brazil is entering 2022 in a less-than-ideal scenario, the thesis is that Wall Street has overreacted to StoneCo's recent struggles. As evidence, just take a closer look at micro- and small-business user and service utilization figures, which have all rocketed higher. The company's active paying client base more than doubled to 1.4 million, with its banking client base quadrupling to north of 422,000 in a year.At some point, StoneCo will have to raise its banking service prices to account for higher interest rates. But the user data clearly shows that Brazil is a largely untapped market for digital purchases and peer-to-peer loans, especially to small businesses and entrepreneurs.Furthermore, StoneCo has a history of generating adjusted profits, and its price-to-sales multiple has come down from north of 30 to approximately 3.5 times Wall Street's consensus revenue figure for 2022. That's a potential bargain.18. Jushi HoldingsThere's an insane amount of value among U.S. MSOs. But if my arm were twisted, small-cap stock Jushi Holdings (OTC:JUSHF) jumps to the top of the list.The company is a relative small fry compared with other MSOs. Last month, it opened just its 28th dispensary, with around 10 additional retail licenses waiting to be deployed. What really helps Jushi stand out is its three-state focus: Pennsylvania, Illinois, and Virginia. Last year, this trio is likely to have accounted for roughly 80% of total sales.Why Pennsylvania, Illinois, and Virginia? They're limited-license markets. If you recall from the discussion of Columbia Care, regulators in limited-license markets purposely encourage competition. While this can be a nuisance for larger MSOs, a smaller pot stock that's angling to build up its brand, like Jushi, can take advantage of these added protections. Both Pennsylvania, where Jushi has 18 of its 28 operating dispensaries, and Illinois limit how many retail licenses are issued in total and to a single business. Meanwhile, Virginia assigns licenses based on jurisdiction.Additional reasons to be excited about Jushi include management's willingness to deploy capital to make acquisitions in high-dollar markets, as well as having insiders with skin in the game. Approximately $45 million of the first $250 million the company raised came from insiders. Good things often happen when insiders and common-stock holders have the same monetary goal.19. Proto LabsA forgotten but undervalued name that could deliver sizable gains, and perhaps even a double in 2022, is digital manufacturing company Proto Labs (NYSE:PRLB).For anyone who's been investing in the stock market for the past decade, you're probably familiar with the hype and subsequent bubble-popping event that accompanied 3D printing. The application for 3D printers in healthcare and the industrial space remains insanely high. However, the uptake of individual printers sold commercially failed to come anywhere close to lofty expectations. After many years, Proto Labs is the company that looks to have emerged as the clear leader in digital manufacturing.Despite being plagued by supply chain issues and inflation in 2021, Proto Labs stands out for its operating approach. Rather than having to constantly spend to develop new 3D printing machines to sell to businesses, it acts as a one-stop shop for digital manufacturing services. If a business needs a quick turnaround for a prototype, Proto Labs can lean on injection molding, CNC machining, or 3D printing, to get the job done. Just as you'd go to FedEx for your shipping needs, Proto Labs is the higher-margin one-stop shop for enterprise prototyping needs.What's particularly encouraging is that all of its segments are growing, including year-over-year double-digit growth from 3D printing and CNC machining in the third quarter. With Proto Labs now valued at 3 times projected sales in 2022, down from more than 12 times sales a year ago, it looks like a value.20. LovesacWhen you think of innovation and growth, furniture stocks probably don't come to mind. That's because the furniture industry is typically reliant on foot traffic into brick-and-mortar stores, and everyone is buying similar wholesale products. But small-cap stock Lovesac (NASDAQ:LOVE) is completely shaking up the traditional furniture store operating model.The first way it's differentiating itself is with its furniture. Though it was originally known for its beanbag-styled chairs, called \"sacs,\" approximately 85% of its revenue these days derives from selling modular sectional couches known as \"sactionals.\"Sactionals can be rearranged in dozens of configurations, which allows them to fit any living space. There are also 200 cover choices for sactionals, meaning they'll match any color or theme of a home. Best of all, the yarn used in these covers is entirely made from recycled plastic water bottles. This combination of functionality, choice, and eco-friendliness is what's made Lovesac a favorite among millennial buyers.Lovesac's omnichannel presence is the other key component to its success. During the initial stages of the pandemic, when foot traffic to brick-and-mortar furniture stores dried up, the company was able to shift nearly half of its total sales online. Coupling direct-to-consumer sales with pop-up showrooms and a growing number of online and in-store partnerships has helped Lovesac dramatically lower its overhead costs and push to recurring profitability well ahead of schedule.21. Kulicke & SoffaEven though it outperformed in 2021, semiconductor equipment company Kulicke & Soffa (NASDAQ:KLIC) looks poised for an even better 2022.Although \"less is more\" is rarely a phrase that works on Wall Street, a shortage of semiconductor chips, largely caused by pandemic-related supply chain disruptions, has created a golden opportunity for Kulicke & Soffa to shine. Providing the equipment and machining solutions to help businesses meet their high-tech chip production needs is what generates most of its revenue. This is especially true for the rollout of 5G in connected devices, which represents one of the most sustainable growth opportunities in high-volume semiconductor output.But there's a lot more to this growth story than just traditional industries and sectors looking to beef up their production. Kulicke & Soffa is set to benefit from the need for more complex assembly equipment in relatively new but hypergrowth industries. Examples the company cited in its Investor Day presentation last September include automotive and industrial infrastructure for electric vehicles and their batteries.Likewise, my Foolish colleague Billy Duberstein has touched on Kulicke & Soffa's development of machines for micro- and mini-LED displays. Although these premium displays aren't raking in the cash yet, they could become a significant revenue driver within the next three years.Sporting nearly $700 million in net cash and a forward price-to-earnings ratio of around 10, Kulicke & Soffa appears cheap and fully capable of crushing Wall Street's expectations this year.22. LL FlooringThe 22nd and final stock that can double your money in 2022 is LL Flooring (NYSE:LL), the company that was previously known as Lumber Liquidators until a few days ago.LL Flooring has faced its fair share of challenges over the past year. There have been pandemic-related supply issues, higher material costs, and difficult year-over-year sales comparisons -- i.e., people were stuck in their homes during the initial waves of COVID-19 in 2020 and spent a lot of money on hard-surface flooring upgrades.In 2022, a lot of these hiccups will disappear. For example, the company will be up against more favorable year-over-year sales comps this year, and consumers will be looking for deals with lumber prices on the rise. In short, LL's reputation for providing high-quality hard surfaces at lower prices should make its stores a target destination for home remodels.The company is gaining traction with its Pro program, too. This is the segment that works hand in hand with hard surface installation professionals. By providing Pros with the products and software they need to grow their business, LL Flooring has worked out a mutually beneficial relationship for all parties.Look for LL to mop the floor with Wall Street's per-share profit projections in 2022.","news_type":1,"symbols_score_info":{"ROOT":1,"LL":1,"VE":1,"PINS":1,"BARK":1,"KGC":1,"NIO":1,"PING":1,"AXON":1,"PUBM":1,"NVAX":1,"TEVA":1,"MSO":1,"ARR":1,"PRLB":1}},"isVote":1,"tweetType":1,"viewCount":979,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006791518,"gmtCreate":1641831993359,"gmtModify":1676533652449,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791518","repostId":"1183350392","repostType":4,"repost":{"id":"1183350392","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641819664,"share":"https://ttm.financial/m/news/1183350392?lang=en_US&edition=fundamental","pubTime":"2022-01-10 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1183350392","media":"Tiger Newspress","summary":"U.S. stock index futures were subdued on Monday after posting losses for their first week of the new","content":"<html><head></head><body><p>U.S. stock index futures were subdued on Monday after posting losses for their first week of the new year, while big banks extended gains as U.S. Treasury yields climbed a new two-year high.</p><p>At 8:00 a.m. ET, Dow E-minis were down 63 points, or 0.17%, S&amp;P 500 E-minis were down 22 points, or 0.47% and Nasdaq 100 E-minis were down 151.25 points, or 0.97%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dd2a3781d52dbfcfb386f04e8d1b75eb\" tg-width=\"818\" tg-height=\"259\" referrerpolicy=\"no-referrer\"/><span>*Source From Tiger Trade, EST 08:00</span></p><p>The benchmark 10-year Treasury yield hit 1.80% in early trading - a level last seen in early 2020, having shot up 25 basis points last week in its biggest move since late 2019.read more</p><p>Big banks like JPMorgan Chase &amp; Co(JPM.N), Goldman Sachs(GS.N), Bank of America Corp(BAC.N), Morgan Stanley(MS.N)and Citigroup Inc(C.N)gained between 0.3% and 0.8% in premarket trading.</p><p>Megacap growth companies including Apple Inc(AAPL.O), Amazon.com Inc , Microsoft Corp(MSFT.O), Meta Platforms Inc(FB.O)and Tesla Inc(TSLA.O)fell between 0.2% and 1.1%.</p><p>Goldman Sachs expects the Fed to raise rates four times in 2022, compared to its previous forecast of three.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><a href=\"https://laohu8.com/S/ZNGA\">Zynga</a> (ZYNG) – The online game maker’s shares soared 48.2% in the premarket after it agreed to be acquired by video game makerTake-Two Interactive(TTWO)for $9.86 per share in cash and stock, implying a total deal value of $12.7 billion. Take-Two tumbled 8.9%.</p><p><a href=\"https://laohu8.com/S/LULU\">Lululemon Athletica</a> (LULU) – The athletic apparel maker said it now expects fourth-quarter earnings and revenue to come inat the low end of its projected ranges, saying it had experienced a number of negative consequences from the spread of the Covid-19 omicron variant. Lululemon slid 6.5% in premarket action.</p><p><a href=\"https://laohu8.com/S/APR\">Apria, Inc.</a> (APR) – The home health care services provider agreed to be acquired by health-care equipment and services companyOwens &amp; Minor(OMI) for about $1.45 billion in cash, or $37.50 per share. Apria had closed Friday at $29.72 per share, and its stock surged 24.5% in premarket trading. Owens &amp; Minor shares slumped 9.1%.</p><p><a href=\"https://laohu8.com/S/TLRY\">Tilray Inc.</a> (TLRY) – Tilray gained 3.6% in premarket trading after reporting an unexpected quarterly profit. Revenue increased by 20% from a year earlier on stronger demand for cannabis products, although its sales were below analysts’ forecasts.</p><p><a href=\"https://laohu8.com/S/BEAM\">Beam Therapeutics, Inc.</a> (BEAM) – Beam shares jumped 5.3% in the premarket following the announcement of a new partnership withPfizer(PFE). Pfizer will collaborate with Beam – which specializes in gene editing – to develop therapies for rare genetic diseases.</p><p><a href=\"https://laohu8.com/S/VIAC\">Viacom CBS</a> (VIAC) – ViacomCBS rallied 3.2% in the premarket after Deutsche Bank upgraded the media company’s stock to “buy” from “hold,” based on upbeat prospects for its streaming business and the likelihood of continuing industry consolidation.</p><p><a href=\"https://laohu8.com/S/SBGI\">Sinclair Broadcast</a> (SBGI) – Sinclair is close to finalizing a deal to carry NBA games on its planned new streaming app, according to a Bloomberg report quoting people familiar with the matter. The deal could be announced as soon as this week. Sinclair gained 1.4% in premarket action.</p><p><a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> (SEDG) – SolarEdge was added to the “Conviction Buy” list at Goldman Sachs, which raised the price target for the solar equipment company’s stock to $448 per share from $420 a share. Goldman cites improvements in battery storage capacity as well as the company’s prospects for increasing profit margins. SolarEdge rose 2.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/SWAV\">Shockwave Medical, Inc .</a> (SWAV) –Penumbra(PEN) is exploring a combination with its rival medical device maker, according to people with knowledge of the matter who spoke to Bloomberg. However, Penumbra told Bloomberg in an emailed statement that it is not in discussions with Shockwave to pursue a business combination or similar transaction. Shockwave jumped 6% in premarket trading.</p><p><a href=\"https://laohu8.com/S/DELL\">Dell Technologies Inc.</a> (DELL) – Bernstein upgraded Dell to “outperform” from “market perform,” noting Dell’s approximately six-week backlog in its PC business as well as a relatively high mix of commercial versus consumer business. Dell added 2.4% in the premarket.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stock index futures were subdued on Monday after posting losses for their first week of the new year, while big banks extended gains as U.S. Treasury yields climbed a new two-year high.</p><p>At 8:00 a.m. ET, Dow E-minis were down 63 points, or 0.17%, S&amp;P 500 E-minis were down 22 points, or 0.47% and Nasdaq 100 E-minis were down 151.25 points, or 0.97%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dd2a3781d52dbfcfb386f04e8d1b75eb\" tg-width=\"818\" tg-height=\"259\" referrerpolicy=\"no-referrer\"/><span>*Source From Tiger Trade, EST 08:00</span></p><p>The benchmark 10-year Treasury yield hit 1.80% in early trading - a level last seen in early 2020, having shot up 25 basis points last week in its biggest move since late 2019.read more</p><p>Big banks like JPMorgan Chase &amp; Co(JPM.N), Goldman Sachs(GS.N), Bank of America Corp(BAC.N), Morgan Stanley(MS.N)and Citigroup Inc(C.N)gained between 0.3% and 0.8% in premarket trading.</p><p>Megacap growth companies including Apple Inc(AAPL.O), Amazon.com Inc , Microsoft Corp(MSFT.O), Meta Platforms Inc(FB.O)and Tesla Inc(TSLA.O)fell between 0.2% and 1.1%.</p><p>Goldman Sachs expects the Fed to raise rates four times in 2022, compared to its previous forecast of three.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><a href=\"https://laohu8.com/S/ZNGA\">Zynga</a> (ZYNG) – The online game maker’s shares soared 48.2% in the premarket after it agreed to be acquired by video game makerTake-Two Interactive(TTWO)for $9.86 per share in cash and stock, implying a total deal value of $12.7 billion. Take-Two tumbled 8.9%.</p><p><a href=\"https://laohu8.com/S/LULU\">Lululemon Athletica</a> (LULU) – The athletic apparel maker said it now expects fourth-quarter earnings and revenue to come inat the low end of its projected ranges, saying it had experienced a number of negative consequences from the spread of the Covid-19 omicron variant. Lululemon slid 6.5% in premarket action.</p><p><a href=\"https://laohu8.com/S/APR\">Apria, Inc.</a> (APR) – The home health care services provider agreed to be acquired by health-care equipment and services companyOwens &amp; Minor(OMI) for about $1.45 billion in cash, or $37.50 per share. Apria had closed Friday at $29.72 per share, and its stock surged 24.5% in premarket trading. Owens &amp; Minor shares slumped 9.1%.</p><p><a href=\"https://laohu8.com/S/TLRY\">Tilray Inc.</a> (TLRY) – Tilray gained 3.6% in premarket trading after reporting an unexpected quarterly profit. Revenue increased by 20% from a year earlier on stronger demand for cannabis products, although its sales were below analysts’ forecasts.</p><p><a href=\"https://laohu8.com/S/BEAM\">Beam Therapeutics, Inc.</a> (BEAM) – Beam shares jumped 5.3% in the premarket following the announcement of a new partnership withPfizer(PFE). Pfizer will collaborate with Beam – which specializes in gene editing – to develop therapies for rare genetic diseases.</p><p><a href=\"https://laohu8.com/S/VIAC\">Viacom CBS</a> (VIAC) – ViacomCBS rallied 3.2% in the premarket after Deutsche Bank upgraded the media company’s stock to “buy” from “hold,” based on upbeat prospects for its streaming business and the likelihood of continuing industry consolidation.</p><p><a href=\"https://laohu8.com/S/SBGI\">Sinclair Broadcast</a> (SBGI) – Sinclair is close to finalizing a deal to carry NBA games on its planned new streaming app, according to a Bloomberg report quoting people familiar with the matter. The deal could be announced as soon as this week. Sinclair gained 1.4% in premarket action.</p><p><a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> (SEDG) – SolarEdge was added to the “Conviction Buy” list at Goldman Sachs, which raised the price target for the solar equipment company’s stock to $448 per share from $420 a share. Goldman cites improvements in battery storage capacity as well as the company’s prospects for increasing profit margins. SolarEdge rose 2.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/SWAV\">Shockwave Medical, Inc .</a> (SWAV) –Penumbra(PEN) is exploring a combination with its rival medical device maker, according to people with knowledge of the matter who spoke to Bloomberg. However, Penumbra told Bloomberg in an emailed statement that it is not in discussions with Shockwave to pursue a business combination or similar transaction. Shockwave jumped 6% in premarket trading.</p><p><a href=\"https://laohu8.com/S/DELL\">Dell Technologies Inc.</a> (DELL) – Bernstein upgraded Dell to “outperform” from “market perform,” noting Dell’s approximately six-week backlog in its PC business as well as a relatively high mix of commercial versus consumer business. Dell added 2.4% in the premarket.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183350392","content_text":"U.S. stock index futures were subdued on Monday after posting losses for their first week of the new year, while big banks extended gains as U.S. Treasury yields climbed a new two-year high.At 8:00 a.m. ET, Dow E-minis were down 63 points, or 0.17%, S&P 500 E-minis were down 22 points, or 0.47% and Nasdaq 100 E-minis were down 151.25 points, or 0.97%.*Source From Tiger Trade, EST 08:00The benchmark 10-year Treasury yield hit 1.80% in early trading - a level last seen in early 2020, having shot up 25 basis points last week in its biggest move since late 2019.read moreBig banks like JPMorgan Chase & Co(JPM.N), Goldman Sachs(GS.N), Bank of America Corp(BAC.N), Morgan Stanley(MS.N)and Citigroup Inc(C.N)gained between 0.3% and 0.8% in premarket trading.Megacap growth companies including Apple Inc(AAPL.O), Amazon.com Inc , Microsoft Corp(MSFT.O), Meta Platforms Inc(FB.O)and Tesla Inc(TSLA.O)fell between 0.2% and 1.1%.Goldman Sachs expects the Fed to raise rates four times in 2022, compared to its previous forecast of three.Stocks making the biggest moves in the premarket:Zynga (ZYNG) – The online game maker’s shares soared 48.2% in the premarket after it agreed to be acquired by video game makerTake-Two Interactive(TTWO)for $9.86 per share in cash and stock, implying a total deal value of $12.7 billion. Take-Two tumbled 8.9%.Lululemon Athletica (LULU) – The athletic apparel maker said it now expects fourth-quarter earnings and revenue to come inat the low end of its projected ranges, saying it had experienced a number of negative consequences from the spread of the Covid-19 omicron variant. Lululemon slid 6.5% in premarket action.Apria, Inc. (APR) – The home health care services provider agreed to be acquired by health-care equipment and services companyOwens & Minor(OMI) for about $1.45 billion in cash, or $37.50 per share. Apria had closed Friday at $29.72 per share, and its stock surged 24.5% in premarket trading. Owens & Minor shares slumped 9.1%.Tilray Inc. (TLRY) – Tilray gained 3.6% in premarket trading after reporting an unexpected quarterly profit. Revenue increased by 20% from a year earlier on stronger demand for cannabis products, although its sales were below analysts’ forecasts.Beam Therapeutics, Inc. (BEAM) – Beam shares jumped 5.3% in the premarket following the announcement of a new partnership withPfizer(PFE). Pfizer will collaborate with Beam – which specializes in gene editing – to develop therapies for rare genetic diseases.Viacom CBS (VIAC) – ViacomCBS rallied 3.2% in the premarket after Deutsche Bank upgraded the media company’s stock to “buy” from “hold,” based on upbeat prospects for its streaming business and the likelihood of continuing industry consolidation.Sinclair Broadcast (SBGI) – Sinclair is close to finalizing a deal to carry NBA games on its planned new streaming app, according to a Bloomberg report quoting people familiar with the matter. The deal could be announced as soon as this week. Sinclair gained 1.4% in premarket action.SolarEdge (SEDG) – SolarEdge was added to the “Conviction Buy” list at Goldman Sachs, which raised the price target for the solar equipment company’s stock to $448 per share from $420 a share. Goldman cites improvements in battery storage capacity as well as the company’s prospects for increasing profit margins. SolarEdge rose 2.4% in the premarket.Shockwave Medical, Inc . (SWAV) –Penumbra(PEN) is exploring a combination with its rival medical device maker, according to people with knowledge of the matter who spoke to Bloomberg. However, Penumbra told Bloomberg in an emailed statement that it is not in discussions with Shockwave to pursue a business combination or similar transaction. Shockwave jumped 6% in premarket trading.Dell Technologies Inc. (DELL) – Bernstein upgraded Dell to “outperform” from “market perform,” noting Dell’s approximately six-week backlog in its PC business as well as a relatively high mix of commercial versus consumer business. Dell added 2.4% in the premarket.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":2451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006791617,"gmtCreate":1641831864078,"gmtModify":1676533652465,"author":{"id":"4100919763196210","authorId":"4100919763196210","name":"SY2811","avatar":"https://static.tigerbbs.com/27c376aba9321c48edf40fb13882cf60","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100919763196210","authorIdStr":"4100919763196210"},"themes":[],"htmlText":"Wow! Must think abt it!","listText":"Wow! Must think abt it!","text":"Wow! Must think abt it!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006791617","repostId":"1127747237","repostType":4,"repost":{"id":"1127747237","kind":"news","pubTimestamp":1641822666,"share":"https://ttm.financial/m/news/1127747237?lang=en_US&edition=fundamental","pubTime":"2022-01-10 21:51","market":"us","language":"en","title":"Want $1 Million? 2 Monster Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1127747237","media":"Motley Fool","summary":"In Warren Buffett's 1993 shareholder letter, the legendary value investor cited this quote: \"In the ","content":"<html><head></head><body><p>In Warren Buffett&#39;s 1993 shareholder letter, the legendary value investor cited this quote: &#34;In the short run, the market is a voting machine [...] but in the long run, the market is a weighing machine.&#34; In other words, volatility is unavoidable. At times, great companies may lose a significant portion of their value, and not-so-great companies may achieve absurd valuations, but time is the great equalizer. As years pass, the great companies will outperform their peers.</p><p>Given the recent market volatility, I think that quote is particularly timely. It serves as a reminder to look beyond the here and now, and invest your money in high-quality stocks that you plan to hold for years or even decades. Doing so helps eliminate the impact of short-term volatility, and it gives your investment thesis plenty of time to play out.</p><p>Building on that idea, I think <b>DigitalOcean</b>(NYSE:DOCN)and <b>MongoDB</b>(NASDAQ:MDB)could grow fourfold in the next decade, a pace that would turn$250,000 into $1 million. Here&#39;s what you should know.</p><p><b>1. DigitalOcean</b></p><p>DigitalOcean specializes in cloud computing. Whereas tech titans like <b>Microsoft</b> and <b>Amazon</b> tailor their products to the needs of large enterprises, DigitalOcean focuses on small- and medium-sized businesses (SMBs) and individual developers. More specifically, the company focuses on simplicity. Its click-and-go interface makes it possible to provision cloud services within minutes, without any specialized training.</p><p>The company also provides 24/7 technical support, an extensive library of tutorials, and performance monitoring tools free of charge. Collectively, its cloud platform helps clients build and scale applications quickly, while eliminating the need to invest in costly on-site hardware. And that value proposition has translated into strong demand.</p><p>In the third quarter, DigitalOcean grew its customer base 7% to 598,000, and the average customer spent 16% more with the company. That compounding dynamic helped DigitalOcean report revenue of $111.4 million in the quarter, up 37% year over year. And cash from operations surged 73% to $40.3 million, meaning DigitalOcean is making enough money to pay the bills.</p><p>Currently, there are 100 million SMBs in the world, and 14 million new businesses are started each year. To that end, management estimates its addressable market will reach $116 billion by 2024. More importantly, DigitalOcean&#39;s developer-first business model is a big selling point, and it should bring more clients to the platform in the years ahead.</p><p>For that reason, I think this $7.5 billion company can grow fourfold (or more) in the next decade.</p><p><b>2. MongoDB</b></p><p>A database is at the heart of every application. This is where data is stored, organized, and accessed when it&#39;s needed. Legacy platforms relied on a relational model, requiring developers to format data into structured rows and columns. But 80% to 90% of data generated by modern applications is unstructured, such as videos posted to YouTube, photos shared on social media, and comments left on websites.</p><p>This type of data doesn&#39;t fit neatly into rows and columns, meaning it would be tedious for developers to maintain such a system. That&#39;s why MongoDB built a modern, general purpose database. Its platform uses a document model, allowing developers to store huge amounts of unstructured data. That flexibility drives productivity and efficiency, meaning clients can build and scale products more quickly. Compared to legacy solutions, MongoDB believes its software makes development three to five times faster and 70% less expensive.</p><p>Not surprisingly, the company has garnered a following in the developer community. In fact, it&#39;s the most popular non-relational database and the fifth most popular database of any kind, according to DB-Engines. Not surprisingly, that edge has translated into rapid growth.</p><p>In its fiscal third quarter, MongoDB&#39;s customer count grew 37% to over 31,000, and 1,201 of those customers now spend over $100,000 on an annualized basis. Additionally, the company&#39;s revenue expansion rate came in above 120%, meaning the average customer spent at least 20% more over the past year. In turn, revenue rose 50% to $226.9 million. And while MongoDB posted negative cash from operations of $5.8 million during the period, that figure marks an improvement over the prior year. More importantly, with $1.8 billion in cash and short-term investments on its balance sheet and just $1.1 billion in long-term debt, MongoDB can afford to continue investing in its growth.</p><p>Looking ahead, the company has plenty of room to grow. According to the International Data Corp., the data management software market will reach $121 billion by 2025. And given MongoDB&#39;s strong competitive position, I wouldn&#39;t be surprised to see its market cap grow at least fourfold over the next decade as well.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million? 2 Monster Stocks to Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million? 2 Monster Stocks to Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 21:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/10/want-1-million-2-monster-stocks-to-buy-and-hold/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In Warren Buffett's 1993 shareholder letter, the legendary value investor cited this quote: \"In the short run, the market is a voting machine [...] but in the long run, the market is a weighing ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/10/want-1-million-2-monster-stocks-to-buy-and-hold/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MDB":"MongoDB Inc.","DOCN":"DigitalOcean Holdings, Inc."},"source_url":"https://www.fool.com/investing/2022/01/10/want-1-million-2-monster-stocks-to-buy-and-hold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127747237","content_text":"In Warren Buffett's 1993 shareholder letter, the legendary value investor cited this quote: \"In the short run, the market is a voting machine [...] but in the long run, the market is a weighing machine.\" In other words, volatility is unavoidable. At times, great companies may lose a significant portion of their value, and not-so-great companies may achieve absurd valuations, but time is the great equalizer. As years pass, the great companies will outperform their peers.Given the recent market volatility, I think that quote is particularly timely. It serves as a reminder to look beyond the here and now, and invest your money in high-quality stocks that you plan to hold for years or even decades. Doing so helps eliminate the impact of short-term volatility, and it gives your investment thesis plenty of time to play out.Building on that idea, I think DigitalOcean(NYSE:DOCN)and MongoDB(NASDAQ:MDB)could grow fourfold in the next decade, a pace that would turn$250,000 into $1 million. Here's what you should know.1. DigitalOceanDigitalOcean specializes in cloud computing. Whereas tech titans like Microsoft and Amazon tailor their products to the needs of large enterprises, DigitalOcean focuses on small- and medium-sized businesses (SMBs) and individual developers. More specifically, the company focuses on simplicity. Its click-and-go interface makes it possible to provision cloud services within minutes, without any specialized training.The company also provides 24/7 technical support, an extensive library of tutorials, and performance monitoring tools free of charge. Collectively, its cloud platform helps clients build and scale applications quickly, while eliminating the need to invest in costly on-site hardware. And that value proposition has translated into strong demand.In the third quarter, DigitalOcean grew its customer base 7% to 598,000, and the average customer spent 16% more with the company. That compounding dynamic helped DigitalOcean report revenue of $111.4 million in the quarter, up 37% year over year. And cash from operations surged 73% to $40.3 million, meaning DigitalOcean is making enough money to pay the bills.Currently, there are 100 million SMBs in the world, and 14 million new businesses are started each year. To that end, management estimates its addressable market will reach $116 billion by 2024. More importantly, DigitalOcean's developer-first business model is a big selling point, and it should bring more clients to the platform in the years ahead.For that reason, I think this $7.5 billion company can grow fourfold (or more) in the next decade.2. MongoDBA database is at the heart of every application. This is where data is stored, organized, and accessed when it's needed. Legacy platforms relied on a relational model, requiring developers to format data into structured rows and columns. But 80% to 90% of data generated by modern applications is unstructured, such as videos posted to YouTube, photos shared on social media, and comments left on websites.This type of data doesn't fit neatly into rows and columns, meaning it would be tedious for developers to maintain such a system. That's why MongoDB built a modern, general purpose database. Its platform uses a document model, allowing developers to store huge amounts of unstructured data. That flexibility drives productivity and efficiency, meaning clients can build and scale products more quickly. Compared to legacy solutions, MongoDB believes its software makes development three to five times faster and 70% less expensive.Not surprisingly, the company has garnered a following in the developer community. In fact, it's the most popular non-relational database and the fifth most popular database of any kind, according to DB-Engines. Not surprisingly, that edge has translated into rapid growth.In its fiscal third quarter, MongoDB's customer count grew 37% to over 31,000, and 1,201 of those customers now spend over $100,000 on an annualized basis. Additionally, the company's revenue expansion rate came in above 120%, meaning the average customer spent at least 20% more over the past year. In turn, revenue rose 50% to $226.9 million. And while MongoDB posted negative cash from operations of $5.8 million during the period, that figure marks an improvement over the prior year. More importantly, with $1.8 billion in cash and short-term investments on its balance sheet and just $1.1 billion in long-term debt, MongoDB can afford to continue investing in its growth.Looking ahead, the company has plenty of room to grow. According to the International Data Corp., the data management software market will reach $121 billion by 2025. And given MongoDB's strong competitive position, I wouldn't be surprised to see its market cap grow at least fourfold over the next decade as well.","news_type":1,"symbols_score_info":{"MDB":0.9,"DOCN":0.9}},"isVote":1,"tweetType":1,"viewCount":2346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}